0001437749-20-006294.txt : 20200327 0001437749-20-006294.hdr.sgml : 20200327 20200327133207 ACCESSION NUMBER: 0001437749-20-006294 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200327 DATE AS OF CHANGE: 20200327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTRUSION INC CENTRAL INDEX KEY: 0000736012 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER COMMUNICATIONS EQUIPMENT [3576] IRS NUMBER: 751911917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20191 FILM NUMBER: 20750280 BUSINESS ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 BUSINESS PHONE: 9722346400 MAIL ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 FORMER COMPANY: FORMER CONFORMED NAME: INTRUSION COM INC DATE OF NAME CHANGE: 20000601 FORMER COMPANY: FORMER CONFORMED NAME: ODS NETWORKS INC DATE OF NAME CHANGE: 19970507 FORMER COMPANY: FORMER CONFORMED NAME: OPTICAL DATA SYSTEMS INC DATE OF NAME CHANGE: 19950517 10-K 1 intz20191231_10k.htm FORM 10-K intz20191231_10k.htm
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 10-K

(Mark One)

   

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019

 

OR

     

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

For the transition period from      to      

 

COMMISSION FILE NUMBER 0-20191


Intrusion Inc.

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

75-1911917

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

     

1101 EAST ARAPAHO ROAD, SUITE 200
RICHARDSON, TEXAS

 

75081

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (972) 234-6400

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.01 par value

(Title of class)


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.

Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                                                                                                                                                     

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).         

                                                                                                                                                                                               Yes ☒ No ☐

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

☐ 

 

Smaller reporting company

     

Emerging growth company

         

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of June 28, 2019: $46,588,000.

 

As of February 28, 2020, 13,753,030 shares of the issuer’s Common Stock were outstanding.

 

 

 

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the Registrant’s definitive Proxy Statement filed in connection with the Registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

 

 

INTRUSION INC.

INDEX

 

PART I

   

Item 1.

Business

3

Item 1A.

Risk Factors

7

Item 2.

Properties

15

Item 3.

Legal Proceedings

15

PART II

   

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

16

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 8.

Financial Statements for years ended December 31, 2019 and 2018

F-1

Item 9A.

Controls and Procedures

22

PART III

   

Item 10.

Directors, Executive Officers and Corporate Governance

24

Item 11.

Executive Compensation

24

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

24

Item 13.

Certain Relationships and Related Transactions, and Director Independence

24

Item 14.

Principal Accounting Fees and Services

24

PART IV

   

Item 15.

Exhibits and Financial Statement Schedules

24

Signatures

 

27

 

2

 

PART I

 

 

Item 1.     Description of Business.

 

In addition to the historical information contained herein, the discussion in this Annual Report on Form 10-K contains certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties, such as statements concerning:

 

 

our ability to maintain sufficient cash to operate our business and to meet future liquidity requirements;

 

the uncertain ramifications related to the coronavirus outbreak;

 

our ability to successfully transitions responsibilities from our president, chairman, and co-founder G. Ward Paxton to Michael Paxton;

 

our ability to secure new financing to replace our prior borrowing ability under the note with our former CEO;

 

Anticipated fluctuations in quarterly revenues;

 

a concentration in governmental customers with unique risks attached;

 

competition from companies with greater financial resources;

 

our response to rapid technological shifts in the network security industry and consistently changing laws and regulations concerning consumer privacy and personally identifiable information; and

 

risks related to our common stock as well as the effect of the superior rights and privileges of our various classes of preferred stock over the rights of the holders of our common stock.

 

 

The cautionary statements made in this Form 10-K should be read as being applicable to all related forward-looking statements whenever they appear in this Form 10-K. Our actual results could differ materially from the results discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the section captioned “Risk Factors” in Item 1A of this Form 10-K as well as those cautionary statements and other factors set forth elsewhere herein.

 

General

 

We develop, market and support a family of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products.

 

Our product families include:

 

 

TraceCop™ for entity identification, cybercrime detection and disclosure, and;

 

Savant™ for high speed data mining and analytics, and advanced persistent threat detection.

 

Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

 

We market and distribute our products through a direct sales force to:

 

 

end-users, and

 

value-added resellers.

 

Our end-user customers include:

 

 

U.S. federal government entities,

 

state and local government entities,

 

large and diverse conglomerates,

 

manufacturing entities, and

 

other customers.

 

We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarks of Intrusion Inc.

 

3

 

Government Sales

 

Sales to U.S. government customers accounted for 87.4% of our revenues for the year ended December 31, 2019, compared to 83.9% of our revenue in 2018. We expect to continue to derive a substantial portion of our revenues from sales to governmental entities in the future as we continue to market our entity identification products and data mining products to the government. Sales to the government present risks in addition to those involved in sales to commercial customers that could adversely affect our revenues, including potential disruption due to irregularities in or interruptions to appropriation and spending patterns, delays in approving a federal budget and the government’s reservation of the right to cancel contracts and purchase orders for its convenience.

 

Generally, we make our sales under purchase orders and contracts. Our customers, including government customers, may cancel their orders or contracts with little or no prior notice and without penalty. Although we transact business with various government entities, we believe that the cancellation of any particular order in itself could have a material adverse effect on our financial results. Because we derive and expect to continue to derive a substantial portion of our revenue from sales to government entities, a large number of cancelled or renegotiated government orders or contracts could have a material adverse effect on our financial results. Currently, we are not aware of any proposed cancellation or renegotiation of any of our existing arrangements with government entities. See risk factor, “Government customers involve unique risks, which could adversely impact our revenues,on page 10.

 

Industry Background

 

We develop, market and support a family of entity identification, data mining and advanced persistent threat detection products. Our product families include:

 

 

The TraceCop™ product line, which includes a number of our proprietary supporting tools, allows our customers and in-house cyber analysts to accurately discover and help identify ‘bad actors’ associated with cybercrime.

 

 

The Savant™ product is a ‘purpose-built’, very high-speed network data mining and analytics software package that is easily installed on commercial off the shelf platforms.

 

Our customers use our products as an integral part of protecting their critical infrastructure and data information assets. By quickly detecting, protecting, analyzing and reporting attacks, along with the potential misuse of classified information, we have become a key component to the daily challenges of cyber security for both state and federal governments and large private commercial enterprises.

 

Products

 

TraceCop

 

Our TraceCop product family includes a database of worldwide IP addresses, registrant information and their associations, along with a plurality of related IP information, some dating back nearly two decades. When combined with Intrusion’s multitude of cyber security ‘global threat feeds’, along with our TraceCop family of proprietary supporting tools, this vast and ever expanding capability is used in conjunction with our customer’s data to help identify areas of vulnerability and potential cyber security threats. In addition to its extensive capability, the TraceCop family includes analytical software with a GUI interface to assist the analysts in locating cybercriminals and other potential ‘bad actors’ or network anomalies. We offer our customers a daily, weekly or monthly enrichment service to assist them in the culling of ‘good’ data traffic from potential threats.

 

Intrusion licenses TraceCop to our customers for a yearly fee and offers scheduled updates. Intrusion will either install and update the database at the Intrusion facility or install TraceCop on a customer server onsite. Updates are delivered via secure Internet feed or removable storage devices.

 

Savant

 

Savant is a high speed network data mining and analysis product which organizes the data into networks of relationships and associations. Its patented design exceeds performance expectations and ensures ‘deep dives’ into data-in-motion in order to quickly and accurately detect advanced persistent threats. Savant can operate on networks with data flows of over 20 gigabits per second, and still maintain a 100% inspection rate of all packets.

 

4

 

The Savant solution provides real-time access and insight into a company’s own indisputable and quantifiable network data for more effective, unbiased examination of their flows. Uses of the Savant product include data mining, data loss prevention, advanced persistent threat detection and identification of Internet habits of network users. Savant is a software product which we license to our customers for which we sell data updates. We also offer the option to fully implement a server and re-sell to the customer as a turn-key solution.

 

Third-Party Products

 

We currently resell standard commercially available computers and servers from various vendors which we integrate with our different software products for implementation into our customer networks. We do not consider any of these third party relationships to be material to the Company’s business or results of operations.

 

Customer Services

 

Our product sales may include installation and threat data interpretation.

 

Product Development

 

The network security industry is characterized by rapidly changing technology standards and customer demands all shaped by the current state of the economy. We believe that our future success depends in large part upon the timely enhancement of existing products as well as the development of new technologically advanced products that meet cybersecurity industry needs and perform successfully and efficiently. We are currently marketing TraceCop and Savant products to meet emerging market requirements and are continuously engaged in testing to ensure that our products interoperate with other manufacturers’ products and which comply with industry standards applicable to those products.

 

During 2019 and 2018, our research and development expenditures were approximately $1.3 and $1.2 million, respectively. All of our expenditures for research and development have been expensed as incurred. At December 31, 2019, we had 25 employees engaged in research, product development and engineering. At certain times during the year, research and development labor expense has been shifted to direct labor to support ongoing projects.

 

Manufacturing and Supplies

 

Our internal manufacturing operations consist primarily of software, packaging, testing and quality control of finished units.

The hardware we sell are standard off-the-shelf products.

 

Intellectual Property and Licenses

 

Our success and our ability to compete are dependent, in part, upon our proprietary technology. We principally rely on a combination of contractual rights, trade secrets and copyright laws to establish and protect our proprietary rights in our products. In addition, we have received two patents. We have also entered into non-disclosure agreements with our suppliers, resellers and certain customers to limit access to and disclosure of proprietary information. There can be no assurance that the steps taken by us to protect our intellectual property will be adequate to prevent misappropriation of our technology or that our competitors will not independently develop technologies that are substantially equivalent or superior to our technology.

 

We have entered into software and product license agreements with various suppliers. These license agreements provide us with additional software and hardware components that add value to our security products. These license agreements do not provide proprietary rights that are unique or exclusive to us and are generally available to other parties on the same or similar terms and conditions, subject to payment of applicable license fees and royalties. We do not consider any of the product license, software or supplier agreements to be material to our business, but rather complementary to our business and product offerings.

 

Sales, Marketing and Customers

 

Field Sales Force. Our direct sales organization focuses on major account sales, channel partners including distributors, value added resellers (VARs) and integrators; promotes our products to current and potential customers; and monitors evolving customer requirements. The field sales and technical support force provides training and technical support to our resellers and end users and assists our customers in designing cyber secure data networking solutions. We currently conduct sales and marketing efforts from our principal office in Richardson (Dallas), Texas. In addition, we have sales personnel, sales engineers or sales representatives located in Virginia and California.

 

5

 

Resellers. Resellers such as domestic and international system integrators and VARs sell our products as stand-alone solutions to end users and integrate our products with products sold by other vendors into network security systems that are sold to end users. Our field sales force and technical support organization provide support to these resellers. Our agreements with resellers are non-exclusive, and our resellers generally sell other products that may compete with our products. Resellers may place higher priority on products of other suppliers who are larger and have more name recognition, and there can be no assurance that resellers will continue to sell and support our products.

 

Foreign Sales. Export sales did not account for any revenue in 2019 and 2018. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this report for a geographic breakdown of our revenue in 2019 and 2018.

 

Marketing. We have implemented several methods to market our products, including participation in trade shows and seminars, distribution of sales literature and product specifications and ongoing communication with our resellers and installed base of end-user customers.

 

Customers. Our end-user customers include U.S. federal government, state and local government entities, large and diversified conglomerates and manufacturing entities. Sales to certain customers and groups of customers can be impacted by seasonal capital expenditure approval cycles, and sales to customers within certain geographic regions can be subject to seasonal fluctuations in demand.

 

In 2019, 87.4% of our revenue was derived from a variety of U.S. government entities through direct sales and indirectly through system integrators and resellers. These sales are attributable to ten U.S. Government customers through direct and indirect channels; three exceeded 10% of total revenue individually in 2019. Comparatively, sales to the U.S. Government through direct and indirect channels totaled 83.9% of total revenues for 2018. Those sales were attributable to ten U.S. Government customers through direct and indirect channels; four exceeded 10% of total revenue individually in 2018. A reduction in our sales to U.S. government entities could have a material adverse effect on our business and operating results if not replaced.

 

Backlog. We believe that only a small portion of our order backlog is non-cancelable and that the dollar amount associated with the non-cancelable portion is immaterial. We purchase, or contract for the purchase of, our inventory based upon our forecast of customer demand, and we maintain inventories in advance of receiving firm orders from customers. Commercial orders are generally fulfilled within two days to two weeks following receipt of an order. Certain orders may be scheduled over several months, generally not exceeding one year.

 

Customer Support, Service and Warranty. We service, repair and provide technical support for our products. Our field sales and technical support force works closely with resellers and end-user customers on-site and by telephone to assist with pre- and post-sales support services such as network security design, system installation and technical consulting. By working closely with our customers, our employees increase their understanding of end-user requirements and are then able to provide specific input in our product development process.

 

We warrant all of our products against defects in materials and workmanship for periods ranging from 90 days to 36 months. Before and after expiration of the product warranty period, we offer both on-site and factory-based support, parts replacement and repair services. Extended warranty services are separately invoiced on a time and materials basis or under an annual maintenance contract.

 

Competition

 

The market for network and data protection security solutions is intensely competitive and subject to frequent product introductions with new technologies, improved price and performance characteristics. Industry suppliers compete in areas such as conformity to existing and emerging industry standards, interoperability with networking and other security products, management and security capabilities, performance, price, ease of use, scalability, reliability, flexibility, product features and technical support. The market for identity identification and data mining is more fragmented and thus allows more opportunities for small companies to compete in.

 

There are numerous companies competing in various segments of the data security markets. At this time, we have limited competitors for TraceCop; however, we expect competitors to emerge in the future. These competitors currently perform only a portion of the functions that we are able to perform with TraceCop. Also, we have been continuously collecting the TraceCop data for more than ten years. We believe that none of our current or future competitors have the ability to provide this historical data. In our newest market segment, data mining and advanced persistent threat detection, we compete with several companies including Niksun, NetScout, Fireeye and Palo Alto Networks.

 

6

 

However, some of our competitors have substantially greater financial, technical, sales and marketing resources, better name recognition and a larger customer base than we do. Even if we do introduce advanced products that meet evolving customer requirements in a timely manner, there can be no assurance that our new products will gain market acceptance.

 

Certain companies in the network security industry have expanded their product lines or technologies in recent years as a result of acquisitions. Further, more companies have developed products which conform to existing and emerging industry standards and have sought to compete on the basis of price. We anticipate increased competition from large networking equipment vendors, which are expanding their capabilities in the network security market. In addition, we anticipate increased competition from private “start-up” companies that have developed, or are developing, advanced security products. Increased competition in the security industry could result in significant price competition, reduced profit margins or loss of market share, any of which could have a material adverse effect on our business, operating results and financial condition. There can be no assurance that we will be able to compete successfully in the future with current or new competitors.

 

Employees

 

As of December 31, 2019, we employed a total of 32 full time persons, including 4 in sales, marketing and technical support, 25 in research, product development, analysis and engineering, and 3 in administration and finance.

 

None of our employees are represented by a labor organization, and we are not a party to any collective bargaining agreement. We have not experienced any work stoppages and consider our relations with our employees to be good.

 

Competition in the recruiting of personnel in the networking and data security industry is intense. We believe that our future success will depend in part on our continued ability to hire, motivate and retain qualified management, sales, marketing, and technical personnel. To date, we have not experienced significant difficulties in attracting or retaining qualified employees.

 

Item 1A. Risk Factors

 

In addition to the other information in this Form 10-K, the following factors should be considered in evaluating Intrusion Inc. and our business.

 

We may be unsuccessful in the transition of responsibilities of our co-founder, G. Ward Paxton upon his unexpected passing on October 24, 2019, which may have a material adverse effect on our results of operations.

 

Mr. G. Ward Paxton co-founded the Company in 1983, and he served as President, Chief Executive Officer, Director, and Chairman of the Board for most of his 36 year tenure. He demonstrated dedication and leadership, and provided a unique insight and understanding of the Company’s operations and business strategy for decades. The loss of that leadership and experience may cause the expenditure of Company’s and its management’s time and attention as it works through this transition with the Company’s management, staff, vendors, suppliers and customers, any or all of whom may be apprehensive regarding the loss of Ward’s leadership. We can provide no assurance of the smoothness, the diversion of the Company’s resources, or the successfulness of this transition.

 

The appointment of our current CFO, Mr. Michael L. Paxton, to the positions of Director and Chairman of the Board, as well as his service as Interim President and Interim CEO, may take significant time, attention, and focus from our day to day operations and the Company’s goals and objectives, perhaps in a material way.

 

Mr. Michael Paxton has been an integral part of our management team for many years, and our Board has expressed confidence that he will provide a smooth transition going forward. Until such time that we are able to fill the CEO position,Mr. Paxton will be tasked with continuing his current obligations of our Chief Financial Officer as well as taking on these additional roles and responsibilities. While we believe that Mike’s long tenure with and understanding of the Company’s operations will be an asset to his ability to quickly adapt to these additional duties, we can provide no assurances of such.

 

As of October 24, 2019, we have lost the ability to borrow, up to $2.7 million under an unsecured revolving promissory note (the CEO Note”) from our former CEO, the loss of which may have a material adverse effect on our business, our results of operation, or even our ability to continue as a going concern. We will continue to seek financing alternatives.

 

With the passing of our former CEO, Mr. G. Ward Paxton, the CEO Note terminated, with the result that future borrowings thereunder will no longer be available to the Company. Our ability to draw funds under the CEO Note has been a major strength behind the Company’s liquidity for a number of years, the loss of which is unable to be measured at this time. However, the lack of this financial backstop could, in the future, have a material adverse effect on our business, our results of our operations, our ability to continue as a going concern, or to continue operations at all. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all; however, we can make no such assurances as to the replacement of this borrowing facility.

 

7

 

We may not have sufficient cash to operate our business and may not be able to maintain future liquidity requirements. Additional debt and equity offerings to fund future operations may not be available and, if available, may significantly dilute the value of our currently outstanding common stock.

 

As of December 31, 2019, we had cash and cash equivalents of approximately $3,334,000, up from approximately $1,652,000 as of December 31, 2018. We generated a net income of $4,465,000 for the year ended December 31, 2019, compared to a net income of $2,287,000 for the year ended December 31, 2018. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year 2020, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through March 31, 2021. As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the “Potential Replacement Facility”). Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possible additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

We had a net income of $4.5 million for the year ended December 31, 2019 and have an accumulated deficit of $54.8 million as of December 31, 2019. To continue profitability, we must continue to generate consistent or increased revenue.

 

For the year ended December 31, 2019, we had a net income of $4.5 million and an accumulated deficit of approximately $54.8 million as of December 31, 2019, compared to a net income of $2.3 million and an accumulated deficit of approximately $59.2 million as of December 31, 2018. We need to continue to generate consistent or greater revenue from the sales of our products and services if we are to continue profitability. If we are unable to generate consistent or greater revenue growth, net losses may occur, and we may not be able to generate positive cash flow from operations in the future.

 

We anticipate a decrease in net revenue for the first quarter of fiscal year 2020, which could adversely affect our results of operation, our liquidity position, and result in a decline in the price of our common stock.

 

As of the date of this annual report, the Company anticipates lower net revenue for the quarterly period ending on March 31, 2020. While it is premature to determine whether this is a trend or merely a reflection of our customers’ varying ordering patterns, a decrease in net revenue could result in lower operating results for the quarter or for the fiscal year 2020, have a negative effect on our cash flow and our overall liquidity position, and potentially affect the perception of the Company’s value in the marketplace and result in a decline in the price of our common stock.

 

Further, our expense levels are based, in part, upon our expectations as to future revenues and are largely fixed in the short term. Therefore, we may not be able to timely adjust our expenditures in order to compensate for an unanticipated shortfall in revenue in any given quarter. Any significant shortfall in revenues that were unanticipated by have an immediate and significant effect on our operating results for that quarter and may lead to a reduced market price for our stock.

 

Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of the federal, state, and local governmental entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.

 

            We have a concentration of customers that are federal, state, and local governmental entities.  Such entities will be required to allocate resources and adjust budgets to accommodate potential contingencies related to the effects of the coronavirus and measures required to be put in place to prevent and contain contamination of the virus.  These uncertainties may result in these customers delaying budget expenditures or re-allocating resources that would result in a decrease in orders from these customers.  Any such decrease in orders from these customers could cause a material adverse effect on our operations and financial results.

 

8

 

A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

 

Should we experience periods where it is not prudent for some or all of our employees to be physically present on-site, we may not have the benefit of the time and skills of such employees or we may be required to adjust our current business operations and processes to permit some or all of our employees at any one of our locations to work remotely in order to avoid the potential spread of the virus.  We can offer no assurances that these adjustments would not cause material disruptions to our daily operations, require us to expend our time, energy and resources to make necessary adjustments, and may result in a material adverse effect on our sales, research and development and other critical areas of our business model.

 

Our common stock may experience volatility in trading or loss in value as a result of the effects of the coronavirus on the US and global economies.

 

            Uncertainties surrounding the effects of the coronavirus on the US and global economies has resulted in an increase in volatility and violent drops in the value of publicly traded securities, including the trading in our common stock.  We can offer no assurances that these effects are temporary or that any losses that are incurred as a result of these uncertainties will be regained if and when this crisis has passed.  As a result, the value of our stock remains subject to such volatility and potential loss of market value.

 

We must expend time and resources addressing potential cyber-security risk, and any breach of our information security safeguards could have a material adverse affect on the Company.

 

            The threat of cyber attacks requires additional time and money to be expended in efforts to prevent any breaches of our information security protocols.  However, we can provide no assurances that we can prevent any and all such attempts from being successful, which could result in expenses to address and remediate such breaches as well as potentially losing the confidence of our customers who depend upon our services to prevent and mitigate such attacks on their respective business.  Should a material breach of our information security systems occur, it would likely have a material adverse impact on our business operations, our customer relations, our current and future sales prospects, resulting in a significant loss of revenue.

 

Fluctuations in our quarterly revenues may cause the price of our common stock to decline.

 

Our operating results have varied significantly from quarter to quarter in the past, and we expect our operating results to vary from quarter to quarter in the future due to a variety of factors, many of which are outside of our control. Significant portions of our expenses are not variable in the short term and we cannot reduce them quickly to respond to unexpected decreases in revenues. Therefore, if revenues are below our expectations, this shortfall is likely to adversely and disproportionately affect our operating results. Accordingly, we may not attain positive operating margins in future quarters. Any of these factors could cause our operating results to be below the expectations of securities analysts and investors, which likely would negatively affect the price of our common stock

 

If our products do not achieve market acceptance, our revenue growth may suffer.

 

Our security products, advanced persistent threat detection and entity identification products have been in the marketplace for a shorter period of time and may have longer sales cycles than our previous products. Accordingly, we may not achieve the meaningful revenue growth needed to sustain operations. We can provide no assurances that sales of our newer products will grow or generate sufficient revenues to sustain our business. If we are unable to recognize revenues due to longer sales cycles or other problems, our results of operations will be adversely affected, perhaps materially.

 

We have not yet received broad market acceptance for our products. We cannot assure you that our present or future products will achieve market acceptance on a sustained basis. In order to achieve market acceptance and achieve future revenue growth, we must introduce complementary security products, incorporate new technologies into our existing product lines and design, develop, and successfully commercialize higher performance products in a timely manner. There is no assurance that we will be able to offer new or complementary products that gain market acceptance quickly enough to avoid decreased revenues during current or future product introductions or transitions.

 

9

 

A large percentage of our revenues are received from U.S. government entities, and the loss of any one of these customers could reduce our revenues and materially harm our business and prospects.

 

A large percentage of our revenues result from sales to U.S. government entities. If we were to lose one or more of these key relationships, our revenues could decline and our business and prospects may be materially harmed. We expect that even if we are successful in developing relationships with non-governmental customers, our revenues will continue to be concentrated among government entities. For the years ended December 31, 2017, 2018 and 2019, sales to U.S. government entities collectively accounted for 81.6%, 83.9% and 87.4% of our total net revenues, respectively. The loss of any of these key relationships may send a negative message to other U.S. government entities or non-governmental customers concerning our product offering. There is no assurance that U.S. government entities will be customers of ours in future periods or that we will be able to diversify our customer portfolio to adequately mitigate the risk of loss of any of these customers.

 

Government customers involve unique risks, which could adversely impact our revenues.

 

We expect to continue to derive a substantial portion of our revenues from U.S. government customers in the future. Sales to the government present risks in addition to those involved in sales to commercial customers, including potential disruption due to appropriation and spending patterns, delays in approving a federal budget and the government’s right to cancel contracts and purchase orders for its convenience. General political and economic conditions, which we cannot accurately predict, directly and indirectly may affect the quantity and allocation of expenditures by federal departments. In addition, obtaining government contracts may involve long purchase and payment cycles, competitive bidding, qualification requirements, delays or changes in funding, budgetary constraints, political agendas, extensive specification development and price negotiations and milestone requirements. Each government entity also maintains its own rules and regulations with which we must comply, which can vary significantly among departments. As a result, cutbacks or re-allocations in the federal budget or losses of government sales due to other factors could have a material adverse effect on our revenues and operating results.

 

We are highly dependent on sales made through indirect channels, the loss of which would materially adversely affect our operations.

 

For the years ended December 31, 2017, 2018 and 2019, we derived 64.5%, 70.3% and 70.3% of our revenues from sales through indirect sales channels, such as distributors, value-added resellers, system integrators, original equipment manufacturers and managed service providers. We must expand our sales through these indirect channels in order to increase our revenues. We cannot assure you that our products will gain market acceptance in these indirect sales channels or that sales through these indirect sales channels will increase our revenues. Further, many of our competitors are also trying to sell their products through these indirect sales channels, which could result in lower prices and reduced profit margins for sales of our products.

 

The payment of dividends on our preferred stock may strain our cash resources.

 

On March 25, 2004, we completed a $5,000,000 private placement pursuant to which we issued 1,000,000 shares of our 5% Convertible Preferred Stock (the “Series 1 Preferred Stock”) and warrants to acquire 556,619 shares of our common stock. The conversion price for the Series 1 Preferred Stock is $3.144 per share. As of February 28, 2020, there were 200,000 shares of the Series 1 Preferred Stock outstanding, representing approximately 318,065 shares of common stock upon conversion.

 

On March 28, 2005, we completed a $2,663,000 private placement pursuant to which we issued 1,065,200 shares of our Series 2 5% Convertible Preferred Stock (the “Series 2 Preferred Stock”) and warrants to acquire 532,600 shares of our common stock. The conversion price for the Series 2 Preferred Stock is $2.50 per share. As of February 28, 2020, there were 420,000 shares of the Series 2 Preferred Stock outstanding, representing 420,000 shares of common stock upon conversion.

 

On December 2, 2005, we completed a $1,230,843 private placement pursuant to which we issued 564,607 shares of our Series 3 5% preferred stock (the “Series 3 Preferred Stock”) and warrants to acquire 282,306 shares of our common stock. The conversion price for the Series 3 Preferred Stock is $2.18 per share. As of February 28, 2020, there were 266,184 shares of Series 3 Preferred Stock outstanding, representing 266,184 shares of common stock upon conversion.

 

During the year ended December 31, 2019, we accrued $50,000 in dividends to the holders of our 5% Preferred Stock, $57,000 in dividends to the holders of our Series 2 5% Preferred Stock and $32,000 in dividends to the holders of our Series 3 5% Preferred Stock. Further, these dividends will continue owing to these preferred stockholders in the future. The ability to make payment of these accrued dividends are conditioned upon the financial condition of the Company and if, and when, we are able to effect such payments may strain our cash resources at the time, perhaps materially.

 

10

 

If we are unable to pay scheduled dividends on shares of our preferred stock it could potentially result in additional consequences, some of them material.

 

As of December 31, 2019 and 2018, we had $20,000 and $594,000, respectively, in accrued and unpaid dividends included in other current liabilities. Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. In the past we have become delinquent in our dividend payments that became past due because we did not have a capital surplus or fiscal year net profits. However, in light of our net profits for the fiscal years ended December 31, 2018 and 2019, we were able to pay past due and current dividends as of the date of this Annual Report. However, dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them, and we cannot assure you that our net assets will exceed our stated capital or that we will have sufficient net profits in order to pay these dividends as they continue to accrue in the future. If we are unable to pay dividends on our preferred stock, we are required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of any failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation.

 

You will experience substantial dilution upon the conversion or redemption of the shares of preferred stock or in the event we raise additional funds through the issuance of new shares of our common stock or securities convertible or exercisable into shares of common stock.

 

On February 28, 2020, we had 13,753,030 shares of common stock outstanding. Upon conversion of all outstanding shares of preferred stock, we would have 14,757,279 shares of common stock outstanding, approximately an 7.3% increase in the number of shares of our common stock outstanding.

 

In addition, management may issue additional shares of common stock or securities exercisable or convertible into shares of common stock in order to finance our continuing operations. Any future issuances of such securities would have additional dilutive effects on the existing holders of our Common Stock.

 

Further, the occurrence of certain events could entitle holders of our Series 2 Preferred Stock and Series 3 Preferred Stock to require us to redeem their shares for a certain number of shares of our common stock. Assuming (i) we have paid all liquidated damages and other amounts to the holders, (ii) paid all outstanding dividends, (iii) a volume weighted average price of $5.13, which was the ten-day volume weighted average closing price of our common stock on February 28, 2020, and (iv) our 13,753,030 shares of common stock outstanding on February 28, 2020, upon exercise of their redemption right by the holders of the Series 3 Preferred Stock and the Series 2 Preferred Stock, we would be obligated to issue approximately 556,000 shares of our common stock. This would represent an increase of approximately 4.0% in the number of shares of our common stock as of February 28, 2020.

 

The conversion of preferred stock we issued in the private placements may cause the price of our common stock to decline.

 

The holders of the shares of our 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of February 28, 2020, 800,000 shares of our 5% Preferred Stock had converted into 1,272,263 shares of common stock.

 

The holders of the shares of Series 2 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of February 28, 2020, 645,200 shares of Series 2 Preferred Stock had converted into 645,200 shares of common stock.

 

The holders of the shares of Series 3 5% Preferred Stock may freely convert their shares of Series 3 Preferred Stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of February 28, 2020, 298,423 shares of Series 3 Preferred Stock had converted into 298,423 shares of common stock.

 

For the four weeks ended on February 28, 2020, the average daily trading volume of our common stock on the OTCQB was 23,020 shares. Consequently, if holders of preferred stock elect to convert their remaining shares and sell a material amount of their underlying shares of common stock on the open market, the increase in selling activity could cause a decline in the market price of our common stock. Furthermore, these sales, or the potential for these sales, could encourage short sales, causing additional downward pressure on the market price of our common stock.

 

Certain rights of the holders of our preferred stock may hinder our ability to raise additional financing.

 

Under the terms of our preferred stock instruments, we cannot issue shares of capital stock with rights senior to those of our existing 5% Preferred Stock, Series 2 5% Preferred Stock or Series 3 5% Preferred Stock without the approval of at least a majority of the holders of our 5% Preferred Stock, all of the holders of our Series 2 5% Preferred Stock, and holders of at least 75% of our Series 3 5% Preferred Stock voting or acting as separate classes. We also cannot incur certain indebtedness without the approval of at least a majority of the holders of each class of our Preferred Stock. These restrictions could prevent us from obtaining additional financing that would require the issuance of equity with superior rights, even is such financing would benefit the Company, strengthen its financial position, and improve our results of operation.

 

11

 

You will experience substantial dilution upon the exercise of certain stock options currently outstanding.

 

On February 28, 2020, we had 13,753,030 shares of common stock outstanding. Upon the exercising of current options issued at or below the exercise price of $2.00, we will have approximately 14,647,000 shares of common stock outstanding, a 6.5% increase in the number of shares of our common stock outstanding.

 

We resemble a developmental stage company and our business strategy may not be successful.

 

We depend exclusively on revenues generated from the sale of our network security/advanced persistent threat detection products (Savant), which have received limited market acceptance, and our entity identification, data mining and analytic product (TraceCop). We can provide no assurances that our products will ever achieve widespread market acceptance or that an adequate market for these products will ever emerge. Consequently, we resemble a developmental stage company and will face the following inherent risks and uncertainties:

 

 

the need for our entity identification, data mining and advanced persistent threat detection products to achieve market acceptance and produce a sustainable revenue stream;

 

 

our ability to manage costs and expenses;

 

 

our dependence on key personnel;

 

 

our ability to obtain financing on acceptable terms; and

 

 

our ability to offer greater value than our competitors.

 

Our business strategy may not successfully address these risks. If we fail to recognize significant revenues from the sales of our entity identification, data mining and advanced persistent threat detection products, our business, financial condition and operating results would be materially adversely affected.

 

If we fail to respond to rapid technological changes in the network security industry, we may lose customers or our products may become obsolete.

 

The network security industry is characterized by frequent product introductions, rapidly changing technology and continued evolution of new industry standards. We must also introduce upgrades to our products rapidly in response to customer needs such as new computer viruses or other novel external attacks on computer networks. In addition, the nature of the network security industry requires our products to be compatible and interoperable with numerous security products, networking products, workstation and personal computer architectures and computer and network operating systems offered by various vendors, including our competitors. As a result, our success depends upon our ability to develop and introduce in a timely manner new products and enhancements to our existing products that meet changing customer requirements and evolving industry standards. The development of technologically advanced network security products is a complex and uncertain process requiring high levels of innovation, rapid response and accurate anticipation of technological and market trends. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully in a timely manner. Further, we or our competitors may introduce new products or product enhancements that shorten the life cycle of our existing products or cause our existing products to become obsolete.

 

We face intense competition from both start-up and established companies that may have significant advantages over us and our products.

 

The market for our products is intensely competitive. There are numerous companies competing with us in various segments of the data security markets, and their products may have advantages over our products in areas such as conformity to existing and emerging industry standards, interoperability with networking and other security products, management and security capabilities, performance, price, ease of use, scalability, reliability, flexibility, product features, and technical support.

 

Our principal competitors in the data mining and advanced persistent threat market include Niksun, NetScout, Fireeye (Mandiant) and Palo Alto Networks. Our current and potential competitors may have one or more of the following significant advantages over us:

 

 

greater financial, technical and marketing resources;

 

 

better name recognition;

 

 

more comprehensive security solutions;

 

 

better or more extensive cooperative relationships; and

 

 

larger customer base.

 

12

 

We cannot assure you that we will be able to compete successfully with our existing or new competitors. Some of our competitors may have, in relation to us, one or more of the following:

 

 

longer operating histories;

 

 

longer-standing relationships with OEM and end-user customers; and

 

 

greater customer service, public relations and other resources.

 

As a result, these competitors may be able to more quickly develop or adapt to new or emerging technologies and changes in customer requirements, or devote greater resources to the development, promotion and sale of their products. Additionally, it is likely that new competitors or alliances among existing competitors could emerge and rapidly acquire significant market share.

 

Our management and larger stockholders exercise significant control over our Company and have the ability to approve or take actions that may be in conflict to your interests.

 

As of February 28, 2020, our executive officers, directors and preferred stockholders beneficially own approximately 24% of our voting power. In addition, other related parties control approximately 35% of our voting power. As a result, these stockholders will be able to exercise significant control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could delay or prevent someone from acquiring or merging with us. These stockholders may use their influence to approve or take actions that may be adverse to the interests of other holders of our Common Stock.

 

Our products are highly technical and if they contain undetected errors, our business could be adversely affected and we might have to defend lawsuits or pay damages in connection with any alleged or actual failure of our products and services.

 

Our products are highly technical and complex, are critical to the operation of many networks and, in the case of our security products, provide and monitor network security and may protect valuable information. Our products have contained and may contain one or more undetected errors, defects or security vulnerabilities. Some errors in our products may only be discovered after a product has been installed and used by end customers. Any errors or security vulnerabilities discovered in our products after commercial release could result in loss of revenues or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business and results of operations. In addition, we could face claims for product liability, tort, or breach of warranty. Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention. In addition, if our business liability insurance coverage is inadequate or future coverage is unavailable on acceptable terms or at all, our financial condition could be harmed.

 

A breach of network security could harm public perception of our security products, which could cause us to lose revenues.

 

If an actual or perceived breach of network security occurs in the network of a customer of our security products, regardless of whether the breach is attributable to our products, the market perception of the effectiveness of our products could be harmed. This could cause us to lose current and potential end customers or cause us to lose current and potential value-added resellers and distributors. Because the techniques used by computer hackers to access or sabotage networks change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques.

 

If our products do not interoperate with our customers’ networks, installations will be delayed or cancelled and could harm our business.

 

Our products are designed to interface with our customers’ existing networks, each of which have different specifications and utilize multiple protocol standards and products from other vendors. Many of our customers’ networks contain multiple generations of products that have been added over time as these networks have grown and evolved. Our products will be required to interoperate with many or all of the products within these networks as well as future products in order to meet our customers’ requirements. If we find errors in the existing software or defects in the hardware used in our customers’ networks, we may have to modify our software or hardware to fix or overcome these errors so that our products will interoperate and scale with the existing software and hardware, which could be costly and negatively impact our operating results. In addition, if our products do not interoperate with those of our customers’ networks, demand for our products could be adversely affected, orders for our products could be cancelled, or our products could be returned. This could hurt our operating results, damage our reputation and seriously harm our business and prospects.

 

13

 

Our products can have long sales and implementation cycles, which may result in us incurring substantial expenses before realizing any associated revenues.

 

The sale and implementation of our products to large companies and government entities typically involves a lengthy education process and a significant technical evaluation and commitment of capital and other resources. This process is also subject to the risk of delays associated with customers’ internal budgeting and other procedures for approving capital expenditures, deploying new technologies within their networks, and testing and accepting new technologies that affect key operations. As a result, sales and implementation cycles for our products can be lengthy, and we may expend significant time and resources before we receive any revenues from a customer or potential customer. Our quarterly and annual operating results could be materially harmed if orders forecast for a specific customer and for a particular period are not realized.

 

Consolidation in the network security industry may limit market acceptance of our products.

 

Several of our competitors have acquired security companies with complementary technologies in the past. We expect consolidation in the network security industry to continue in the future. These acquisitions may permit our competitors to accelerate the development and commercialization of broader product lines and more comprehensive solutions than we currently offer. Acquisitions of vendors or other companies with which we have a strategic relationship by our competitors may limit our access to commercially significant technologies. Further, business combinations in the network security industry are creating companies with larger market shares, customer bases, sales forces, product offerings and technology and marketing expertise, which may make it more difficult for us to compete.

 

We must adequately protect our intellectual property in order to prevent loss of valuable proprietary information.

 

We rely primarily on a combination of patent, copyright, trademark and trade secret laws, confidentiality procedures, and non-disclosure agreements to protect our proprietary technology. However, unauthorized parties may attempt to copy or reverse-engineer aspects of our products or to obtain and use information that we regard as proprietary. Policing unauthorized use of our products is difficult, and we cannot be certain that the steps we have taken will prevent misappropriation of our intellectual property. This is particularly true in foreign countries whose laws may not protect proprietary rights to the same extent as the laws of the United States and may not provide us with an effective remedy against unauthorized use. If our protection of our intellectual property proves to be inadequate or unenforceable, others may be able to use our proprietary developments without compensation to us, resulting in potential cost advantages to our competitors.

 

We may incur substantial expenses defending ourselves against claims of infringement.

 

There are numerous patents held by many companies relating to the design and manufacture of network security systems. Third parties may claim that our products infringe on their intellectual property rights. Any claim, with or without merit, could consume our management’s time, result in costly litigation, cause delays in sales or implementations of our products or require us to enter into royalty or licensing agreements. Royalty and licensing agreements, if required and available, may be on terms unacceptable to us or detrimental to our business. Moreover, a successful claim of product infringement against us or our failure or inability to license the infringed or similar technology on commercially reasonable terms could seriously harm our business.

 

Our common stock is thinly traded, which may negatively affect your ability to sell our shares on the OTCQB Marketplace (the “OTCQB”) as well as adversely affect the price at which you may be able to sell those shares.

 

For the four weeks ended on February 28, 2020, the average daily trading volume of our common stock on the OTCQB was 23,020 shares. Such thin trading may make it more difficult for you to liquidate your holdings in our common stock or negatively affect the price per share that you are able to realize from such sales.

 

14

 

The price of our common stock has been volatile in the past and may continue to be volatile in the future due to factors outside of our control.

 

The market price of our common stock has been highly volatile in the past and may continue to be volatile in the future. During fiscal year 2019, the market price of our common stock on the OTCQB fluctuated between $2.90 and $5.55 per share and between $0.81 and $3.91 in 2018. The market price of our common stock may fluctuate significantly in the future in response to a number of factors, many of which are outside our control, including:

 

 

variations in our quarterly operating results;

 

 

changes in estimates of our financial performance by securities analysts;

 

 

changes in market valuations of our competitors;

 

 

thinly traded common stock;

 

 

announcements by us or our competitors of new products, significant contracts, acquisitions, strategic relationships, joint ventures or capital commitments;

 

 

product or design flaws, product recalls or similar occurrences;

 

 

additions or departures of key personnel;

 

 

sales of common stock in the future; and

 

 

fluctuations in stock market prices and volume, which are relatively typical for high technology companies.

 

Our acquisition of complementary products or businesses may adversely affect our financial condition.

 

We have made acquisitions in the past and, in the future we may acquire or invest in additional companies, business units, product lines or technologies to accelerate the development of products and sales channels complementary to our existing products and sales channels. Negotiation of potential acquisitions and integration of acquired products, technologies or businesses could divert our management’s time and resources. Future acquisitions could cause us to issue equity securities that would dilute your ownership of us, incur debt or contingent liabilities, amortize intangible assets or write off in-process research and development, goodwill and other acquisition-related expenses that could seriously harm our financial condition and operating results. Further, if we are not able to properly integrate acquired products, technologies or businesses with our existing products and operations, train, retain and motivate personnel from the acquired business or combine potentially different corporate cultures, we may not receive the intended benefits of our acquisitions, which could adversely affect our business, operating results and financial condition.

 

Compliance with export regulations may hinder our sales to foreign customers.

 

Certain of our data security products incorporate encryption and other technology that may require clearance and export licenses from the U.S. Department of Commerce under United States export regulations. Any inability to obtain these clearances or licenses or any foreign regulatory approvals, if required, on a timely basis could delay sales and have a material adverse effect on our operating results.

 

Item 2.     Properties.

 

Our headquarters are located in a two-story building in Richardson, Texas. We occupy approximately 23,000 square feet of floor space in this facility. This facility houses our corporate administration, operations, marketing, research and development, engineering, sales and technical support personnel. The lease for this facility extends through November 2024.

 

Approximately thirty percent of our security software research and development and engineering staff are located in two separate small facilities in San Diego, California. The leases for these facilities are currently set to expire in March 2020 and March 2021. The two San Diego facilities are in the process of closing due to all California employees currently working from home offices.

 

We believe that the existing facilities at December 31, 2019, will be adequate to meet our operational requirements through 2020. We believe that all such facilities are adequately covered by appropriate property insurance. See Note 4 to our Consolidated Financial Statements for additional information regarding our obligations under leases.

 

Item 3.     Legal Proceedings.

 

We are subject to legal proceedings and claims that arise in the ordinary course of business. We do not believe that any claims exist where the outcome of such matters would have a material adverse effect on our consolidated financial position, operating results or cash flows. However, there can be no assurance such legal proceedings will not have a material impact on future results.

 

15

 

PART II

 

Item 5.     Market for Common Equity and Related Stockholder Matters and Business Issuer Purchases of Equity Securities.

 

Our common stock trades on the OTCQB, where it is currently listed under the symbol “INTZ.” As of February 28, 2020, there were approximately 120 registered holders of record of our common stock. Quotations on the OTCQB reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

Shares of our 5% convertible preferred stock accrue cash dividends equal to $0.25 per share per annum, payable in arrears on March 31 and September 30 of each year, and shares of our Series 2 5% and Series 3 5% convertible preferred stock accrue cash dividends equal to $0.125 and $0.109 per share per annum, respectively, payable in arrears on the first business day of March, June, September and December of each year. During the fiscal year ended December 31, 2019, we accrued $50,000 in dividends to the holders of our 5% Preferred Stock, $57,000 in dividends to the holders of our Series 2 5% Preferred Stock and $32,000 in dividends to the holders of our Series 3 5% Preferred Stock. Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year.

 

All stock option plans under which our common stock is reserved for issuance have previously been approved by our stockholders. The following table provides summary information as of December 31, 2019 for all of our equity compensation plans (in thousands, except per share data). See Note 9 to our consolidated financial statements for additional discussion.

 

   

Number of shares of
common stock to be
issued upon exercise
of outstanding
options

   

Weighted average
exercise price of
outstanding options

   

No. of shares of
common stock
remaining available
for future issuance
under equity
compensation plans

 
                         

Equity compensation plans approved by security holders

    975.1  (1)   $ 0.96       449.0  

Equity compensation plans not approved by security holders

                 

Total

    975.1     $ 0.96       449.0  

 


 

(1)

Included in the outstanding options are 824,100 from the 2005 Stock Incentive Plan and 151,000 from the 2015 Stock Option Plan.

 

Item 7.     Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995

 

This Annual Report on Form 10-K, including the sections entitled “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Description of Business,” contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could materially affect actual results, levels of activity, performance or achievements. Factors that may cause actual results to differ materially from current expectations, which we describe in more detail elsewhere in this Annual Report on Form 10-K under the heading “Risk Factors,” include, but are not limited to:

 

 

our ability to maintain sufficient cash to operate our business and to meet future liquidity requirements;

 

our ability to successfully transition responsibilities from our president, chairman, and co-founder G. Ward Paxton to Michael Paxton;

 

our ability to secure new financing to replace our prior borrowing ability under the note with our former CEO and our facility with Silicon Valley Bank, neither of which is available to us moving forward;

 

anticipated fluctuations in quarterly revenues;

 

a concentration in governmental customers with unique risks attached;

 

competition from companies with greater financial resources;

 

our response to rapid technological shifts in the network security industry and consistently changing laws and regulations concerning consumer privacy and personally identifiable information; and

 

risks related to our common stock as well as the effect of the superior rights and privileges of our various classes of preferred stock over the rights of the holders of our common stock.

 

16

 

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. Any forward-looking statement you read in this filing reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

 

Overview

 

We develop, market and support a family of entity identification products, data mining and advanced persistent threat detection products. Our product families include:

 

 

The TraceCop™ product line, including many of our proprietary supporting tools, allows our customers and in-house cyber analysts to accurately discover and help identify ‘bad actors’ associated with cybercrime. The TraceCop product family is built upon an extensive database based on over 20 years of Internet data, Internet understanding and cyber security analytical experience. Along with a multitude of cyber security ‘global threat feeds’, this vast and ever expanding database is used in conjunction with our customer’s data to help identify areas of vulnerability and potential cyber security threats. We offer our customers a daily, weekly or monthly enrichment service to assist them in the culling of ‘good’ data traffic from potential threats.

 

 

The Savant™ product is a ‘purpose-built’, very high-speed network data mining and analytics software package that is easily installed on COTS (commercial off the shelf) platforms. Its patented design exceeds performance expectations and ensures ‘deep dives’ into data-in-motion in order to quickly and accurately detect advanced persistent threats.

 

Our customers’ use our products and services as an integral part of protecting their critical infrastructure and data information assets. By quickly detecting, protecting, analyzing and reporting attacks, along with the potential misuse of classified information, we have become a key component to the daily challenges of cybercrime for both state and federal governments and large private commercial enterprises.

 

Our revenues have been fairly consistent over the past few years due primarily to our focus on our TraceCop and Savant product lines. To date, we have not encountered significant competition in the TraceCop and Savant markets that has caused us to decrease our sales prices when compared to sales prices in previous years. To help keep our operation expenses under control, we held our employee headcount at a reasonable level in 2019 compared to 2018. At December 31, 2018, we employed 31 full time persons and at December 31, 2019, we employed 32 full time persons. Our margins for direct labor only were comparable at 63.0% in 2018, and 61.0% in 2019.

 

In order for us to operate and grow our business, we must generate and sustain sufficient operating profits and cash flow in future periods. This will require us to continue to generate revenues from sales of our entity identification software, data mining and advanced persistent threat products. In order to obtain these sales, our products must gain acceptance in a competitive industry. We believe our ability to market and sell our TraceCop and Savant products into the marketplace in a timely manner and our efforts to effectively control spending levels will help us achieve these results.

 

Critical Accounting Policies and Estimates

 

Management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to product returns, bad debts, inventories, income taxes, warranty obligations, maintenance contracts and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

17

 

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Revenue Recognition

 

We generally recognize product revenue upon shipment. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do not currently offer software on a subscription basis. Warranty costs and sales returns have not been material.

 

We recognize sales of our data sets in accordance with FASB ASC Topic 606 whereby revenue from contracts with customers is not recognized until all five of the following have been met:

 

 

i)

identify the contract with a customer;

 

ii)

identify the performance obligations in the contract;

 

iii)

determine the transaction price;

 

iv)

allocate the transaction price to the separate performance obligations; and

 

v)

recognize revenue upon satisfaction of a performance obligation.

 

Data updates are typically done monthly and revenue will be matched accordingly. Product sales may include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We may defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally one year.

 

Service revenue, primarily including maintenance, training and installation, are recognized upon delivery of the service and typically are unrelated to product sales. To date, maintenance, training and installation revenue has not been material. Our normal payment terms offered to customers, distributors and resellers are net 30 days domestically and net 45 days internationally. We do not offer payment terms that extend beyond one year and rarely do we extend payment terms beyond our normal terms. If certain customers do not meet our credit standards, we do require payment in advance to limit our credit exposure.

 

Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue.

 

Allowances for Doubtful Accounts

 

We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Our receivables are uncollaterized, and we expect to continue this policy in the future. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, increased allowances may be required. Historically, our estimates for sales returns and doubtful accounts have not differed materially from actual results.

 

Fair Value of Financial Instruments

 

We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loan payable to officer is with a related party and as a result does not bear market rates of interest. Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.

 

18

 

Results of Operations

 

The following tables set forth, for the periods indicated, certain financial data as a percentage of net revenue.

 

   

Year Ended December 31,

 
   

2019

   

2018

 
                 

Net product revenue

    100.0

%

    100.0

%

                 

Total cost of revenue

    39.2       37.4  
                 

Gross profit

    60.8       62.6  

Operating expenses:

               

Sales and marketing

    9.5       15.6  

Research and development

    9.6       12.1  

General and administrative

    8.7       10.8  

Operating income

    33.0       24.1  

Interest expense

    (0.3

)

    (1.8

)

Interest income

           

Income from operations before income taxes

    32.7       22.3  

Income tax provision

           

Net income

    32.7       22.3  

Preferred stock dividends accrued

    (1.0

)

    (1.4

)

Net income attributable to common stockholders

    31.7

%

    20.9

%

 

 

 

2019 compared with 2018

 

Net Revenue

 

Total revenue increased 32.8% to $13.6 million in 2019 from $10.3 million in 2018. The increase in revenue was related to growth in our TraceCop product line. We expect our product revenues to increase in the future if we are able to increase sales to existing customers and add new customers.

 

There were no export sales in 2019 and 2018 primarily due to our focus on domestic revenue sales. Sales of our products internationally may be subject to currency exchange risk, which may cause our products to effectively increase in price, if the exchange rate moves significantly and the dollar gains value over the foreign currency.

 

Historically, due to the timing of our sales cycle, a significant portion of our monthly sales occurs in the second half of the month. Accordingly, our receivables increase at the end of each month, which causes a higher accounts receivable balance at month end. This monthly trend also causes an inflated comparative relationship between revenue and accounts receivable. We believe that this monthly trend will continue because monthly sales forecast and planning meetings are held in the first week of every month, the middle of the month is focused on sales calls to customers and the latter half of the month on closing sales.

 

Gross Profit

 

Gross profit increased 29.1% to $8.3 million in 2019 from $6.4 million in 2018. As a percentage of net revenue, gross profit decreased from 62.6% in 2018 to 60.8% in 2019. Gross profit as a percentage of revenue, decreased in 2019 compared to 2018 because of higher labor costs related to certain projects.

 

Gross profit as a percentage of net revenue is impacted by several factors, including shifts in product mix, changes in channels of distribution, sales volume, fluctuations in manufacturing costs, labor costs, pricing strategies, and fluctuations in sales of integrated third-party products.

 

Sales and Marketing

 

Sales and marketing expenses decreased to $1.3 million or 9.5% of net revenue in 2019, compared to $1.6 million or 15.6% of net revenue in 2018. The decrease in sales and marketing expense was mainly due to collecting a payment of $200 thousand from a customer related sales and marketing expense that occurred during the year 2018. Sales and marketing expenses may vary in the future. We expect sales and marketing expenses to increase if we are able to increase net revenue levels in 2020. Sales and marketing expense levels may fluctuate due to labor expense shifting to direct labor.

 

19

 

Research and Development

 

Research and development expenses increased to $1.3 million or 9.6% of net revenue in 2019 compared to $1.2 million or 12.1% of net revenue in 2018. The increase in research and development expense was due to less labor expense shifted to direct labor costs. Our research and development costs are expensed in the period in which they are incurred. We expect research and development expenses to increase if we are able to increase net revenue levels in 2020. Research and development expense levels may fluctuate due to labor expense shifting to direct labor.

 

General and Administrative

 

General and administrative expenses remained fairly constant at $1.2 million, or 8.7% of net revenue in 2019 compared to $1.1 million or 10.8% of net revenue in 2018 as a result of continuing efforts to keep spending under control. We expect general and administration expenses to remain fairly constant but increase if we are able to increase net revenue levels in 2020.

 

Interest Expense

 

Interest expense decreased to $46 thousand in 2019, compared to $189 thousand in 2018. Interest expense decreased due to decreased amount of Loan Payable to Officer culminating in our repayment of the balance in May 2019. Interest expense will vary in the future based on our cash flow and borrowing needs.

 

Interest Income

 

Interest income earned on bank deposits was $4 thousand in 2019 compared to none in 2018.

 

Income Taxes

 

Our effective income tax rate was 0% in 2019 and 2018 as valuation allowances have been recorded for the entire amount of the net deferred tax assets due to uncertainty of realization. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (“the Tax Act”) which significantly changed U.S. tax law.  The Tax Act lowered the Company’s statutory federal income tax rate from a maximum of 39% to a rate of 21% effective January 1, 2018.

 

Liquidity and Capital Resources

 

Our principal source of liquidity at December 31, 2019 was $3.3 million of cash and cash equivalents. As of December 31, 2019, we did not hold investments with a stated maturity beyond one year. Working capital at December 31, 2019 was $3.1 million, while at December 31, 2018, it was $0.5 million.

 

Net cash provided by operations for the twelve months ended December 31, 2019, was $4.3 million due primarily to a net income of $4.5 million and the following sources of cash and non-cash items: $232 thousand in noncash lease costs, a $401 thousand decrease in accounts receivable, $125 thousand in depreciation expense, $59 thousand in amortization expense of capital leases and other assets, $47 thousand in stock-based compensation , and $6 thousand in waived penalties on dividends. This was partially offset by a $496 thousand decrease in accounts payable and accrued expenses, a $488 thousand decrease in deferred revenue, and a $61 thousand increase in prepaid expenses and other assets. Net cash provided by operations for the twelve months ended December 31, 2018, was $2.6 million due primarily to a net income of $2.3 million and the following sources of cash and non-cash items: an $598 thousand increase in deferred revenue, a $421 thousand increase in accounts payable and accrued expenses, $68 thousand in depreciation expense, $65 thousand in amortization expense of capital leases and other assets, a $64 thousand write-off of the United Kingdom’s cumulative translation adjustment, $47 thousand in waived penalties on dividends, $20 thousand in stock-based compensation, and a $15 thousand decrease in inventories. This was partially offset by a $1.0 million increase in accounts receivable and a $2 thousand increase in prepaid expenses and other assets. Future fluctuations in accounts receivable, inventory balances and accounts payable will be dependent upon several factors, including quarterly sales, timely collection of accounts receivable, and the accuracy of our forecasts of product demand and component requirements.

 

Net cash used in investing activities in 2019 was $260 thousand for purchases of property and equipment. Net cash used in investing activities in 2018 was $202 thousand for purchases of property and equipment.

 

20

 

Net cash used in financing activities in 2019 was $2.3 million primarily due to payments on the loan by an officer of $1.8 million, $714 thousand payment of dividends on preferred stock, and $58 thousand payments on principal on capital leases. This was directly offset by a provision of cash of $239 thousand from the exercise of stock options. Net cash used in financing activities in 2018 was $0.9 million primarily due to payments on the loan by an officer of $1.2 million with a $66 thousand payment on principal on capital leases. This was directly offset by the following provisions of cash: proceeds from a loan by an officer of $150 thousand and $168 thousand from the exercise of stock options.

 

At December 31, 2019, we had a commitment of $66 thousand for future finance lease liabilites. Operating lease commitments of $1.8 million are detailed in the Contractual Obligations section below. At December 31, 2018, we had a commitment of $128 thousand for future finance lease liabilties, while operating lease commitments were $2.1 million. During 2019, we funded our operations through the use of available cash and cash equivalents.

 

As of December 31, 2019, we had cash and cash equivalents in the amount of approximately $3.3 million, increasing from $1.7 million as of December 31, 2018.

 

On February 8, 2018, the Company entered into an unsecured revolving promissory note to borrow up to $3,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer (the “CEO Note”). Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $3,700,000 at any given time through March 2020.

 

On February 7, 2019, the Company amended the unsecured revolving promissory note to borrow up to $2,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1%. Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,700,000 at any given time through March 2021. We reduced our borrowing under this note to zero as of May 2019.

 

As of October 24, 2019, G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will no longer be available to the Company. Our management will be assessing whether to replace this borrowing base and assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all.

 

As of December 31, 2019, we had cash and cash equivalents of approximately $3,334,000, up from approximately $1,652,000 as of December 31, 2018. We generated a net income of $4,465,000 for the year ended December 31, 2019 compared to a net income of $2,287,000 for the year ended December 31, 2018. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year 2020, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through March 31, 2021. As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing base and assessing what terms may be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the “Potential Replacement Facility”). Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

We may explore the possible acquisitions of businesses, products and technologies that are complementary to our existing business. We are continuing to identify and prioritize additional security technologies, which we may wish to develop, either internally or through the licensing, or acquisition of products from third parties. While we may engage from time to time in discussions with respect to potential acquisitions, there can be no assurances that any such acquisitions will be made or that we will be able to successfully integrate any acquired business. In order to finance such acquisitions and working capital it may be necessary for us to raise additional funds through public or private financings. Any equity or debt financings, if available at all, may be on terms, which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders.

 

Contractual Obligations

 

The following table sets forth certain information concerning the future contractual obligations under our leases at December 31, 2019. We had no other significant contractual obligations at December 31, 2019.

 

21

 

Future minimum lease obligations consisted of the following at December 31, 2019 (in thousands):

 

   

Operating

   

Finance

         

Period ending December 31,

 

ROU Leases

   

ROU Leases

   

Total

 

2020

  $ 362     $ 45     $ 407  

2021

    361       21       382  

2022

    369             369  

2023

    380             380  

2024

    352             352  
    $ 1,824     $ 66     $ 1,890  

Less Interest*

    (225

)

    (2

)

       
    $ 1,599     $ 64          

 

*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2019, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

 

Recent Accounting Pronouncements

 

See Note 2 Consolidated Financial Statements

 

Item 9A.     Controls and Procedures

 

Evaluation of Effectiveness of Disclosure Controls and Procedures

 

The Company’s management, under the supervision and with the participation of the Interim Chief Executive Officer and Chief Financial Officer (Michael L. Paxton currently holds both positions), conducted an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, the Interim Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management, including the Company’s principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Management Report on Internal Control over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

 

The Company’s management, under the supervision and with the participation of the Interim Chief Executive Officer and Chief Financial Officer (Michael L. Paxton currently holds both positions), conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting based on criteria established in 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s evaluation included an assessment of elements such as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and the Company’s overall control environment. Based on its evaluation, management concluded that the Company’s internal control over financial reporting was effective as of the year ended December 31, 2019 to provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles. The Company reviewed the results of management’s assessment with the Audit Committee of the Board of Directors.

 

22

 

This Annual Report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report. This report shall not be deemed to be filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Inherent Limitations on Effectiveness of Controls

 

The Company’s management, including the Interim Chief Executive Officer and Chief Financial Officer (Michael L. Paxton currently holds both positions), does not expect that the Company’s disclosure controls or internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

Changes in Internal Control over Financial Reporting

 

During the quarter ended December 31, 2019, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

23

 

PART III

 

Certain information required by Part III is omitted from this Form 10-K because we will file a definitive Proxy Statement for our 2020 annual meeting of stockholders pursuant to Regulation 14A (the “Proxy Statement”) no later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, and certain information to be included therein is incorporated herein by reference.

 

Item 10.

Directors, Executive Officers and Corporate Governance.

 

The information called for by this item is incorporated herein by reference to the Proxy Statement.

 

Item 11.

Executive Compensation.

 

The information called for by this item is incorporated herein by reference to the Proxy Statement.

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The information called for by this item is incorporated herein by reference to the Proxy Statement.

 

Item 13.

Certain Relationships and Related Transactions, and Director Independence.

 

The information called for by this item is incorporated herein by reference to the Proxy Statement.

 

Item 14.

Principal Accounting Fees and Services.

 

The information called for by this item is incorporated herein by reference to the Proxy Statement.

 

PART IV

 

Item 15.

Exhibits and Financial Statement Schedules.

 

(a)     1.   Consolidated Financial Statements.

 

The following consolidated financial statements of Intrusion Inc. and subsidiaries, are submitted as a separate section of this report (See F-pages):

 

Report of Independent Registered Public Accounting Firm

F-1

Consolidated Balance Sheets at December 31, 2019 and 2018

F-2

Consolidated Statements of Operations for the years ended December 31, 2019 and 2018

F-3

Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the years ended December 31, 2019 and 2018

F-4

Consolidated Statements of Cash Flows for the years ended December 31, 2019 and 2018

F-5

Notes to Consolidated Financial Statements

F-6

 

 

 

Exhibit
Number

 

Description of Exhibit

3.1(3)

 

Restated Certificate of Incorporation of the Registrant

3.2(5)

 

Certificate of Amendment to Certificate of Incorporation of Registrant

3.3(6)

 

Certificate of Designations for the Registrant’s 5% Convertible Preferred Stock

3.4(8)

 

Certificate of Designations of the Registrant’s Series 2 5% Convertible Preferred Stock

3.5(9)

 

Certificate of Designations for the Registrant’s Series 3 5% Convertible Preferred Stock

3.6(2)

 

Bylaws of the Registrant

4.1(7)

 

Specimen Common Stock Certificate

4.2(6)

 

Specimen 5% Convertible Preferred Stock Certificate

4.3(8)

 

Specimen Series 2 5% Convertible Preferred Stock Certificate

4.4(9)

 

Specimen Series 3 5% Convertible Preferred Stock Certificate

10.1(11)

 

Form of Indemnification Agreement

 

24

 

Exhibit
Number

 

Description of Exhibit

10.2(7)

 

Lease Agreement between CalWest Industrial Holdings Texas, L.P. and Intrusion Inc.

10.3(13)

 

Fourth Amendment to Lease, executed on September 27, 2018, by and between Intrusion Inc. and JP-CORPORATE PLACE, LP.

10.4(2)

 

Amended and Restated 401(k) Savings Plan of the Registrant

10.5(4)

 

Intrusion Inc. 401(k) Savings Plan Summary of Material Modifications

10.6(10)

 

Amended 2005 Stock Incentive Plan of the Registrant

10.7(12)

 

2015 Stock Incentive Plan of the Registrant

10.8(13)

 

Form of Notice of Grant of Stock Option

10.9(13)

 

Form of Stock Option Agreement

10.10(13)

 

Form of Notice of Grant of Non-Employee Director Automatic Stock Option (Initial Grant)

10.11(13)

 

Form of Notice of Grant of Non-Employee Director Automatic Stock Option (Annual Grant)

10.12(13)

 

Form of Automatic Stock Option Agreement

21(11)

 

List of Subsidiaries of Registrant

23.1(14)

 

Consent of Whitley Penn LLP, Independent Registered Public Accounting Firm

31.1(14)

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act

31.2(14)

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act

32.1(14)

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2(14)

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS(14)

 

XBRL Instance Document.

101.SCH(14)

 

XBRL Taxonomy Extension Schema Document.

101.CAL(14)

 

XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF(14)

 

XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB(14)

 

XBRL Taxonomy Extension Label Linkbase Document.

101.PRE(14)

 

XBRL Taxonomy Extension Presentation Linkbase Document.

 


(1)

Filed as an Exhibit in the Registrant’s Registration Statement on Form S-1, as amended (File No. 33-6899), which was declared effective on May 21, 1992, by the Securities and Exchange Commission, which Exhibit is incorporated herein by reference.

 

(2)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K, for the fiscal year ended December 31, 2000, which Exhibit is incorporated herein by reference.

 

(3)

Filed as an Exhibit to the Registrant’s Current Report on Form 8-K dated June 15, 2010, which Exhibit is incorporated herein by reference.

 

(4)

Filed as an Exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2002, which Exhibit is incorporated herein by reference.

 

(5)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 (as amended), which Exhibit is incorporated herein by reference.

 

(6)

Filed as an Exhibit to the Registrant’s Current Report on Form 8-K dated March 26, 2004 (as amended), which Exhibit is incorporated by reference.

 

(7)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003 (as amended), which Exhibit is incorporated herein by reference.

 

(8)

Filed as an Exhibit to the Registrant’s Current Report on Form 8-K dated March 29, 2005, which Exhibit is incorporated herein by reference

 

(9)

Filed as an Exhibit to the Registrant’s Current Report on Form 8-K dated December 6, 2005, which Exhibit is incorporated herein by reference.

 

25

 

(10)

Filed as an Exhibit to the Registrant’s Current Report on Form 8-K dated June 15, 2005, which Exhibit is incorporated herein by reference.

 

(11)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (as amended), which Exhibit is incorporated herein by reference.

 

(12)

Filed as an Exhibit to the Registrant’s Definitive Proxy Statement on Schedule 14A in connection with the solicitation of proxies for its Annual Meeting of Stockholders held May 14, 2015, which Exhibit is incorporated herein by reference.

 

(13)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (as amended), which Exhibit is incorporated herein by reference.

 

(14)

Filed herewith.

 

26

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: March 27, 2020

INTRUSION INC.

 
 

(Registrant)

 
       
 

By:

/s/ MICHAEL L. PAXTON

 
   

Michael L. Paxton

 
   

Chairman, Interim President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary

 
   

(Principal Executive Officer and Principal Financial Officer)

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

         

/s/ MICHAEL L. PAXTON

 

Chairman, Interim President, Interim Chief Executive Officer,

 

March 27, 2020

Michael L. Paxton

 

Chief Financial Officer, Treasurer, Secretary and Director

   
   

(Principal Executive Officer, Principal Financial and Accounting Officer)

   
         

/s/ T. JOE HEAD

 

Vice Chairman, Vice President

 

March 27, 2020

T. Joe Head

 

and Director

   
         
         

/s/ JAMES F. GERO

 

Director

 

March 27, 2020

James F. Gero

       
         

/s/ DALE BOOTH

 

Director

 

March 27, 2020

Dale Booth

       
         

/s/ DONALD M. JOHNSTON

 

Director

 

March 27, 2020

Donald M. Johnston

       

 

27

 

ANNUAL REPORT ON FORM 10-K

ITEM 8

 

FINANCIAL STATEMENTS

YEARS ENDED DECEMBER 31, 2019 and 2018

INTRUSION INC.

RICHARDSON, TEXAS

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

Board of Directors and Shareholders

Intrusion Inc.

 

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Intrusion Inc. and subsidiaries (the “Company”) as of December 31, 2019 and 2018, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

We have served as the Company's auditor since 2009.

 

/s/ Whitley Penn LLP

Dallas, Texas

March 27, 2020

 

F-1

 

 

INTRUSION INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)

 

   

December 31,

 
   

2019

   

2018

 

Assets

               

Current Assets:

               

Cash and cash equivalents

  $ 3,334     $ 1,652  

Accounts receivable

    1,566       1,967  

Prepaid expenses

    152       91  

Total current assets

    5,052       3,710  

Property and Equipment:

               

Equipment

    1,138       881  

Furniture and fixtures

    43       43  

Leasehold improvements

    63       63  
      1,244       987  

Accumulated depreciation and amortization

    (909

)

    (787

)

      335       200  

Finance leases, right-of-use assets, net

    62       121  

Operating leases, right-of-use assets, net

    1,348        

Other assets

    38       38  

TOTAL ASSETS

  $ 6,835     $ 4,069  
                 

Liabilities and Stockholders’ Equity (Deficit)

               

Current Liabilities:

               

Accounts payable, trade

  $ 252     $ 193  

Accrued expenses

    828       1,403  

Dividends payable

    20       594  

Finance leases liabilities, current portion

    43       58  

Operating leases liabilities, current portion

    284        

Deferred revenue

    516       1,004  

Total current liabilities

    1,943       3,252  
                 

Loan payable to officer

          1,815  

Finance leases liability, noncurrent portion

    21       64  

Operating leases liability, noncurrent portion

    1,315        
                 

Commitments and contingencies

               
                 

Stockholders’ Equity (Deficit):

               

Preferred stock, $0.01 par value:

               

Authorized shares — 5,000

               

Series 1 shares issued and outstanding — 200 Liquidation preference of $1,013 in 2019 and $1,213 in 2018

    707       707  

Series 2 shares issued and outstanding — 460 Liquidation preference of $1,155 in 2019 and $1,385 in 2018

    724       724  

Series 3 shares issued and outstanding — 289 Liquidation preference of $634 in 2019 and $760 in 2018

    412       412  

Common stock, $0.01 par value:

               

Authorized shares — 80,000

               

Issued shares — 13,552 in 2019 and 13,259 in 2018

               

Outstanding shares — 13,542 in 2019 and 13,249 in 2018

    136       133  

Common stock held in treasury, at cost—10 shares

    (362

)

    (362

)

Additional paid-in-capital

    56,759       56,609  

Accumulated deficit

    (54,777

)

    (59,242

)

Accumulated other comprehensive loss

    (43

)

    (43

)

Total stockholders’ equity (deficit)

    3,556       (1,062

)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

  $ 6,835     $ 4,069  

 

See accompanying notes.

 

F-2

 

 

INTRUSION INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

 

   

Year Ended December 31,

 
   

2019

   

2018

 
                 

Net product revenue

  $ 13,643     $ 10,276  

Cost of revenue

    5,342       3,847  

Gross profit

    8,301       6,429  

Operating expenses:

               

Sales and marketing

    1,298       1,604  

Research and development

    1,314       1,237  

General and administrative

    1,182       1,112  

Operating income

    4,507       2,476  

Interest expense

    (46

)

    (189

)

Interest income

    4        

Income from operations before income taxes

    4,465       2,287  

Income tax provision

           

Net income

    4,465       2,287  

Preferred stock dividends accrued

    (139

)

    (139

)

Net income attributable to common stockholders

  $ 4,326     $ 2,148  
                 

Net income per share attributable to common stockholders, basic

  $ 0.32     $ 0.16  

Net income per share attributable to common stockholders, diluted

  $ 0.28     $ 0.14  
                 

Weighted average common shares outstanding:

               

Basic

    13,502       13,049  

Diluted

    15,352       15,063  

 

See accompanying notes.

 

F-3

 

 

INTRUSION INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(In thousands)

 

   

Year Ended December 31,

 
   

2019

   

2018

 

NUMBER OF PREFERRED SHARES—ISSUED AND OUTSTANDING

               

Balance, beginning of year and end of year

    949       949  

PREFERRED STOCK

               

Balance, beginning of year and end of year

  $ 1,843     $ 1,843  

NUMBER OF COMMON SHARES—ISSUED

               

Balance, beginning of year

    13,259       12,808  

Exercise of stock options

    293       451  

Balance, end of year

    13,552       13,259  

COMMON STOCK

               

Balance, beginning of year

  $ 133     $ 128  

Exercise of stock options

    3       5  

Balance, end of year

  $ 136     $ 133  

TREASURY SHARES

               

Balance, beginning of year and end of year

  $ (362

)

  $ (362

)

ADDITIONAL PAID-IN-CAPITAL

               

Balance, beginning of year

  $ 56,609     $ 56,518  

Stock-based compensation

    47       20  

Exercise of stock options

    236       163  

Preferred stock dividends declared, net of waived penalties by shareholders

    (133

)

    (92

)

Balance, end of year

  $ 56,759     $ 56,609  

ACCUMULATED DEFICIT

               

Balance, beginning of year

  $ (59,242

)

  $ (61,529

)

Net income

    4,465       2,287  

Balance, end of year

  $ (54,777

)

  $ (59,242

)

ACCUMULATED OTHER COMPREHENSIVE LOSS

               

Balance, beginning of year

  $ (43

)

  $ (107

)

Extinguishment of U.K. cumulative translation adjustment

          64  

Balance, end of year

  $ (43

)

  $ (43

)

                 

TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)

  $ 3,556     $ (1,062

)

 

See accompanying notes.

 

F-4

 

 

INTRUSION INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

   

Year Ended December 31,

 
   

2019

   

2018

 

Operating Activities:

               

Net income

  $ 4,465     $ 2,287  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    184       133  

Noncash lease costs

    232        

Stock-based compensation

    47       20  

Penalties and waived penalties on dividends

    6       47  

Extinguishment of U.K. cumulative translation adjustment

          64  

Changes in operating assets and liabilities:

               

Accounts receivable

    401       (1,005

)

Inventories

          15  

Prepaid expenses and other assets

    (61

)

    (2

)

Accounts payable and accrued expenses

    (496

)

    421  

Deferred revenue

    (488

)

    598  

Net cash provided by operating activities

    4,290       2,578  
                 

Investing Activities:

               

Purchases of property and equipment

    (260

)

    (202

)

Net cash used in investing activities

    (260

)

    (202

)

                 

Financing Activities:

               

Borrowings on loan from officer

          150  

Payments on loan from officer

    (1,815

)

    (1,200

)

Payments of dividends

    (714

)

     

Principal payments on capital lease equipment

    (58

)

    (66

)

Proceeds from stock options exercised

    239       168  

Net cash used in financing activities

    (2,348

)

    (948

)

Net increase in cash and cash equivalents

    1,682       1,428  

Cash and cash equivalents at beginning of year

    1,652       224  

Cash and cash equivalents at end of year

  $ 3,334     $ 1,652  
                 

SUPPLEMENTAL CASH FLOW INFORMATION:

               

Interest paid on leased assets

  $ 4     $ 3  

Interest paid on loan from officer

  $ 513     $  

Income taxes paid

  $     $  
                 

SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:

               

Preferred stock dividends accrued

  $ 139     $ 139  

Purchase of equipment through capital lease

  $     $ 128  

 

See accompanying notes.

 

F-5

 

INTRUSION INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

1. Description of Business

 

We develop, market, and support a family of entity identification, data mining, regulated information compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

 

We market and distribute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.

 

References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Compliance Commander™ and TraceCop™ are registered trademarks of Intrusion Inc.

 

As of December 31, 2019, we had cash and cash equivalents of approximately $3,334,000, up from approximately $1,652,000 as of December 31, 2018. We generated a net income of $4,465,000 for the year ended December 31, 2019 compared to a net income of $2,287,000 for the year ended December 31, 2018. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year 2020, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through March 31, 2021. As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing base and assessing what terms may be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the “Potential Replacement Facility”). Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

 

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.

 

Cash and Cash Equivalents

 

Cash and all highly liquid investments purchased with an original maturity of less than three months are considered to be cash and cash equivalents.

 

Risk Concentration

 

Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with two major U.S. financial institutions. We do not believe that we are subject to any unusual financial risk with our banking arrangements. We have not experienced any significant losses on our cash and cash equivalents.

 

We sell our products to customers primarily in the United States. In the future, we may sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. We perform ongoing credit evaluations of our customers’ financial condition and generally require no collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.

 

F-6

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Trade accounts receivable are stated at the amount we expect to collect. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Management considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. If the financial condition of our customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required. Based on management’s assessment, we provide for estimated uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after we have used reasonable collection efforts are written off through a charge to the valuation allowance. There was no allowance at December 31, 2019 and 2018.

 

Property and Equipment

 

Equipment and furniture and fixtures are stated at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives vary from 1 to 5 years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from 2 to 5 years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs are expensed as incurred. Depreciation and amortization expense totaled approximately $184,000 and $133,000 for the years ended December 31, 2019 and 2018, respectively.

 

Long-Lived Assets

 

We review long-lived assets, including property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are written down to fair value. During the years ended December 31, 2019 and 2018, there was no impairment of long-lived assets.

 

Foreign Currency

 

All assets and liabilities in the balance sheets of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation gains and losses are not included in determining net income but are shown in accumulated other comprehensive loss in the stockholders’ deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss and were not significant.

 

Accounting for Stock Options

 

We account for stock options using the guidance in Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 718. FASB ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.

 

Stock-based compensation expense recognized in the statements of operations for the years ended 2019 and 2018 is based on awards ultimately expected to vest, reduced by estimated forfeitures. FASB ASC Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

Valuation Assumptions

 

The fair values of option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended December 31, 2019 and 2018, respectively:

 

   

2019

   

2018

 
                 

Weighted average grant date fair value

  $ 3.69     $ 0.49  

Weighted average assumptions used:

               

Expected dividend yield

    0.00

%

    0.00

%

Risk-free interest rate

    2.00

%

    0.83

%

Expected volatility

    124.58

%

    225.21

%

Expected life (in years)

    5.00       4.91  

 

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award.

 

F-7

 

Net Loss Per Share

 

We report two separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted average number of common shares and dilutive common stock equivalents outstanding for the year. Our common stock equivalents include all common stock issuable upon conversion of convertible preferred stock and the exercise of outstanding options. Common stock equivalents are included in the diluted loss per share for the years ended December 31, 2019 and 2018 except in cases where the issuance would be anti-dilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the year ended December 31, 2019 and 2018 totaled 30,630 and zero, respectively.

 

Revenue Recognition

 

On January 1, 2018 we adopted ASU No. 2014-09, Revenue from Contracts with Customers, as amended, using the modified retrospective approach. At the date of adoption there was no impact on the balance sheet or statement of operation. ASU No. 2014-09 did not have a material effect on the Company’s financial position, results of operations or cash flows for the year ended December 31, 2019.

 

We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do not currently offer software on a subscription basis. Warranty costs and sales returns have not been material.

 

We recognize sales of our data sets in accordance with FASB ASC Topic 606 whereby revenue from contracts with customers is not recognized until all five of the following have been met:

 

 

i)

identify the contract with a customer;

 

ii)

identify the performance obligations in the contract;

 

iii)

determine the transaction price;

 

iv)

allocate the transaction price to the separate performance obligations; and

 

v)

recognize revenue upon satisfaction of a performance obligation.

 

Data updates are typically done monthly and revenue will be matched accordingly. Product sales may include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We may defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally one year.

 

Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has not been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.

 

Our normal payment terms offered to customers, distributors and resellers are net 30 days domestically and net 45 days internationally. We do not offer payment terms that extend beyond one year and rarely do we extend payment terms beyond our normal terms. If certain customers do not meet our credit standards, we do require payment in advance to limit our credit exposure.

 

Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

 

Research and Development Costs

 

We incur research and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major enhancements to existing services and products. Research and development costs are comprised primarily of salaries and related benefits expenses, contract labor and prototype and other related expenses.

 

F-8

 

Software development costs are included in research and development and are expensed as incurred. FASB ASC Topic 350 Intangibles—Goodwill and Other requires that software development costs incurred subsequent to reaching technological feasibility be capitalized, if material. If the process of developing a new product or major enhancement does not include a detailed program design, technological feasibility is determined only after completion of a working model. To date, the period between achieving technological feasibility and the general availability of such software has been short, and the software development costs qualifying for capitalization have been insignificant.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but not limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.

 

Fair Value of Financial Instruments

 

We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest.  Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loan payable to officer. None of these instruments are held for trading purposes.

 

Income Taxes

 

Deferred income taxes are determined using the liability method in accordance with FASB ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.

 

FASB ASC 740 creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FASB ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. There are no unrecognized tax benefits to disclose in the notes to the consolidated financial statements.

 

We file income tax returns in the United States federal jurisdiction. At December 31, 2019, tax returns related to fiscal years ended December 31, 2016 through December 31, 2018 remain open to possible examination by the tax authorities. No tax returns are currently under examination by any tax authorities. We did not incur any penalties or interest during the years ended December 31, 2019 and 2018.   On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (“the Tax Act”) which significantly changed U.S. tax law.  The Tax Act lowered the Company’s statutory federal income tax rate from a maximum of 39% to a rate of 21% effective January 1, 2018.

 

Recent Accounting Pronouncements

 

On January 1, 2019 we adopted ASU No. 2016-02, Leases (topic 842). At the date of adoption there was no impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU No. 2016-02 did not have a material effect on the Company’s results of operations or cash flows for the year ended December 31, 2019.

 

F-9

 

 

3. Accrued Expenses (in thousands)

 

   

December 31,

 
   

2019

   

2018

 
                 

Accrued payroll

  $ 193     $ 154  

Accrued vacation

    311       310  

Accrued bonus

    245       170  

Rent payable

          191  

Accrued interest, related party

          479  

Other

    79       99  
    $ 828     $ 1,403  

 

 

 

4. Commitments and Contingencies

 

Right-of-use Asset and Leasing Liabilities

 

Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a three year life and are in various stages of completion. The Richardson operating lease liability has a life of four years and eleven months as of December 31, 2019. The San Marcos operating lease liability has a life of fifteen months as of December 31, 2019. The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of $1,580 thousand and a related lease liability of $1,771 thousand.

 

Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC 842 prospectively and elected the package of transition practical expedients that does not require reassessment of: (1) whether any existing or expired contracts are or contain leases, (2) lease classification and (3) initial direct costs. In addition, the Company has elected other available practical expedients to not separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of 12 months or less.

 

As the implicit rate is not readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.

 

Supplemental cash flow information includes operating cash flows related to operating leases. For the years ended December 31, 2019 and 2018, the Company had approximately $294,000 and $264,000, respectively, in operating cash flows related to operating leases.

 

 

Schedule of Items Appearing on the Statement of Operations:

 

   

Year Ended

 
   

December 30, 2019

   

December 31, 2018

 

Operating expense:

               

Amortization expense – Finance ROU

    59       65  

Lease expense – Operating ROU

    433       316  

Other expense:

               

Interest expense – Finance ROU

    4       5  

 

F-10

 

Future minimum lease obligations consisted of the following at December 31, 2019 (in thousands):

 

   

Operating

   

Finance

         

Period ending December 31,

 

ROU Leases

   

ROU Leases

   

Total

 

2020

  $ 362     $ 45     $ 407  

2021

    361       21       382  

2022

    369             369  

2023

    380             380  

2024

    352             352  
    $ 1,824     $ 66     $ 1,890  

Less Interest*

    (225

)

    (2

)

       
    $ 1,599     $ 64          

 

*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

 

Legal Proceedings

 

We are subject to legal proceedings and claims that arise in the ordinary course of business. We do not believe that the outcome of those matters will have a material adverse effect on our consolidated financial position, operating results or cash flows. However, there can be no assurance such legal proceedings will not have a material impact.

 

We are not aware of any material claims outstanding or pending against Intrusion Inc. at December 31, 2019.

 

 

5. Employee Benefit Plan

 

Employee 401(k) Plan

 

We have a plan known as the Intrusion Inc. 401(k) Savings Plan (the “Plan”) to provide retirement and incidental benefits for our employees. The Plan covers substantially all employees who meet minimum age and service requirements. As allowed under Section 401(k) of the Internal Revenue Code, the Plan provides tax deferred salary deductions for eligible employees.

 

Employees may contribute from 1% to 25% of their annual compensation to the Plan, limited to a maximum amount as set by the Internal Revenue Service. Participants who are over the age of 50 may contribute an additional amount of their salary per year, as defined annually by the Internal Revenue Service. We match employee contributions at the rate of $0.25 per each $1.00 of contribution on the first 4% of compensation. Matching contributions to the Plan were approximately $32,000 and $30,000, respectively, for the years ended December 31, 2019 and 2018.

 

 

6. Borrowings from Officer

 

On February 8, 2018, the Company entered into an unsecured revolving promissory note to borrow up to $3,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer (the “CEO Note”). Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $3,700,000 at any given time through March 2020.

 

On February 7, 2019, the Company amended the unsecured revolving promissory note to borrow up to $2,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1%. Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,700,000 at any given time through March 2021. We reduced our borrowing under this note to zero as of May 2019

 

As of October 24, 2019, G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will no longer be available to the Company. Our management will be assessing whether to replace this borrowing base and assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all.

 

F-11

 

 

7. Income Taxes

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets (liabilities) as of December 31, 2019 and 2018 are as follows (in thousands):

 

   

December 31

 
   

2019

   

2018

 
                 

Net operating loss carryforwards

  $ 18,771     $ 20,720  

Net operating loss carryforwards of foreign subsidiaries

    374       374  

Depreciation expense

    (77

)

    4  

Stock-based compensation expense

    36       28  

Other

    68       78  

Net deferred tax assets

    19,172       21,204  

Valuation allowance for net deferred tax assets

    (19,172

)

    (21,204

)

Net deferred tax assets, net of allowance

  $     $  

 

Deferred tax assets are required to be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Realization of the future benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate taxable income within the near to medium term. Management has considered these factors in determining the valuation allowance for 2019 and 2018.

 

The differences between the provision for income taxes and income taxes computed using the federal statutory rate for the years ended December 31, 2019 and 2018 are as follows (in thousands):

 

   

2019

   

2018

 
                 

Reconciliation of income tax benefit to statutory rate:

               

Income benefit at statutory rate

  $ 938     $ 480  

State income taxes (benefit), net of federal income tax benefit

    1,066       57  

Permanent differences

    10       (91

)

Change in valuation allowance

    (2,030

)

    (450

)

Other

    16       4  
    $     $  

 

At December 31, 2019, we had federal net operating loss carryforwards of approximately $81.7 million for income tax purposes that begin to expire in 2022 and are subject to the ownership change limitations under Internal Revenue Code Section 382.

 

 

8. Stock Options

 

At December 31, 2019, we had two stock-based compensation plans, which are described below. These plans were developed to retain and attract key employees and directors.

 

On March 17, 2005, the Board approved the 2005 Stock Incentive Plan (the “2005 Plan”), which was approved by the stockholders on June 14, 2005. The 2005 Plan provided for the issuance of up to 750,000 shares of common stock upon exercise of options granted pursuant to the 2005 Plan. On May 30, 2007, the stockholders approved an Amendment to the 2005 Plan that increased this amount by 750,000 for a total of 1,500,000 shares of common stock that may be issued upon the exercise of options granted pursuant to the 2005 Plan. On May 29, 2008 and May 21, 2009, the stockholders approved an increase of 500,000 shares, respectively, of common stock that may be issued pursuant to the 2005 Plan for a total of 2,500,000 shares. On May 20, 2010, the stockholders approved an additional increase of 500,000 shares of common stock that may be issued pursuant to the 2005 Plan for a total of 3,000,000 shares. On May 19, 2011, the stockholders approved an additional increase of 400,000 shares of common stock that may be issued pursuant to the 2005 Plan for a total of 3,400,000 shares. Finally, on May 17, 2012, the stockholders approved an additional increase of 300,000 shares of common stock that may be issued pursuant to the 2005 Plan for a total of 3,700,000 shares. At December 31, 2019, 1,563,235 had been exercised and options to purchase a total of 824,100 shares of common stock were outstanding. A total of 3,892,000 options had been granted under the 2005 Plan, of which 1,504,665 have been cancelled. The 2005 Plan expired on June 14, 2015, and no shares remain for grant.

 

On March 19, 2015, the Board approved the 2015 Stock Incentive Plan (the “2015 Plan”), which was approved by the stockholders on May 14, 2015. The 2015 Plan serves as a replacement for the 2005 Plan which expired by its terms on June 14, 2015. The approval of the 2015 Plan had no effect on the 2005 Plan or any options granted pursuant to the plan. All options will continue with their existing terms and will be subject to the 2005 Plan. Further, the Company will not be able to re-issue any option which is cancelled or terminated under the 2005 Plan. The 2015 Plan provided for the issuance of up to 600,000 shares of common stock upon exercise of options granted pursuant to the 2015 Plan.

 

F-12

 

The 2015 Plan consists of three separate equity incentive programs: the Discretionary Option Grant Program; the Stock Issuance Program; and the Automatic Option Grant Program for non-employee Board members. Officers and employees, non-employee Board members and independent contractors are eligible to participate in the Discretionary Option Grant and Stock Issuance Programs. Participation in the Automatic Option Grant Program is limited to non-employee members of the Board. Each non-employee Board member will receive an option grant for 10,000 shares of common stock upon initial election or appointment to the Board, provided that such individual has not previously been employed by the Company in the preceding three (3) months. In addition, on the date of each annual stockholders meeting, each Board member will automatically be granted an option to purchase 8,000 shares of common stock, provided he or she has served as a non-employee Board member for at least three months. At December 31, 2019, no options had been exercised and options to purchase a total of 151,000 shares of common stock were outstanding. A total of 154,000 options had been granted under the 2015 Plan, 3,000 shares have been cancelled, and options for 449,000 shares remained available for future grant. No shares have been issued pursuant to the Stock Issuance Program.

 

Common shares reserved for future issuance, including conversions of preferred stock, outstanding options and options available for future grant under all of the stock option plans totaled 2,491,543 shares at December 31, 2019 as follows, in thousands:

 

(In thousands)

 

Common Shares
Reserved for Future
Issuance

 
         

Preferred Stock

    1,067  

2015 Plan

    600  

2005 Plan

    824  

Total

    2,491  

 

The Compensation Committee of our Board of Directors determines for all employee options, the term of each option, option exercise price within limits set forth in the plans, number of shares for which each option is granted and the rate at which each option is exercisable (generally ratably over one, three or five years from grant date). However, the exercise price of any incentive stock option may not be less than the fair market value of the shares on the date granted (or less than 110% of the fair market value in the case of optionees holding more than 10% of our voting stock of the Company), and the term cannot exceed ten years (five years for incentive stock options granted to holders of more than 10% of our voting stock).

 

Stock Incentive Plan Summary

 

A summary of our stock option activity and related information for the years ended December 31, 2019 and 2018 is as follows:

 

   

2019

   

2018

 
   

Number of
Options (in
thousands)

   

Weighted
Average
Exercise
Price

   

Number of
Options (in
thousands)

   

Weighted
Average
Exercise
Price

 
                                 

Outstanding at beginning of year

    1,235     $ 0.83       1,746     $ 0.68  

Granted at price = market value

    34       4.40       24       1.15  

Granted at price > market value

                       

Exercised

    (294

)

    0.81       (451

)

    0.37  

Forfeited

                       

Expired

                (84

)

    0.22  
                                 

Outstanding at end of year

    975     $ 0.96       1,235     $ 0.83  

Options exercisable at end of year

    917     $ 0.84       1,172     $ 0.84  

 

F-13

 

Stock Options Outstanding and Exercisable

 

Information related to stock options outstanding at December 31, 2019, is summarized below:

 

       

Options Outstanding

   

Options Exercisable

 

Range of Exercise Prices

 

Outstanding at
12/31/1
9 (in
thousands)

   

Weighted
Average
Remaining
Contractual Life (years)

   

Weighted
Average
Exercise
Price

   

Exercisable at
12/31/1
9 (in
thousands)

   

Weighted
Average
Exercise
Price

 
                                             

$ 0.34

- $0.50     391       2.86     $ 0.42       383     $ 0.42  

$ 0.51

- $1.00     330       1.53       0.68       330       0.68  

$ 1.01

- $2.00     173       4.69       1.71       157       1.77  

$ 2.01

- $4.75     81       6.95       3.12       47       2.20  
          975       3.08     $ 0.96       917     $ 0.84  

 

 

Summarized information about outstanding stock options as of December 31, 2019, that are fully vested and those that are expected to vest in the future as well as stock options that are fully vested and currently exercisable, are as follows:

 

   

Outstanding Stock
Options (Fully Vested
and Expected to Vest)*

   

Options that are
Exercisable

 

As of December 31, 2019

               

Number of outstanding options (in thousands)

    970       917  

Weighted average remaining contractual life

    3.04       2.71  

Weighted average exercise price per share

  $ 0.95     $ 0.84  

Intrinsic value (in thousands)

  $ 4,411     $ 4,278  

 

* Includes effects of expected forfeitures

 

As of December 31, 2019, the total unrecognized compensation cost related to non-vested options not yet recognized in the statement of operations totaled approximately $86 thousand (including expected forfeitures) and the weighted average period over which these awards are expected to vest was 1.18 years.

 

 

9. Preferred Stock

 

5% Preferred Stock

 

On March 25, 2004, we completed a $5.0 million private placement of our 5% convertible preferred stock and warrants. In the private placement, we sold 1,000,000 shares of our 5% preferred stock at a price of $5.00 per share for gross proceeds of $5.0 million, less $275,000 of issuance costs. The 5% preferred shares were initially convertible into 1,590,331 shares of common stock at a conversion price of $3.144 per share. Holders of the 5% convertible preferred stock include 140,000 shares purchased by our former CEO and 60,000 shares purchased by a director of the Company.

 

The 5% dividends related to the 5% preferred stock are paid semi-annually on the last business day in March and September of each year, beginning with September 2004. Preferred stockholders vote together with common stockholders on an as converted to common stock basis. Based on the conversion rate of the preferred stock, holders of our 5% preferred stock will receive 1.5903 votes per share rounded to the nearest whole number. The liquidation preference for the 5% preferred stock is an amount equal to $5.00 per share plus any accrued and unpaid dividends. Holders of our 5% preferred stock have liquidation preference rights over common stockholders.

 

All warrants previously issued to 5% convertible preferred stockholders have expired.

 

We have the right to redeem any or all of the outstanding 5% preferred stock at a price of $5.00 per share plus accrued dividends at any time if certain conditions are met.

 

At December 31, 2019, there were 200,000 shares of the Series 1 Preferred Stock outstanding, representing approximately 318,065 shares of common stock upon conversion.

 

F-14

 

Series 2 5% Preferred Stock

 

On March 28, 2005, we completed a $2.7 million private placement of Series 2 5% convertible preferred stock and warrants. In the private placement, we sold 1,065,200 shares of preferred stock at a price of $2.50 per share for gross proceeds of $2.7 million, less $173,000 of issuance costs. The shares of Series 2 5% preferred stock are convertible into 1,065,200 shares of common stock at an initial conversion price of $2.50 per share. Holders of the Series 2 5% preferred stock include 260,000 shares by our former CEO, 100,000 shares by our CFO and 60,000 shares by a director of the Company.

 

The 5% dividends accruing on the Series 2 5% preferred stock are required to be paid quarterly on the first business day in March, June, September and December of each year, beginning with June 2005. The liquidation preference for the preferred stock is an amount equal to $2.50 per share plus any accrued and unpaid dividends. Holders of our Series 2 5% preferred stock have liquidation preference rights over our 5% preferred stockholders as well as our common stockholders. The holders of the Series 2 5% preferred stock are not entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.

 

All warrants previously issued to Series 2 5% convertible preferred stockholders have expired.

 

Holders of Series 2 5% preferred stock have the right to require us to redeem any or all of the their shares upon the occurrence of certain events within the Company’s control that are defined in Certificate of Designation at a price equal the sum of (1) the greater of $3.25 and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by $2.50 divided by the conversion price then in effect plus (2) any accrued but unpaid dividends on the Series 2 5% preferred stock plus (3) all liquidated damages or other amounts payable to the holders of Series 2 5% preferred stock.

 

At December 31, 2019 there were 460,000 shares of the Series 2 Preferred Stock outstanding, representing 460,000 shares of common stock upon conversion.

 

Series 3 5% Preferred Stock

 

On December 2, 2005, we completed a $1.2 million private placement of Series 3 5% convertible preferred stock and warrants. In the private placement, we sold 564,607 shares of preferred stock at a price of $2.18 per share for gross proceeds of $1.2 million, less $100,000 of issuance costs. The shares of Series 3 5% preferred stock are convertible into 564,607 shares of common stock at an initial conversion price of $2.18 per share. Holders of the Series 3 5% preferred stock include 123,853 shares by our former CEO, 68,808 shares by our CFO and 27,523 shares purchased by a director of the Company.

 

The 5% dividends accruing on the Series 3 5% preferred stock are required to be paid quarterly on the first business day in March, June, September and December of each year, beginning with March 1, 2006. The liquidation preference for the preferred stock is an amount equal to $2.18 per share plus any accrued and unpaid dividends. Holders of our Series 3 5% preferred stock have liquidation preference rights over holders of our 5% preferred, Series 2 5% preferred stock and common stock. The holders of the Series 3 5% preferred stock are not entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.

 

All warrants previously issued to Series 3 5% convertible preferred stockholders have expired.

 

Holders of Series 3 5% preferred stock have the right to require us to redeem any or all of their shares upon the occurrence of certain events within the Company’s control that are defined in the certificate of designation at a price equal the sum of (1) the greater of $2.834 and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by $2.18 divided by the conversion price then in effect plus (2) any accrued but unpaid dividends on the Series 3 5% preferred stock plus (3) all liquidated damages or other amounts payable to the holders of Series 3 5% preferred stock.

 

At December 31, 2019 there were 289,377 shares of Series 3 Preferred Stock outstanding, representing 289,377 shares of common stock upon conversion.

 

Dividends Payable

 

During the year ended December 31, 2019, we accrued $50,000 in dividends to the holders of our 5% Preferred Stock, $57,000 in dividends to the holders of our Series 2 5% Preferred Stock and $32,000 in dividends to the holders of our Series 3 5% Preferred Stock. As of December 31, 2019 and 2018, we had $20,000 and $594,000 in accrued and unpaid dividends included in other current liabilities. Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. This has been in effect since December 31, 2014. However, in light of our net profits for the fiscal year ended December 31, 2019 and 2018, we are able to and have paid these past due dividends as of the date of this Annual Report. However, dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them, and we cannot assure you that our net assets will exceed our stated capital or that we will have sufficient net profits in order to pay these dividends as they continue to accrue in the future. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock.

 

F-15

 

 

10. Concentrations

 

Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 87.4% of total revenues for 2019 and 83.9% of total revenues for 2018. During 2019 approximately 68.1% of total revenues were attributable to three government customers. During 2018 approximately 61.4% of total revenues are attributable to four government customers. Three individual government customers at December 31, 2019 and four at December 31, 2018 exceeded 10% of total accounts receivable balance at respective year ends, comprising 78.8% and 48.9% of the respective total accounts receivable balance. During 2019 approximately 10.4% of total revenues were attributable to one commercial customer, and during 2018, 14.1% of total revenues were attributable to one commercial customer. Only one individual commercial customer at December 31, 2019 exceeded 10% of total accounts receivable balance, and only one at December 31, 2018. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

 

 

11. Contract Assets and Contract Liabilities

 

Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. For the year ended December 31, 2019, the Company had contract assets balance of $1,566,000, a decrease of $401,000 from the prior year due to cash receipts exceeding new contract assets. For the year ended December 31, 2018, the Company had contract assets balance of $1,967,000.

 

Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies deferred revenue as a contract liablility. For the year ended December 31, 2019, the Company had contract liabilities balance of $516,000. For the year ended December 31, 2018, the Company had contract liabilities balance of $1,004,000.

 

 

12. Coronavirus Outbreak in the United States

 

                Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.  The extent of the impact of COVID-19 on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted.  A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

 

F-16

 

EX-23.1 2 ex_178441.htm EXHIBIT 23.1 ex_178441.htm

EXHIBIT 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement Nos. 333-125816,
333-167577 and 333-224810 on Form S-8 of our report dated March 27, 2020, with respect to the consolidated financial statements of Intrusion Inc. and subsidiaries included in this Annual Report on Form 10-K for the year ended December 31, 2019.

 

/s/Whitley Penn LLP

 

Dallas, Texas

March 27, 2020

 

 

 

EX-31.1 3 ex_178445.htm EXHIBIT 31.1

EXHIBIT 31.1

 

I, Michael L. Paxton, Interim Chief Executive Officer of Intrusion Inc., certify that:

 

 

(1)

I have reviewed this annual report on Form 10-K of Intrusion Inc.:

 

 

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

(4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

(5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: March 27, 2020

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Interim Chief Executive Officer

 

 

EX-31.2 4 ex_178444.htm EXHIBIT 31.2

EXHIBIT 31.2

 

I, Michael L. Paxton, Chief Financial Officer of Intrusion Inc., certify that:

 

 

(1)

I have reviewed this annual report on Form 10-K of Intrusion Inc.:

 

 

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

(4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

(5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: March 27, 2020

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Chief Financial Officer

 

 

EX-32.1 5 ex_178443.htm EXHIBIT 32.1

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Intrusion Inc. (the “Company”) on Form 10-K for the fiscal year ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael L. Paxton, Interim Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

March 27, 2020

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Interim Chief Executive Officer

 

 

EX-32.2 6 ex_178442.htm EXHIBIT 32.2

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Intrusion Inc. (the “Company”) on Form 10-K for the fiscal year ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael L. Paxton, Chief Financial Officer of the Company certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

March 27, 2020

/s/ Michael L. Paxton

 
 

Michael L. Paxton

 

Chief Financial Officer

 

EX-101.INS 7 intz-20191231.xml XBRL INSTANCE DOCUMENT false --12-31 FY 2019 2019-12-31 10-K 0000736012 13753030 Yes false Non-accelerated Filer Yes 46588000 Intrusion Inc false true No No Common Stock, $0.01 par value 1563235 0 0.01 0.25 P50Y 64000 64000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; margin-left: 36pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Finance</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 43%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Period ending December 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2020</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">362</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">407</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2021</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2022</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2023</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2024</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,824</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,890</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Less Interest*</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(225</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,599</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">64</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> </table></div> 1890000 352000 380000 369000 382000 407000 3 3 4 4 1 1 1 1 3 2 2 232000 6000 47000 P30D P45D 3.144 2.50 2.18 275000 173000 100000 0.18 1.5903 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 84%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">(In thousands)</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Common Shares<br /> Reserved for Future<br /> Issuance</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Preferred Stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2015 Plan</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">600</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2005 Plan</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">824</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Total</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,491</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> P3Y P5Y 1.1 8000 1504665 3000 3892000 154000 34000 24000 10000 P90D 0.1 P5Y 4.40 1.15 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div> </div><div style="display: inline; font-weight: bold;">Accrued Expenses</div><div style="display: inline; font-weight: bold;"> (in thousands)</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: auto; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued payroll</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">193</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued vacation</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">310</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued bonus</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">245</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">170</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Rent payable</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued interest, related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">479</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">79</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">99</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">828</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,403</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 252000 193000 1566000 1967000 245000 170000 828000 1403000 191000 193000 154000 311000 310000 909000 787000 -43000 -43000 56759000 56609000 133000 92000 47000 20000 0 0 30630 0 6835000 4069000 5052000 3710000 128000 3334000 1652000 224000 1682000 1428000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Cash and Cash Equivalents</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Cash and all highly liquid investments purchased with an original maturity of less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months are considered to be cash and cash equivalents.</div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div> Commitments and Contingencies</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Right-of-use Asset and Leasing Liabilities</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> year life and are in various stages of completion. The Richardson operating lease liability has a life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eleven</div> months as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019. </div>The San Marcos operating lease liability has a life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifteen</div> months as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019. </div>The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,580</div> thousand and a related lease liability of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,771</div> thousand.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> prospectively and elected the package of transition practical expedients that does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require reassessment of: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) whether any existing or expired contracts are or contain leases, (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) lease classification and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) initial direct costs. In addition, the Company has elected other available practical expedients to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months or less.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As the implicit rate is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Supplemental cash flow information includes operating cash flows related to operating leases. For the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$294,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$264,000,</div> respectively, in operating cash flows related to operating leases.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Schedule of Items Appearing on the S</div><div style="display: inline; font-weight: bold;">tatement of Operations:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 15%; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 30, 2019</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 64%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Operating expense:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Amortization expense &#x2013; Finance ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">65</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Lease expense &#x2013; Operating ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">433</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other expense:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Interest expense &#x2013; Finance ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Future minimum lease obligations consisted of the following at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 (</div>in thousands):</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 20%; margin-left: 36pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Finance</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 43%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Period ending December 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2020</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">362</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">407</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2021</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2022</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">369</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">369</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2023</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2024</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">352</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,824</div></td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66</div></td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,890</div></td> <td style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Less Interest*</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(225</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,599</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">64</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Legal Proceedings</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We are subject to legal proceedings and claims that arise in the ordinary course of business. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that the outcome of those matters will have a material adverse effect on our consolidated financial position, operating results or cash flows. However, there can be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance such legal proceedings will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> aware of any material claims outstanding or pending against Intrusion Inc. at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div></div></div> 2491543 1067000 600000 824000 0.01 0.01 80000000 80000000 13552000 13259000 13542000 13249000 136000 133000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers primarily in the United States. In the future, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company&#x2019;s operating results. We perform ongoing credit evaluations of our customers&#x2019; financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></div><div style="display: inline; font-weight: bold;">. Concentrations</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our operations are concentrated in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> area&#x2014;security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87.4%</div> of total revenues for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83.9%</div> of total revenues for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68.1%</div> of total revenues were attributable to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> government customers. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61.4%</div> of total revenues are attributable to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> government customers. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Three</div> individual government customers at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>exceeded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total accounts receivable balance at respective year ends, comprising <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78.8%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">48.9%</div> of the respective total accounts receivable balance. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.4%</div> of total revenues were attributable to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> commercial customer, and during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.1%</div> of total revenues were attributable to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> commercial customer. Only <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> individual commercial customer at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>exceeded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total accounts receivable balance, and only <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>Our similar product and service offerings are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> viewed as individual segments, as our management analyzes the business as a whole and expenses are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> allocated to each product offering.</div></div> 0.874 0.839 0.681 0.614 0.788 0.489 0.104 0.141 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Principles of Consolidation</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.</div></div></div></div></div></div></div></div></div></div></div> 1566000 1967000 516000 1004000 1590331 318065 1065200 460000 564607 289377 5342000 3847000 0.01 19172000 21204000 18771000 20720000 374000 374000 68000 78000 4000 36000 28000 19172000 21204000 77000 32000 30000 0.04 0.0025 184000 133000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></div><div style="display: inline; font-weight: bold;">. Stock Options</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> we had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> stock-based compensation plans, which are described below. These plans were developed to retain and attract key employees and directors.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> the Board approved the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Stock Incentive Plan (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x201c;2005</div> Plan&#x201d;), which was approved by the stockholders on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005.</div> The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan provided for the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">750,000</div> shares of common stock upon exercise of options granted pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2007,</div> the stockholders approved an Amendment to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan that increased this amount by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">750,000</div> for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,500,000</div> shares of common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued upon the exercise of options granted pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009,</div> the stockholders approved an increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> shares, respectively, of common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500,000</div> shares. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010,</div> the stockholders approved an additional increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> shares of common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000,000</div> shares. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> the stockholders approved an additional increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div> shares of common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,400,000</div> shares. Finally, on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the stockholders approved an additional increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300,000</div> shares of common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be issued pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,700,000</div> shares. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,563,235</div> had been exercised and options to purchase a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">824,100</div>&nbsp;shares of common stock were outstanding. A total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,892,000</div> options had been granted under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,504,665</div> have been cancelled. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan expired on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 14, 2015, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> shares remain for grant.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Board approved the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Stock Incentive Plan (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x201c;2015</div> Plan&#x201d;), which was approved by the stockholders on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan serves as a replacement for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan which expired by its terms on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> The approval of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan or any options granted pursuant to the plan. All options will continue with their existing terms and will be subject to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan. Further, the Company will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be able to re-issue any option which is cancelled or terminated under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan provided for the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">600,000</div> shares of common stock upon exercise of options granted pursuant to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> separate equity incentive programs: the Discretionary Option Grant Program; the Stock Issuance Program; and the Automatic Option Grant Program for non-employee Board members. Officers and employees, non-employee Board members and independent contractors are eligible to participate in the Discretionary Option Grant and Stock Issuance Programs. Participation in the Automatic Option Grant Program is limited to non-employee members of the Board. Each non-employee Board member will receive an option grant for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,000</div> shares of common stock upon initial election or appointment to the Board, provided that such individual has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> previously been employed by the Company in the preceding <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)&nbsp;months. In addition, on the date of each annual stockholders meeting, each Board member will automatically be granted an option to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000</div> shares of common stock, provided he or she has served as a non-employee Board member for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> options had been exercised and options to purchase a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">151,000</div> shares of common stock were outstanding. A total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154,000</div> options had been granted under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> Plan, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div> shares have been cancelled, and options for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">449,000</div>&nbsp;shares remained available for future grant. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> shares have been issued pursuant to the Stock Issuance Program.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Common shares reserved for future issuance, including conversions of preferred stock, outstanding options and options available for future grant under all of the stock option plans totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,491,543</div> shares at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> as follows, in thousands:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 84%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">(In thousands)</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Common Shares<br /> Reserved for Future<br /> Issuance</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Preferred Stock</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,067</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2015 Plan</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">600</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2005 Plan</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">824</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Total</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,491</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The Compensation Committee of our Board of Directors determines for all employee options, the term of each option, option exercise price within limits set forth in the plans, number of shares for which each option is granted and the rate at which each option is exercisable (generally ratably over one, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years from grant date). However, the exercise price of any incentive stock option <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be less than the fair market value of the shares on the date granted (or less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110%</div> of the fair market value in the case of optionees holding more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our voting stock of the Company), and the term cannot exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years for incentive stock options granted to holders of more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our voting stock).</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Stock Incentive Plan Summary</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">A summary of our stock option activity and related information for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> is as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 15%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of<br /> Options (in<br /> thousands)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of<br /> Options (in<br /> thousands)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Outstanding at beginning of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,235</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,746</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Granted at price = market value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.40</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.15</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Granted at price &gt; market value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(294</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(451</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.37</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Forfeited</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(84</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.22</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Outstanding at end of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">975</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.96</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,235</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Options exercisable at end of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,172</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Stock Options Outstanding and Exercisable</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Information related to stock options outstanding at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> is summarized below:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Outstanding</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 16%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Exercisable</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="3" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 9%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Range of Exercise Prices</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding at<br /> 12/31/1</div><div style="display: inline; font-weight: bold;">9</div><div style="display: inline; font-weight: bold;"> (in<br /> thousands)</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Remaining<br /> Contractual Life (years)</div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable at<br /> 12/31/1</div><div style="display: inline; font-weight: bold;">9</div><div style="display: inline; font-weight: bold;"> (in<br /> thousands)</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 5%;">&nbsp;</td> <td style="width: 4%;">&nbsp;</td> <td style="width: 16%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 0.34</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">391</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.86</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">383</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 0.51</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">330</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.53</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">330</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 1.01</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.69</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.71</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.77</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 2.01</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.75</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">81</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.95</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.12</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.20</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">975</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.08</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.96</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Summarized information about outstanding stock options as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> that are fully vested and those that are expected to vest in the future as well as stock options that are fully vested and currently exercisable, are as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding Stock<br /> Options (Fully Vested<br /> and Expected to Vest)*</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options that are<br /> Exercisable</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">As of December 31, 201</div><div style="display: inline; font-weight: bold;">9</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Number of outstanding options (in thousands)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">970</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Weighted average remaining contractual life</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.04</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.71</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Weighted average exercise price per share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.95</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Intrinsic value (in thousands)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,411</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,278</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt;">&nbsp;</div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">* Includes effects of expected forfeitures</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> the total unrecognized compensation cost related to non-vested options <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet recognized in the statement of operations totaled approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$86</div> thousand (including expected forfeitures) and the weighted average period over which these awards are expected to vest was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.18</div> years.</div></div> 20000 594000 20000 594000 139000 139000 0.32 0.16 0.28 0.14 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Net Loss Per Share</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We report <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted average number of common shares and dilutive common stock equivalents outstanding for the year. Our common stock equivalents include all common stock issuable upon conversion of convertible preferred stock and the exercise of outstanding options. Common stock equivalents are included in the diluted loss per share for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> except in cases where the issuance would be anti-dilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,630</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div>, respectively.</div></div></div></div></div></div></div></div></div></div></div> 0.39 0.21 P1Y65D 86000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> bear market rates of interest. &nbsp;Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> obtain comparable amounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party financing, and as such cannot estimate the fair value of the loan payable to officer. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of these instruments are held for trading purposes.</div></div></div></div></div></div></div></div></div></div></div> 4000 5000 4000 3000 64000 43000 58000 21000 64000 66000 45000 21000 2000 58000 66000 62000 121000 59000 65000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Foreign Currency</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">All assets and liabilities in the balance sheets of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation gains and losses are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in determining net income but are shown in accumulated other comprehensive loss in the stockholders&#x2019; deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss and were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significant.</div></div></div></div></div></div></div></div></div></div></div> 43000 43000 1182000 1112000 8301000 6429000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Long-Lived Assets</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We review long-lived assets, including property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are written down to fair value. During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div>impairment of long-lived assets.</div></div></div></div></div></div></div></div></div></div></div> 4465000 2287000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></div><div style="display: inline; font-weight: bold;">. Income Taxes</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets (liabilities) as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are as follows (in thousands):</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Net operating loss carryforwards</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,771</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Net operating loss carryforwards of foreign subsidiaries</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Depreciation expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Stock-based compensation expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Net deferred tax assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,204</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Valuation allowance for net deferred tax assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,204</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Net deferred tax assets, net of allowance</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Deferred tax assets are required to be reduced by a valuation allowance if it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that some portion or all of the deferred tax assets will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be realized. Realization of the future benefits related to the deferred tax assets is dependent on many factors, including the Company&#x2019;s ability to generate taxable income within the near to medium term. Management has considered these factors in determining the valuation allowance for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The differences between the provision for income taxes and income taxes computed using the federal statutory rate for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are as follows (in thousands):</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Reconciliation of income tax benefit to statutory rate:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Income benefit at statutory rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">938</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">State income taxes (benefit), net of federal income tax benefit</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Permanent differences</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(91</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Change in valuation allowance</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,030</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&#x2014;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&#x2014;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> we had federal net operating loss carryforwards of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$81.7</div> million for income tax purposes that begin to expire in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2022</div> and are subject to the ownership change limitations under Internal Revenue Code Section&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382.</div></div></div> 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Income Taxes</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Deferred income taxes are determined using the liability method in accordance with FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740,</div> <div style="display: inline; font-style: italic;">Accounting for Income Taxes</div>. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that some portion of the deferred tax asset will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be realized.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> unrecognized tax benefits to disclose in the notes to the consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We file income tax returns in the United States federal jurisdiction. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> tax returns related to fiscal years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> remain open to possible examination by the tax authorities. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> tax returns are currently under examination by any tax authorities. We did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> </div>incur any penalties or interest during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div>&nbsp;&nbsp;&nbsp;On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2017, </div>the U.S. enacted the Tax Cuts and Jobs Act (&#x201c;the Tax Act&#x201d;) which significantly changed U.S. tax law.&nbsp; The Tax Act lowered the Company&#x2019;s statutory federal income tax rate from a maximum of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39%</div> to a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018.</div></div></div></div></div></div></div></div></div></div></div></div> -2030000 -450000 938000 480000 10000 -91000 16000 4000 1066000 57000 -496000 421000 -401000 1005000 401000 -488000 598000 -15000 61000 2000 46000 189000 513000 479000 4000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 30, 2019</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 64%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Operating expense:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Amortization expense &#x2013; Finance ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Lease expense &#x2013; Operating ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">433</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other expense:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Interest expense &#x2013; Finance ROU</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 63000 63000 P3Y 1824000 352000 380000 369000 361000 362000 225000 P5Y150D P1Y90D 6835000 4069000 1943000 3252000 0 3700000 2700000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.</div> Coronavirus Outbreak in the United States</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </div>Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.&nbsp; The extent of the impact of COVID-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div> on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted.&nbsp; A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>require additional cost and effort should our employees <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be able to be physically on-premises.</div></div> 1138000 881000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Description of Business</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We develop, market, and support a family of entity identification, data mining, regulated information compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion&#x2019;s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distribute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">References to the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;, &#x201c;Intrusion&#x201d; or &#x201c;Intrusion&nbsp;Inc.&#x201d; refer to Intrusion&nbsp;Inc. and its subsidiaries. Compliance Commander&#x2122; and TraceCop&#x2122; are registered trademarks of Intrusion Inc.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>we had cash and cash equivalents of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,334,000,</div> up from approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,652,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>We generated a net income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,465,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>compared to a net income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,287,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2021. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2019, </div>our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing base and assessing what terms <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the &#x201c;Potential Replacement Facility&#x201d;). Any equity or debt financings, if available at all, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be on terms which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> favorable to us and, in the case of equity financings, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate positive cash flow in the upcoming year, or if we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to implement our business plan, fund our liquidity needs or even continue our operations.</div></div> -2348000 -948000 -260000 -202000 4290000 2578000 4465000 2287000 4465000 2287000 4326000 2148000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019 </div>we adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases (topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)</div>. At the date of adoption there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s results of operations or cash flows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div></div></div></div></div></div></div></div></div></div></div> 1815000 4507000 2476000 433000 316000 1771000 1599000 284000 1315000 294000 264000 1580000 1348000 81700000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Summary of Significant Accounting Policies</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Principles of Consolidation</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Cash and Cash Equivalents</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Cash and all highly liquid investments purchased with an original maturity of less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months are considered to be cash and cash equivalents.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers primarily in the United States. In the future, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company&#x2019;s operating results. We perform ongoing credit evaluations of our customers&#x2019; financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Trade accounts receivable are stated at the amount we expect to collect. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Management considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. If the financial condition of our customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required. Based on management&#x2019;s assessment, we provide for estimated uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after we have used reasonable collection efforts are written off through a charge to the valuation allowance. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> allowance at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Property and Equipment</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Equipment and furniture and fixtures are stated at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives vary from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs are expensed as incurred. Depreciation and amortization expense totaled approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$184,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$133,000</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Long-Lived Assets</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We review long-lived assets, including property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are written down to fair value. During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> impairment of long-lived assets.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Foreign Currency</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">All assets and liabilities in the balance sheets of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation gains and losses are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in determining net income but are shown in accumulated other comprehensive loss in the stockholders&#x2019; deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss and were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significant.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounting for Stock Options</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We account for stock options using the guidance in Financial Accounting Standards Board Accounting Standards Codification (&#x201c;FASB ASC&#x201d;) Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.</div> FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div> requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Stock-based compensation expense recognized in the statements of operations for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> is based on awards ultimately expected to vest, reduced by estimated forfeitures. FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div> requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Valuation Assumptions</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The fair values of option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average grant date fair value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.69</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average assumptions used:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected dividend yield</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected volatility</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">124.58</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">225.21</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.91</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:35pt;">Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Net Loss Per Share</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We report <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted average number of common shares and dilutive common stock equivalents outstanding for the year. Our common stock equivalents include all common stock issuable upon conversion of convertible preferred stock and the exercise of outstanding options. Common stock equivalents are included in the diluted loss per share for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> except in cases where the issuance would be anti-dilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,630</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div>, respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>we adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>, as amended, using the modified retrospective approach. At the date of adoption there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the balance sheet or statement of operation. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s financial position, results of operations or cash flows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently offer software on a subscription basis. Warranty costs and sales returns have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been material.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;">We recognize sales of our data sets in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> whereby revenue from contracts with customers is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognized until all <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> of the following have been met:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">i)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">identify the contract with a customer;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">ii)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">identify the performance obligations in the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">iii)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">determine the transaction price;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">iv)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">allocate the transaction price to the separate performance obligations; and</div> </td> </tr> </table> <table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 18pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">v)</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">recognize revenue upon satisfaction of a performance obligation.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Data updates are typically done monthly and revenue will be matched accordingly. Product sales <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our normal payment terms offered to customers, distributors and resellers are net <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> days domestically and net <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div> days internationally. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> offer payment terms that extend beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year and rarely do we extend payment terms beyond our normal terms. If certain customers do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet our credit standards, we do require payment in advance to limit our credit exposure.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Research and Development Costs</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We incur research and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major enhancements to existing services and products. Research and development costs are comprised primarily of salaries and related benefits expenses, contract labor and prototype and other related expenses.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Software development costs are included in research and development and are expensed as incurred. FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div><div style="display: inline; font-style: italic;"> Intangibles&#x2014;Goodwill and Other</div> requires that software development costs incurred subsequent to reaching technological feasibility be capitalized, if material. If the process of developing a new product or major enhancement does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include a detailed program design, technological feasibility is determined only after completion of a working model. To date, the period between achieving technological feasibility and the general availability of such software has been short, and the software development costs qualifying for capitalization have been insignificant.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> bear market rates of interest. &nbsp;Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> obtain comparable amounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party financing, and as such cannot estimate the fair value of the loan payable to officer. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of these instruments are held for trading purposes.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Income Taxes</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Deferred income taxes are determined using the liability method in accordance with FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740,</div> <div style="display: inline; font-style: italic;">Accounting for Income Taxes</div>. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that some portion of the deferred tax asset will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be realized.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> unrecognized tax benefits to disclose in the notes to the consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We file income tax returns in the United States federal jurisdiction. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> tax returns related to fiscal years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> remain open to possible examination by the tax authorities. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> tax returns are currently under examination by any tax authorities. We did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> incur any penalties or interest during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div>&nbsp;&nbsp;&nbsp;On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2017, </div>the U.S. enacted the Tax Cuts and Jobs Act (&#x201c;the Tax Act&#x201d;) which significantly changed U.S. tax law.&nbsp; The Tax Act lowered the Company&#x2019;s statutory federal income tax rate from a maximum of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39%</div> to a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019 </div>we adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases (topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)</div>. At the date of adoption there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s results of operations or cash flows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div></div> 79000 99000 38000 38000 714000 260000 202000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.</div> Employee Benefit Plan</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Employee <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">401</div>(k)&nbsp;Plan</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We have a plan known as the Intrusion&nbsp;Inc. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">401</div>(k)&nbsp;Savings Plan (the &#x201c;Plan&#x201d;) to provide retirement and incidental benefits for our employees. The Plan covers substantially all employees who meet minimum age and service requirements. As allowed under Section&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">401</div>(k)&nbsp;of the Internal Revenue Code, the Plan provides tax deferred salary deductions for eligible employees.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Employees <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>contribute from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of their annual compensation to the Plan, limited to a maximum amount as set by the Internal Revenue Service. Participants who are over the age of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>contribute an additional amount of their salary per year, as defined annually by the Internal Revenue Service. We match employee contributions at the rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per each <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div> of contribution on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4%</div> of compensation. Matching contributions to the Plan were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$32,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30,000,</div> respectively, for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div> 0.05 0.05 0.05 50000 57000 32000 139000 139000 1013 1213 1155 1385 634 760 5 2.50 2.18 0.01 0.01 5 3.25 2.834 5000000 5000000 200000 200000 460000 460000 289000 289000 200000 200000 460000 460000 289000 289000 200000 460000 289377 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></div><div style="display: inline; font-weight: bold;">. Preferred Stock</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2004,</div> we completed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.0</div> million private placement of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stock and warrants. In the private placement, we sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,000,000</div> shares of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.00</div> per share for gross proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.0</div> million, less <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$275,000</div> of issuance costs. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred shares were initially convertible into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,590,331</div> shares of common stock at a conversion price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.144</div> per share. Holders of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stock include <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,000</div> shares purchased by our former CEO and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div> shares purchased by a director of the Company.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> dividends related to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are paid semi-annually on the last business day in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div>of each year, beginning with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2004.</div> Preferred stockholders vote together with common stockholders on an as converted to common stock basis. Based on the conversion rate of the preferred stock, holders of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock will receive <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.5903</div> votes per share rounded to the nearest whole number. The liquidation preference for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock is an amount equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.00</div> per share plus any accrued and unpaid dividends. Holders of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock have liquidation preference rights over common stockholders.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">All warrants previously issued to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stockholders have expired.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We have the right to redeem any or all of the outstanding <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.00</div> per share plus accrued dividends at any time if certain conditions are met.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:35pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,000</div> shares of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> Preferred Stock outstanding, representing approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">318,065</div> shares of common stock upon conversion.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> we completed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.7</div> million private placement of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stock and warrants. In the private placement, we sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,065,200</div> shares of preferred stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.50</div> per share for gross proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.7</div> million, less <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$173,000</div> of issuance costs. The shares of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are convertible into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,065,200</div> shares of common stock at an initial conversion price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.50</div> per share. Holders of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock include <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260,000</div> shares by our former CEO, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div> shares by our CFO and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div> shares by a director of the Company.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> dividends accruing on the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are required to be paid quarterly on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> business day in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div>of each year, beginning with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005.</div> The liquidation preference for the preferred stock is an amount equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.50</div> per share plus any accrued and unpaid dividends. Holders of our Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock have liquidation preference rights over our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stockholders as well as our common stockholders. The holders of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">All warrants previously issued to Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stockholders have expired.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Holders of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock have the right to require us to redeem any or all of the their shares upon the occurrence of certain events within the Company&#x2019;s control that are defined in Certificate of Designation at a price equal the sum of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;the greater of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.25</div> and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.50</div> divided by the conversion price then in effect plus (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>)&nbsp;any accrued but unpaid dividends on the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock plus (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)&nbsp;all liquidated damages or other amounts payable to the holders of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">460,000</div> shares of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> Preferred Stock outstanding, representing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">460,000</div> shares of common stock upon conversion.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> we completed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.2</div> million private placement of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stock and warrants. In the private placement, we sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">564,607</div> shares of preferred stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.18</div> per share for gross proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.2</div> million, less <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> of issuance costs. The shares of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are convertible into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">564,607</div> shares of common stock at an initial conversion price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.18</div> per share. Holders of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock include <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">123,853</div> shares by our former CEO, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68,808</div> shares by our CFO and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,523</div> shares purchased by a director of the Company.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> dividends accruing on the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are required to be paid quarterly on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> business day in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div>of each year, beginning with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006.</div> The liquidation preference for the preferred stock is an amount equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.18</div> per share plus any accrued and unpaid dividends. Holders of our Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock have liquidation preference rights over holders of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred, Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock and common stock. The holders of the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">All warrants previously issued to Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> convertible preferred stockholders have expired.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Holders of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock have the right to require us to redeem any or all of their shares upon the occurrence of certain events within the Company&#x2019;s control that are defined in the certificate of designation at a price equal the sum of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;the greater of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.834</div> and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.18</div> divided by the conversion price then in effect plus (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>)&nbsp;any accrued but unpaid dividends on the Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock plus (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)&nbsp;all liquidated damages or other amounts payable to the holders of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> preferred stock.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">289,377</div> shares of Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> Preferred Stock outstanding, representing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">289,377</div> shares of common stock upon conversion.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Dividends Payable</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> we accrued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50,000</div> in dividends to the holders of our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$57,000</div> in dividends to the holders of our Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$32,000</div> in dividends to the holders of our Series&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> Preferred Stock. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$594,000</div> in accrued and unpaid dividends included in other current liabilities. Delaware law provides that we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>only pay dividends out of our capital surplus or, if <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. This has been in effect since <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2014. </div>However, in light of our net profits for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we are able to and have paid these past due dividends as of the date of this Annual Report. However, dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them, and we cannot assure you that our net assets will exceed our stated capital or that we will have sufficient net profits in order to pay these dividends as they continue to accrue in the future. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18%</div> per annum on the unpaid dividends for the Series <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> Preferred Stock and Series <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> Preferred Stock.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div></div> 707000 707000 724000 724000 412000 412000 152000 91000 5000000 2700000 1200000 150000 239000 168000 1244000 987000 335000 200000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Property and Equipment</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Equipment and furniture and fixtures are stated at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives vary from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs are expensed as incurred. Depreciation and amortization expense totaled approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$184,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$133,000</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively.</div></div></div></div></div></div></div></div></div></div></div> P1Y P5Y P2Y P5Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></div><div style="display: inline; font-weight: bold;">. Borrowings from Officer</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 8, 2018, </div>the Company entered into an unsecured revolving promissory note to borrow up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,700,000</div> from G. Ward Paxton, the Company&#x2019;s former Chief Executive Officer (the &#x201c;CEO Note&#x201d;). Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,700,000</div> at any given time through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> the Company amended the unsecured revolving promissory note to borrow up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,700,000</div> from G. Ward Paxton, the Company&#x2019;s former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank&#x2019;s (&#x201c;SVB&#x201d;) prime rate plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%.</div> Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,700,000</div> at any given time through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2021.</div> We reduced our borrowing under this note to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2019</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.5pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2019, </div>G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer be available to the Company. Our management will be assessing whether to replace this borrowing base and assessing what terms <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be available to the Company, including whether any such terms are acceptable to the Company, if at all.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div></div> 1815000 1200000 1314000 1237000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Research and Development Costs</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We incur research and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major enhancements to existing services and products. Research and development costs are comprised primarily of salaries and related benefits expenses, contract labor and prototype and other related expenses.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> </div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Software development costs are included in research and development and are expensed as incurred. FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div><div style="display: inline; font-style: italic;"> Intangibles&#x2014;Goodwill and Other</div> requires that software development costs incurred subsequent to reaching technological feasibility be capitalized, if material. If the process of developing a new product or major enhancement does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include a detailed program design, technological feasibility is determined only after completion of a working model. To date, the period between achieving technological feasibility and the general availability of such software has been short, and the software development costs qualifying for capitalization have been insignificant.</div></div></div></div></div></div></div></div></div></div></div> -54777000 -59242000 13643000 10276000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>we adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>, as amended, using the modified retrospective approach. At the date of adoption there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the balance sheet or statement of operation. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s financial position, results of operations or cash flows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently offer software on a subscription basis. Warranty costs and sales returns have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been material.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;">We recognize sales of our data sets in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> whereby revenue from contracts with customers is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognized until all <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> of the following have been met:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">i)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">identify the contract with a customer;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">ii)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">identify the performance obligations in the contract;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">iii)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">determine the transaction price;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;">&nbsp;</td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">iv)</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">allocate the transaction price to the separate performance obligations; and</div> </td> </tr> </table> <table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 18pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">v)</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">recognize revenue upon satisfaction of a performance obligation.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Data updates are typically done monthly and revenue will be matched accordingly. Product sales <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our normal payment terms offered to customers, distributors and resellers are net <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> days domestically and net <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div> days internationally. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> offer payment terms that extend beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year and rarely do we extend payment terms beyond our normal terms. If certain customers do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet our credit standards, we do require payment in advance to limit our credit exposure.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.</div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-weight: bold;">. </div><div style="display: inline; font-weight: bold;">Contract Assets and Contract Liabilities</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company had contract assets balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,566,000,</div> a decrease of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$401,000</div> from the prior year due to cash receipts exceeding new contract assets. For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company had contract assets balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,967,000.</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies deferred revenue as a contract liablility. For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company had contract liabilities balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$516,000.</div> For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company had contract liabilities balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,004,000.</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="margin-right: auto; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued payroll</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">193</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued vacation</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">311</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">310</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued bonus</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Rent payable</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Accrued interest, related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">479</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">79</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">99</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">828</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,403</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; margin-left: 18pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Net operating loss carryforwards</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,771</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Net operating loss carryforwards of foreign subsidiaries</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">374</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Depreciation expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Stock-based compensation expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Net deferred tax assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,204</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Valuation allowance for net deferred tax assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,204</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Net deferred tax assets, net of allowance</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Reconciliation of income tax benefit to statutory rate:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Income benefit at statutory rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">938</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">State income taxes (benefit), net of federal income tax benefit</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,066</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Permanent differences</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(91</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Change in valuation allowance</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,030</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&#x2014;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&#x2014;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 4%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Outstanding</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 16%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Exercisable</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="3" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 9%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Range of Exercise Prices</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding at<br /> 12/31/1</div><div style="display: inline; font-weight: bold;">9</div><div style="display: inline; font-weight: bold;"> (in<br /> thousands)</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Remaining<br /> Contractual Life (years)</div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable at<br /> 12/31/1</div><div style="display: inline; font-weight: bold;">9</div><div style="display: inline; font-weight: bold;"> (in<br /> thousands)</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 5%;">&nbsp;</td> <td style="width: 4%;">&nbsp;</td> <td style="width: 16%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 0.34</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">391</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.86</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">383</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.42</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 0.51</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">330</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.53</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">330</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 1.01</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.69</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.77</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">$ 2.01</div> </td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.75</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.95</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&nbsp;</td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.96</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 15%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of<br /> Options (in<br /> thousands)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of<br /> Options (in<br /> thousands)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise<br /> Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Outstanding at beginning of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,746</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Granted at price = market value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.40</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Granted at price &gt; market value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(294</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(451</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Forfeited</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Outstanding at end of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">975</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.96</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Options exercisable at end of year</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,172</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average grant date fair value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.69</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average assumptions used:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected dividend yield</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected volatility</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">124.58</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">225.21</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.91</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 1298000 1604000 47000 20000 0 0 1.2458 2.2521 0.02 0.0083 750000 500000 500000 400000 300000 750000 1500000 2500000 3000000 3400000 3700000 600000 449000 917000 1172000 0.84 0.84 84000 3.69 0.49 824100 151000 1235000 1746000 975000 0.83 0.68 0.96 4411000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding Stock<br /> Options (Fully Vested<br /> and Expected to Vest)*</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options that are<br /> Exercisable</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">As of December 31, 201</div><div style="display: inline; font-weight: bold;">9</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Number of outstanding options (in thousands)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">970</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Weighted average remaining contractual life</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.71</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Weighted average exercise price per share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.95</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Intrinsic value (in thousands)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,411</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,278</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 970000 0.95 0.81 0.37 0.22 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounting for Stock Options</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We account for stock options using the guidance in Financial Accounting Standards Board Accounting Standards Codification (&#x201c;FASB ASC&#x201d;) Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.</div> FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div> requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Stock-based compensation expense recognized in the statements of operations for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> is based on awards ultimately expected to vest, reduced by estimated forfeitures. FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div> requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">&nbsp;</div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Valuation Assumptions</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The fair values of option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average grant date fair value</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.69</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average assumptions used:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected dividend yield</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.83</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected volatility</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">124.58</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">225.21</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.91</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:35pt;">Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award.</div></div></div></div></div></div></div></div></div></div></div> 0.34 0.51 1.01 2.01 383000 330000 157000 47000 917000 391000 330000 173000 81000 975000 0.50 1 2 4.75 5 2.50 2.18 P10Y P5Y P4Y332D 4278000 P2Y259D P3Y14D 0.42 0.68 1.77 2.20 0.84 0.42 0.68 1.71 3.12 0.96 P2Y313D P1Y193D P4Y251D P6Y346D P3Y29D 949000 949000 13259000 12808000 13552000 -362000 -362000 56759000 56609000 1000000 140000 60000 1065200 260000 100000 60000 564607 123853 68808 27523 0 293000 451000 294000 451000 5000000 2700000 1200000 3000 5000 236000 163000 3556000 -1062000 1843000 1843000 133000 128000 136000 56609000 56518000 -59242000 -61529000 -54777000 -43000 -107000 -43000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Trade accounts receivable are stated at the amount we expect to collect. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Management considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. If the financial condition of our customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required. Based on management&#x2019;s assessment, we provide for estimated uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after we have used reasonable collection efforts are written off through a charge to the valuation allowance. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div>allowance at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div></div></div></div></div></div></div></div></div></div> 10000 10000 362000 362000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div></div></div></div></div></div></div></div></div></div></div> 15352000 15063000 13502000 13049000 Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations. Includes effects of expected forfeitures xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000736012 srt:ChiefExecutiveOfficerMember us-gaap:SeriesAPreferredStockMember 2004-03-25 2004-03-25 0000736012 srt:DirectorMember us-gaap:SeriesAPreferredStockMember 2004-03-25 2004-03-25 0000736012 us-gaap:SeriesAPreferredStockMember 2004-03-25 2004-03-25 0000736012 srt:ChiefExecutiveOfficerMember us-gaap:SeriesBPreferredStockMember 2005-03-28 2005-03-28 0000736012 srt:ChiefFinancialOfficerMember us-gaap:SeriesBPreferredStockMember 2005-03-28 2005-03-28 0000736012 srt:DirectorMember us-gaap:SeriesBPreferredStockMember 2005-03-28 2005-03-28 0000736012 us-gaap:SeriesBPreferredStockMember 2005-03-28 2005-03-28 0000736012 srt:ChiefExecutiveOfficerMember us-gaap:SeriesCPreferredStockMember 2005-12-02 2005-12-02 0000736012 srt:ChiefFinancialOfficerMember us-gaap:SeriesCPreferredStockMember 2005-12-02 2005-12-02 0000736012 srt:DirectorMember us-gaap:SeriesCPreferredStockMember 2005-12-02 2005-12-02 0000736012 us-gaap:SeriesCPreferredStockMember 2005-12-02 2005-12-02 0000736012 intz:The2005StockIncentivePlanMember 2007-05-30 2007-05-30 0000736012 intz:The2005StockIncentivePlanMember 2008-05-29 2008-05-29 0000736012 intz:The2005StockIncentivePlanMember 2010-05-20 2010-05-20 0000736012 intz:The2005StockIncentivePlanMember 2011-05-19 2011-05-19 0000736012 intz:The2005StockIncentivePlanMember 2012-05-17 2012-05-17 0000736012 2017-01-01 2017-12-31 0000736012 2018-01-01 2018-12-31 0000736012 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember intz:FourGovernmentCustomersMember 2018-01-01 2018-12-31 0000736012 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember intz:OneCommercialCustomerMember 2018-01-01 2018-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:FourGovernmentCustomersMember 2018-01-01 2018-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:OneCommercialCustomerMember 2018-01-01 2018-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2018-01-01 2018-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0000736012 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0000736012 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0000736012 2019-01-01 2019-12-31 0000736012 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember intz:OneCommercialCustomerMember 2019-01-01 2019-12-31 0000736012 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember intz:ThreeGovernmentCustomersMember 2019-01-01 2019-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:OneCommercialCustomerMember 2019-01-01 2019-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:ThreeGovernmentCustomersMember 2019-01-01 2019-12-31 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2019-01-01 2019-12-31 0000736012 intz:The2015StockIncentivePlanMember 2019-01-01 2019-12-31 0000736012 intz:The2015StockIncentivePlanMember intz:NonemployeeBoardMemberMember 2019-01-01 2019-12-31 0000736012 intz:EquipmentAndFurnitureAndFixturesMember srt:MaximumMember 2019-01-01 2019-12-31 0000736012 intz:EquipmentAndFurnitureAndFixturesMember srt:MinimumMember 2019-01-01 2019-12-31 0000736012 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2019-01-01 2019-12-31 0000736012 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2019-01-01 2019-12-31 0000736012 srt:MaximumMember 2019-01-01 2019-12-31 0000736012 srt:MinimumMember 2019-01-01 2019-12-31 0000736012 intz:Range1Member 2019-01-01 2019-12-31 0000736012 intz:Range2Member 2019-01-01 2019-12-31 0000736012 intz:Range3Member 2019-01-01 2019-12-31 0000736012 intz:Range4Member 2019-01-01 2019-12-31 0000736012 intz:Series2PreferredStockAndSeries3PreferredStockMember 2019-01-01 2019-12-31 0000736012 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-12-31 0000736012 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-12-31 0000736012 us-gaap:SeriesCPreferredStockMember 2019-01-01 2019-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000736012 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000736012 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember us-gaap:PrimeRateMember 2019-02-07 2019-02-07 0000736012 us-gaap:SeriesAPreferredStockMember 2004-03-25 0000736012 srt:MinimumMember us-gaap:SeriesBPreferredStockMember 2005-03-28 0000736012 us-gaap:SeriesBPreferredStockMember 2005-03-28 0000736012 srt:MinimumMember us-gaap:SeriesCPreferredStockMember 2005-12-02 0000736012 us-gaap:SeriesCPreferredStockMember 2005-12-02 0000736012 intz:The2005StockIncentivePlanMember 2007-05-30 0000736012 intz:The2005StockIncentivePlanMember 2009-05-21 0000736012 intz:The2005StockIncentivePlanMember 2010-05-20 0000736012 intz:The2005StockIncentivePlanMember 2011-05-19 0000736012 intz:The2005StockIncentivePlanMember 2012-05-17 0000736012 intz:The2015StockIncentivePlanMember 2015-03-19 0000736012 2017-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000736012 us-gaap:CommonStockMember 2017-12-31 0000736012 us-gaap:PreferredStockMember 2017-12-31 0000736012 us-gaap:RetainedEarningsMember 2017-12-31 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2018-02-08 0000736012 2018-12-31 0000736012 us-gaap:OtherCurrentLiabilitiesMember 2018-12-31 0000736012 intz:Series1PreferredStockMember 2018-12-31 0000736012 intz:Series2PreferredStockMember 2018-12-31 0000736012 intz:Series3PreferredStockMember 2018-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000736012 us-gaap:CommonStockMember 2018-12-31 0000736012 us-gaap:PreferredStockMember 2018-12-31 0000736012 us-gaap:RetainedEarningsMember 2018-12-31 0000736012 us-gaap:TreasuryStockMember 2018-12-31 0000736012 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-02-07 0000736012 2019-06-28 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-09-30 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-10-24 0000736012 2019-12-31 0000736012 us-gaap:OtherCurrentLiabilitiesMember 2019-12-31 0000736012 us-gaap:DomesticCountryMember 2019-12-31 0000736012 intz:The2005StockIncentivePlanMember 2019-12-31 0000736012 intz:The2015StockIncentivePlanMember 2019-12-31 0000736012 intz:RichardsonPropertyMember 2019-12-31 0000736012 intz:TheSanMarcosPropertyMember 2019-12-31 0000736012 intz:Range1Member 2019-12-31 0000736012 intz:Range2Member 2019-12-31 0000736012 intz:Range3Member 2019-12-31 0000736012 intz:Range4Member 2019-12-31 0000736012 intz:Series1PreferredStockMember 2019-12-31 0000736012 intz:Series2PreferredStockMember 2019-12-31 0000736012 intz:Series3PreferredStockMember 2019-12-31 0000736012 us-gaap:SeriesAPreferredStockMember 2019-12-31 0000736012 us-gaap:SeriesBPreferredStockMember 2019-12-31 0000736012 us-gaap:SeriesCPreferredStockMember 2019-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000736012 us-gaap:CommonStockMember 2019-12-31 0000736012 us-gaap:PreferredStockMember 2019-12-31 0000736012 us-gaap:RetainedEarningsMember 2019-12-31 0000736012 us-gaap:TreasuryStockMember 2019-12-31 0000736012 2020-02-28 EX-101.SCH 8 intz-20191231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Description of Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Accrued Expenses (In Thousands) link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Employee Benefit Plan link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Borrowings From Officer link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Stock Options link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Preferred Stock link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Concentrations link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Contract Assets and Contract Liabilities link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Coronavirus Outbreak in the United States link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Accrued Expenses (In Thousands) (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Commitments and Contingencies (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 7 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 8 - Stock Options (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 1 - Description of Business (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 3 - Accrued Expenses (in Thousands) - Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Commitments and Contingencies - Schedule of Items Appearing on the Statement of Operations (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 4 - Commitments and Contingencies - Future Minimum Lease Obligations (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 5 - Employee Benefit Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 6 - Borrowings From Officer (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 7 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 7 - Income Taxes - Income Tax Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 8 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 8 - Stock Options - Common Shares Reserved for Future Issuance (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 8 - Stock Options - Number & Weighted Average Exercise Price (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 8 - Stock Options - Exercise Price (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 8 - Stock Options - Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 9 - Preferred Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 10 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 11 - Contract Assets and Contract Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 9 intz-20191231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 intz-20191231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 intz-20191231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Expected dividend yield Note To Financial Statement Details Textual Significant Accounting Policies Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Note 2 - Summary of Significant Accounting Policies Income benefit at statutory rate Note 3 - Accrued Expenses (In Thousands) Risk-free interest rate Note 4 - Commitments and Contingencies Note 7 - Income Taxes Note 8 - Stock Options Note 2 - Summary of Significant Accounting Policies - Valuation Assumptions (Details) Note 3 - Accrued Expenses (in Thousands) - Accrued Expenses (Details) Note 4 - Commitments and Contingencies - Schedule of Items Appearing on the Statement of Operations (Details) Income Tax Disclosure [Text Block] Note 4 - Commitments and Contingencies - Future Minimum Lease Obligations (Details) Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Note 7 - Income Taxes - Income Tax Reconciliation (Details) Expected volatility Note 8 - Stock Options - Common Shares Reserved for Future Issuance (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 8 - Stock Options - Number & Weighted Average Exercise Price (Details) Note 8 - Stock Options - Exercise Price (Details) Note 8 - Stock Options - Outstanding (Details) Notes To Financial Statements Expected life (in years) (Year) Notes To Financial Statements [Abstract] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Share-based Payment Arrangement, Option, Activity [Table Text Block] Weighted average remaining contractual life (Year) Number of outstanding options (in thousands) (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Weighted average exercise price per share (in dollars per share) Intrinsic value (in thousands) Options exercisable at end of year (in dollars per share) Weighted average exercise price per share (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Weighted average remaining contractual life (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Intrinsic value (in thousands) Options exercisable at end of year (in shares) Number of outstanding options (in thousands) (in shares) Weighted average grant date fair value (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding at beginning of year (in dollars per share) Outstanding at end of year (in dollars per share) Forfeited (in dollars per share) Deferred revenue Contract with Customer, Liability, Current Expired (in dollars per share) Exercised (in dollars per share) Accrued expenses Total accrued expenses Accrued interest, related party Dividends payable Dividends Payable, Current Accounts payable, trade Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance Outstanding at beginning of year (in shares) Outstanding at end of year (in shares) Accrued bonus us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Expired (in shares) Purchase of equipment through capital lease Credit Facility [Axis] Credit Facility [Domain] us-gaap_OtherAccruedLiabilitiesCurrent Other Accrued payroll us-gaap_PolicyTextBlockAbstract Accounting Policies Accrued vacation Rent payable us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Weighted average common shares outstanding: Current Liabilities: us-gaap_Assets TOTAL ASSETS Plan Name [Axis] Preferred Stock [Text Block] Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Property and Equipment: Lease expense – Operating ROU us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net income attributable to common stockholders Share-based Payment Arrangement [Text Block] us-gaap_PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact Preferred stock dividends accrued Net income Net Income (Loss) Attributable to Parent, Total Net income Three Government Customers [Member] Represents three government customers. Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated depreciation and amortization us-gaap_PropertyPlantAndEquipmentNet Contingencies Disclosure [Text Block] us-gaap_PropertyPlantAndEquipmentGross Equipment Furniture and fixtures Leasehold improvements Investing Activities: Accounts payable and accrued expenses us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Related Party Transactions Disclosure [Text Block] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income from operations before income taxes Income tax provision us-gaap_DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost intz_PreferredStockIssuanceCosts Preferred Stock Issuance Costs Represents the cost incurred for the issuance of preferred stock. General and administrative us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay intz_PreferredStockConversionPricePerShare Preferred Stock, Conversion Price Per Share Represents the conversion price per share of the preferred stock. us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match intz_PreferredStockVotingRightsNumber Preferred Stock, Voting Rights Number Represents the number of votes per share that holders of preferred stock will receive based on the conversion rate of the preferred stock. Equipment and Furniture and Fixtures [Member] Information pertaining to equipment and furniture and fixtures. Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year intz_NumberOfMajorUnitedStatesFinancialInstitutions Number of Major United States Financial Institutions Represents the number of major U.S. financial institutions with whom cash, cash equivalents and investments are maintained by the entity. intz_PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically Period of Payment Terms Offered to Customers Distributions and Resellers Domestically Represents the period of payment terms offered to domestic customers, distributors and resellers. intz_PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally Period of Payment Terms Offered to Customers Distributors and Resllers Internationally Represents the period of payment terms offered to international customers, distributors and resellers. Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block] Tabular disclosure of undiscounted cash flows of lessee's operating lease liability and finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability and finance lease liability recognized in statement of financial position. intz_AggregateStockOptionsExercisedForThePlan Aggregate Stock Options Exercised for the Plan Represents the aggregate number of stock options that have been issued under the stock option plan. intz_NumberOfStockbasedCompensationPlans Number of Stock-based Compensation Plans Represents the number of stock-based compensation plans of the entity. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAggregate Share-based Compensation Arrangement by Share-based Payment Award, Options Forfeitures Aggregate The aggregate number of shares under options that have been cancelled under the stock option plan as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree 2022 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. The 2005 Stock Incentive Plan [Member] Represents the 2005 Stock Incentive Plan. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo 2021 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextRollingTwelveMonths 2020 Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsAggregate Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants Aggregate Aggregate number of share options (or share units) granted under the stock option plan. Amendment Flag intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFive 2024 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_NumberOfEquityIncentivePrograms Number of Equity Incentive Programs Represents the number of separate equity incentive programs of the entity. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour 2023 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsThatWillBeGrantedUponInitialElectionOrAppointmentToBoard Share-based Compensation Arrangement by Share-based Payment Award, Options That Will Be Granted Upon Initial Election Or Appointment to Board Represents the number of share options of common stock that will be granted under the stock based compensation plan upon initial election or appointment to the Board, provided that individual has not previously been employed by the entity in the preceding six months. Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] intz_SharebasedCompensationArrangementBySharebasedPaymentAwardPrecedingPeriodWithInWhichIndividualShouldNotBeEmployed Share-based Compensation Arrangement by Share-based Payment Award, Preceding Period With in Which Individual Should Not Be Employed Represents the preceding period within which an individual should not be previously employed by the entity to receive an option grant for shares of common stock upon initial election or appointment to the Board. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionThatWillBeGrantedToPurchaseSharesOnDateOfEachAnnualStockholdersMeeting Share-based Compensation Arrangement by Share-based Payment Award, Option That Will Be Granted to Purchase Shares On Date of Each Annual Stockholders Meeting Represents the option that will be granted to purchase shares of common stock on the date of each annual stockholders meeting, provided he or she has served as a non-employee Board member for at least six months for the entity. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue Amount of lessee's undiscounted obligation for lease payments for operating and finance lease. Non-employee Board Member [Member] Represents the Non-employee Board Member. The 2015 Stock Incentive Plan [Member] Represents the 2015 Stock Incentive Plan. us-gaap_SharesOutstanding Balance, beginning of year and end of year (in shares) Balance, beginning of year and end of year (in shares) Balance, end of year (in shares) Common stock, shares outstanding (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding, Ending Balance intz_SharebasedCompensationArrangementBySharebasedPaymentAwardOfExercisePriceOfCommonStockPercentageInCaseOfOptioneesHoldingMoreThanSpecifiedPercentageOfVotingStock Share-based Compensation Arrangement By Share-based Payment Award Of Exercise Price Of Common Stock Percentage In Case Of Optionees Holding More Than Specified Percentage Of Voting Stock Represents the exercise price expressed as a percentage of the fair market value of common stock in case of optionees holding more than specified percent of voting stock of the entity. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardVotingStockPercentageToBeHeldByOptionees Share-based Compensation Arrangement By Share-based Payment Award Voting Stock Percentage To Be Held By Optionees Represents the percentage of voting stock to be held by optionees for entitlement to exercise price less than the specified percentage of the fair market value of common stock. intz_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod2 Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisable Period 2 Represents the options exercisable period two. Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate intz_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod3 Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisable Period 3 Represents the options exercisable period three. intz_DefinedContributionPlanMinimumAgeRequiredForContributionOfAdditionalAmountOfSalaryPerYear Defined Contribution Plan, Minimum age Required for Contribution of Additional Amount of Salary Per Year Represents the minimum age required for contribution of an additional amount of salary per year by participants. intz_SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationTermForOptionsGrantedToHoldersOfMoreThanSpecifiedPercentageOfVotingStock Share-based Compensation Arrangements By Share-based Payment Award, Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock The period of time from the grant date until the time at which the share-based option award expires for holders of incentive stock options of more than the specified percentage of voting stock. intz_DefineContributionPlanPercentageOfContributionByEmployees Define Contribution Plan, Percentage of Contribution by Employees Represents the percentage of annual compensation of employee for which employee may contribute to a defined contribution plan. us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets Schedule of Common Shares Reserved for Future Issuance [Table text Block] Tabular disclosure of aggregate number of common shares reserved for future issuance. Document Fiscal Period Focus Document Fiscal Year Focus Consolidation, Policy [Policy Text Block] Lease, Cost [Table Text Block] Granted at price = market value (in dollars per share) Weighted average price equal to the market value at which grantees can acquire the shares reserved for issuance on stock options awarded. Document Period End Date Granted at price = market value (in shares) Represents the gross number of share options (or share units) granted at price equal to the market value during the period. Penalties and waived penalties on dividends Amount of penalties and waived penalties on dividends during the period. Granted at price > market value (in shares) Represents the gross number of share options (or share units) granted at price greater than the market value during the period. Range 2 [Member] Range 2 in a series of exercise price ranges. Entity Emerging Growth Company Granted at price > market value (in dollars per share) Weighted average price greater than the market value at which grantees can acquire the shares reserved for issuance on stock options awarded. Document Type Range 1 [Member] Range 1 in a series of exercise price ranges. Entity Small Business Entity Shell Company Range 3 [Member] Range 3 in a series of exercise price ranges. Document Information [Line Items] Document Information [Table] Entity Public Float Entity Filer Category Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Variable Rate [Domain] Prime Rate [Member] us-gaap_ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Preferred stock dividends declared, net of waived penalties by shareholders Variable Rate [Axis] us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Stock-based compensation Entity Central Index Key Entity Registrant Name One Commercial Customer [Member] Represents one commercial customer. Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] SUPPLEMENTAL CASH FLOW INFORMATION: Concentration Risk Type [Axis] us-gaap_AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss, Ending Balance Concentration Risk Type [Domain] us-gaap_TreasuryStockValue Common stock held in treasury, at cost—10 shares Entity Common Stock, Shares Outstanding (in shares) Revenue Benchmark [Member] Accounts Receivable [Member] us-gaap_IncreaseDecreaseInInventories Inventories Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Nature of Operations [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Exercise of stock options (in shares) Exercised (in shares) us-gaap_TableTextBlock Notes Tables us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity Exercise of stock options Related Party [Axis] Related Party [Domain] us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Forfeited (in shares) Sales and marketing us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues us-gaap_LiabilitiesAndStockholdersEquity TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) us-gaap_StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues us-gaap_IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset Accumulated deficit Research and development Accumulated other comprehensive loss Extinguishment of U.K. cumulative translation adjustment Represents for extinguishment of UK cumulative translation adjustment. us-gaap_InterestExpense Interest expense Changes in operating assets and liabilities: us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Operating leases liability, noncurrent portion Operating ROU Leases Operating Lease, Liability, Total Operating leases liabilities, current portion Finance leases liabilities, current portion Pension and Other Postretirement Benefits Disclosure [Text Block] Finance leases liability, noncurrent portion Operating leases, right-of-use assets, net Operating Lease, Right-of-Use Asset us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue Operating ROU Leases Undiscounted Obligation us-gaap_FinanceLeasePrincipalPayments Principal payments on capital lease equipment us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Operating ROU Leases, Less Interest* Finance ROU Leases Finance leases, right-of-use assets, net Fair Value of Financial Instruments, Policy [Policy Text Block] Operating ROU Leases, 2023 Operating ROU Leases, 2024 Operating ROU Leases, 2020 Operating ROU Leases, 2021 Operating ROU Leases, 2022 Foreign Currency Transactions and Translations Policy [Policy Text Block] Stock-based compensation Other assets Earnings Per Share, Policy [Policy Text Block] Operating expenses: Income Tax, Policy [Policy Text Block] Series 2 Preferred Stock [Member] Represents series 2 preferred stock. Series 1 Preferred Stock [Member] Represents series 1 preferred stock. us-gaap_LesseeOperatingLeaseTermOfContract Lessee, Operating Lease, Term of Contract Series 3 Preferred Stock [Member] Represents series 3 preferred stock. Research and Development Expense, Policy [Policy Text Block] Depreciation and amortization Depreciation, Depletion and Amortization, Total us-gaap_AssetsCurrent Total current assets Share-based Payment Arrangement [Policy Text Block] us-gaap_LesseeFinanceLeaseTermOfContract1 Lessee, Finance Lease, Term of Contract Common stock held in treasury, at cost, shares (in shares) Common stock, $0.01 par value: Authorized shares — 80,000, Issued shares — 13,552 in 2019 and 13,259 in 2018, Outstanding shares — 13,542 in 2019 and 13,249 in 2018 Adjustments to reconcile net income to net cash provided by operating activities: Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Common stock, par value (in dollars per share) Revenue from Contract with Customer [Policy Text Block] Common shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance us-gaap_DeferredTaxAssetsValuationAllowance Valuation allowance for net deferred tax assets Statistical Measurement [Domain] us-gaap_OperatingLeasePayments Operating Lease, Payments Maximum [Member] Minimum [Member] Statistical Measurement [Axis] Interest paid on leased assets Preferred stock, liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share us-gaap_ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, Net, Current, Total Preferred stock us-gaap_DeferredTaxAssetsLiabilitiesNet Net deferred tax assets, net of allowance Preferred stock, shares issued (in shares) Interest paid on loan from officer Income taxes paid Prepaid expenses Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] us-gaap_DeferredTaxAssetsOther Other Net deferred tax assets Preferred stock, shares authorized (in shares) Preferred stock, par value (in dollars per share) us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion Net product revenue Customer [Axis] Customer [Domain] us-gaap_PreferredStockRedemptionPricePerShare Preferred Stock, Redemption Price Per Share Depreciation expense, asset intz_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. U.S. Government [Member] Represents the U.S. Government. us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Deferred revenue us-gaap_IncreaseDecreaseInDeferredRevenue us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage Operating Activities: Statement [Line Items] Accounts receivable Additional paid-in-capital Stock-based compensation expense intz_PreferredStockUnpaidDividendsAdditionalLateFeePenaltyPercentage Preferred Stock Unpaid Dividends Additional Late Fee Penalty Percentage Represents the percentage of additional late fee penalty the entity will be required to pay on unpaid dividends for the preferred stock. AOCI Attributable to Parent [Member] Stockholders’ Equity (Deficit): Leasehold Improvements [Member] Property, Plant and Equipment, Policy [Policy Text Block] Series 2 Preferred Stock and Series 3 Preferred Stock [Member] Series 2 preferred stock and Series 3 preferred stock. Property, Plant and Equipment, Type [Axis] Noncash lease costs Amount of amortization expense for right-of-use asset from operating lease. Property, Plant and Equipment, Type [Domain] Net operating loss carryforwards Chief Financial Officer [Member] Chief Executive Officer [Member] Current Assets: Range 4 [Member] Range 4 in a series of exercise price ranges. Net operating loss carryforwards of foreign subsidiaries Four Government Customers [Member] Represents four government customers. Interest income us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities Commitments and contingencies Director [Member] us-gaap_OperatingIncomeLoss Operating income us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase in cash and cash equivalents us-gaap_GrossProfit Gross profit Cost of revenue Accounting Standards Update 2016-02 [Member] Type of Adoption [Domain] Concentration Risk, Credit Risk, Policy [Policy Text Block] us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment Depreciation expense, liability Adjustments for New Accounting Pronouncements [Axis] us-gaap_PaymentsOfDividends Payments of dividends Retained Earnings [Member] Proceeds from stock options exercised Title of Individual [Domain] Title of Individual [Axis] Treasury Stock [Member] us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock Additional Paid-in Capital [Member] Common Stock [Member] Preferred Stock [Member] us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued, Total Equity Components [Axis] Equity Component [Domain] Other Current Liabilities [Member] us-gaap_LineOfCredit Long-term Line of Credit, Total Income Tax Authority [Axis] Income Tax Authority [Domain] Domestic Tax Authority [Member] Revenue from Contract with Customer [Text Block] Accounts Receivable [Policy Text Block] us-gaap_RepaymentsOfRelatedPartyDebt Payments on loan from officer Cash and Cash Equivalents, Policy [Policy Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Domain] us-gaap_UnrecognizedTaxBenefits Unrecognized Tax Benefits, Ending Balance Accounting Policies [Abstract] Concentration Risk Disclosure [Text Block] Entity Interactive Data Current Title of 12(g) Security Borrowings on loan from officer Name of Property [Axis] Name of Property [Domain] Loan payable to officer us-gaap_SharePrice Share Price us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Diluted (in shares) us-gaap_OperatingLossCarryforwards Operating Loss Carryforwards, Total Statement [Table] Statement of Financial Position [Abstract] Net income per share attributable to common stockholders, diluted (in dollars per share) Basic (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] Net income per share attributable to common stockholders, basic (in dollars per share) Statement of Cash Flows [Abstract] Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Schedule of Accrued Liabilities [Table Text Block] Interest expense – Finance ROU us-gaap_FinanceLeaseLiabilityPaymentsDue Finance ROU Leases Undiscounted Obligation Amortization expense – Finance ROU Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount Finance ROU Leases, Less Interest* Finance ROU Leases, 2023 Finance ROU Leases, 2024 Finance ROU Leases, 2020 Finance ROU Leases, 2021 Finance ROU Leases, 2022 Other Financing Activities: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Change in valuation allowance Preferred stock dividends accrued Series C Preferred Stock [Member] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Total stockholders’ equity (deficit) Balance, beginning of year and end of year Balance, end of year Permanent differences Class of Stock [Axis] Class of Stock [Domain] Options outstanding weighted average exercise price (in dollars per share) Options outstanding weighted average remaining contractual life (Year) Options exercisable (in shares) Options exercisable weighted average exercise price (in dollars per share) Richardson Property [Member] Represents richardson property. Exercise price, high end of range (in dollars per share) Outstanding at the end of the period (in shares) Exercise Price Range [Axis] State income taxes (benefit), net of federal income tax benefit Exercise Price Range [Domain] The San Marcos Property [Member] Represents San Marcos property. Exercise price, low end of range (in dollars per share) EX-101.PRE 12 intz-20191231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Note 2 - Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
2.
Summary of Significant Accounting Policies
 
Principles of Consolidation
 
Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
 
Cash and Cash Equivalents
 
Cash and all highly liquid investments purchased with an original maturity of less than
three
months are considered to be cash and cash equivalents.
 
Risk Concentration
 
Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with
two
major U.S. financial institutions. We do
not
believe that we are subject to any unusual financial risk with our banking arrangements. We have
not
experienced any significant losses on our cash and cash equivalents.
 
We sell our products to customers primarily in the United States. In the future, we
may
sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. We perform ongoing credit evaluations of our customers’ financial condition and generally require
no
collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.
 
Accounts Receivable and Allowance for Doubtful Accounts
 
Trade accounts receivable are stated at the amount we expect to collect. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Management considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. If the financial condition of our customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required. Based on management’s assessment, we provide for estimated uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after we have used reasonable collection efforts are written off through a charge to the valuation allowance. There was
no
allowance at
December 
31,
2019
and
2018.
 
Property and Equipment
 
Equipment and furniture and fixtures are stated at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives vary from
1
to
5
years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from
2
to
5
years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs are expensed as incurred. Depreciation and amortization expense totaled approximately
$184,000
and
$133,000
for the years ended
December 
31,
2019
and
2018,
respectively.
 
Long-Lived Assets
 
We review long-lived assets, including property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may
not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are written down to fair value. During the years ended
December 
31,
2019
and
2018,
there was
no
impairment of long-lived assets.
 
Foreign Currency
 
All assets and liabilities in the balance sheets of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation gains and losses are
not
included in determining net income but are shown in accumulated other comprehensive loss in the stockholders’ deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss and were
not
significant.
 
Accounting for Stock Options
 
We account for stock options using the guidance in Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic
718.
FASB ASC Topic
718
requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.
 
Stock-based compensation expense recognized in the statements of operations for the years ended
2019
and
2018
is based on awards ultimately expected to vest, reduced by estimated forfeitures. FASB ASC Topic
718
requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
Valuation Assumptions
 
The fair values of option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended
December 
31,
2019
and
2018,
respectively:
 
   
201
9
   
2018
 
                 
Weighted average grant date fair value
  $
3.69
    $
0.49
 
Weighted average assumptions used:
               
Expected dividend yield
   
0.00
%
   
0.00
%
Risk-free interest rate
   
2.00
%
   
0.83
%
Expected volatility
   
124.58
%
   
225.21
%
Expected life (in years)
   
5.00
     
4.91
 
 
Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award.
 
Net Loss Per Share
 
We report
two
separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted average number of common shares and dilutive common stock equivalents outstanding for the year. Our common stock equivalents include all common stock issuable upon conversion of convertible preferred stock and the exercise of outstanding options. Common stock equivalents are included in the diluted loss per share for the years ended
December 
31,
2019
and
2018
except in cases where the issuance would be anti-dilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the year ended
December 
31,
2019
and
2018
totaled
30,630
and
zero
, respectively.
 
Revenue Recognition
 
On
January 1, 2018
we adopted ASU
No.
2014
-
09,
Revenue from Contracts with Customers
, as amended, using the modified retrospective approach. At the date of adoption there was
no
impact on the balance sheet or statement of operation. ASU
No.
2014
-
09
did
not
have a material effect on the Company’s financial position, results of operations or cash flows for the year ended
December 31, 2019.
 
We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do
not
currently offer software on a subscription basis. Warranty costs and sales returns have
not
been material.
 
We recognize sales of our data sets in accordance with FASB ASC Topic
606
whereby revenue from contracts with customers is
not
recognized until all
five
of the following have been met:
 
 
i)
identify the contract with a customer;
 
ii)
identify the performance obligations in the contract;
 
iii)
determine the transaction price;
 
iv)
allocate the transaction price to the separate performance obligations; and
 
v)
recognize revenue upon satisfaction of a performance obligation.
 
Data updates are typically done monthly and revenue will be matched accordingly. Product sales
may
include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We
may
defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally
one
year.
 
Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has
not
been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.
 
Our normal payment terms offered to customers, distributors and resellers are net
30
days domestically and net
45
days internationally. We do
not
offer payment terms that extend beyond
one
year and rarely do we extend payment terms beyond our normal terms. If certain customers do
not
meet our credit standards, we do require payment in advance to limit our credit exposure.
 
Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.
 
Research and Development Costs
 
We incur research and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major enhancements to existing services and products. Research and development costs are comprised primarily of salaries and related benefits expenses, contract labor and prototype and other related expenses.
 
Software development costs are included in research and development and are expensed as incurred. FASB ASC Topic
350
Intangibles—Goodwill and Other
requires that software development costs incurred subsequent to reaching technological feasibility be capitalized, if material. If the process of developing a new product or major enhancement does
not
include a detailed program design, technological feasibility is determined only after completion of a working model. To date, the period between achieving technological feasibility and the general availability of such software has been short, and the software development costs qualifying for capitalization have been insignificant.
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but
not
limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.
 
Fair Value of Financial Instruments
 
We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do
not
bear market rates of interest.  Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could
not
obtain comparable amounts of
third
party financing, and as such cannot estimate the fair value of the loan payable to officer.
None
of these instruments are held for trading purposes.
 
Income Taxes
 
Deferred income taxes are determined using the liability method in accordance with FASB ASC
740,
Accounting for Income Taxes
. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than
not
that some portion of the deferred tax asset will
not
be realized.
 
FASB ASC
740
creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FASB ASC
740
also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. There are
no
unrecognized tax benefits to disclose in the notes to the consolidated financial statements.
 
We file income tax returns in the United States federal jurisdiction. At
December 
31,
2019,
tax returns related to fiscal years ended
December 
31,
2016
through
December 
31,
2018
remain open to possible examination by the tax authorities.
No
tax returns are currently under examination by any tax authorities. We did
not
incur any penalties or interest during the years ended
December 
31,
2019
and
2018.
   On
December 22, 2017,
the U.S. enacted the Tax Cuts and Jobs Act (“the Tax Act”) which significantly changed U.S. tax law.  The Tax Act lowered the Company’s statutory federal income tax rate from a maximum of
39%
to a rate of
21%
effective
January 1, 2018.
 
Recent Accounting Pronouncements
 
On
January 1, 2019
we adopted ASU
No.
2016
-
02,
Leases (topic
842
)
. At the date of adoption there was
no
impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU
No.
2016
-
02
did
not
have a material effect on the Company’s results of operations or cash flows for the year ended
December 31, 2019.
 
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Net product revenue $ 13,643,000 $ 10,276,000
Cost of revenue 5,342,000 3,847,000
Gross profit 8,301,000 6,429,000
Operating expenses:    
Sales and marketing 1,298,000 1,604,000
Research and development 1,314,000 1,237,000
General and administrative 1,182,000 1,112,000
Operating income 4,507,000 2,476,000
Interest expense (46,000) (189,000)
Interest income 4,000
Income from operations before income taxes 4,465,000 2,287,000
Income tax provision
Net income 4,465,000 2,287,000
Preferred stock dividends accrued (139,000) (139,000)
Net income attributable to common stockholders $ 4,326,000 $ 2,148,000
Net income per share attributable to common stockholders, basic (in dollars per share) $ 0.32 $ 0.16
Net income per share attributable to common stockholders, diluted (in dollars per share) $ 0.28 $ 0.14
Weighted average common shares outstanding:    
Basic (in shares) 13,502 13,049
Diluted (in shares) 15,352 15,063
XML 15 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Note 6 - Borrowings From Officer
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
6
. Borrowings from Officer
 
On
February 8, 2018,
the Company entered into an unsecured revolving promissory note to borrow up to
$3,700,000
from G. Ward Paxton, the Company’s former Chief Executive Officer (the “CEO Note”). Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of
$3,700,000
at any given time through
March 2020.
 
On
February 
7,
2019,
the Company amended the unsecured revolving promissory note to borrow up to
$2,700,000
from G. Ward Paxton, the Company’s former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus
1%.
Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of
$2,700,000
at any given time through
March 
2021.
We reduced our borrowing under this note to
zero
as of
May 2019
 
As of
October 24, 2019,
G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will
no
longer be available to the Company. Our management will be assessing whether to replace this borrowing base and assessing what terms
may
be available to the Company, including whether any such terms are acceptable to the Company, if at all.
 
XML 16 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Note 10 - Concentrations
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
1
0
. Concentrations
 
Our operations are concentrated in
one
area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled
87.4%
of total revenues for
2019
and
83.9%
of total revenues for
2018.
During
2019
approximately
68.1%
of total revenues were attributable to
three
government customers. During
2018
approximately
61.4%
of total revenues are attributable to
four
government customers.
Three
individual government customers at
December 31, 2019
and
four
at
December 31, 2018
exceeded
10%
of total accounts receivable balance at respective year ends, comprising
78.8%
and
48.9%
of the respective total accounts receivable balance. During
2019
approximately
10.4%
of total revenues were attributable to
one
commercial customer, and during
2018,
14.1%
of total revenues were attributable to
one
commercial customer. Only
one
individual commercial customer at
December 31, 2019
exceeded
10%
of total accounts receivable balance, and only
one
at
December 31, 2018.
Our similar product and service offerings are
not
viewed as individual segments, as our management analyzes the business as a whole and expenses are
not
allocated to each product offering.
XML 17 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Net operating loss carryforwards $ 18,771 $ 20,720
Net operating loss carryforwards of foreign subsidiaries 374 374
Depreciation expense, liability (77)  
Depreciation expense, asset   4
Stock-based compensation expense 36 28
Other 68 78
Net deferred tax assets 19,172 21,204
Valuation allowance for net deferred tax assets (19,172) (21,204)
Net deferred tax assets, net of allowance
XML 18 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Commitments and Contingencies - Future Minimum Lease Obligations (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Operating ROU Leases, 2020 $ 362
Finance ROU Leases, 2020 45
2020 407
Operating ROU Leases, 2021 361
Finance ROU Leases, 2021 21
2021 382
Operating ROU Leases, 2022 369
Finance ROU Leases, 2022
2022 369
Operating ROU Leases, 2023 380
Finance ROU Leases, 2023
2023 380
Operating ROU Leases, 2024 352
Finance ROU Leases, 2024
2024 352
Operating ROU Leases Undiscounted Obligation 1,824
Finance ROU Leases Undiscounted Obligation 66
1,890
Operating ROU Leases, Less Interest* (225) [1]
Finance ROU Leases, Less Interest* (2) [1]
Operating ROU Leases 1,599
Finance ROU Leases $ 64
[1] Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.
XML 19 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options - Number & Weighted Average Exercise Price (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Outstanding at beginning of year (in shares) 1,235 1,746
Outstanding at beginning of year (in dollars per share) $ 0.83 $ 0.68
Granted at price = market value (in shares) 34 24
Granted at price = market value (in dollars per share) $ 4.40 $ 1.15
Granted at price > market value (in shares)
Granted at price > market value (in dollars per share)
Exercised (in shares) (294) (451)
Exercised (in dollars per share) $ 0.81 $ 0.37
Forfeited (in shares)
Forfeited (in dollars per share)
Expired (in shares) (84)
Expired (in dollars per share) $ 0.22
Outstanding at end of year (in shares) 975 1,235
Outstanding at end of year (in dollars per share) $ 0.96 $ 0.83
Options exercisable at end of year (in shares) 917 1,172
Options exercisable at end of year (in dollars per share) $ 0.84 $ 0.84
XML 20 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Note 3 - Accrued Expenses (in Thousands) - Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Accrued payroll $ 193 $ 154
Accrued vacation 311 310
Accrued bonus 245 170
Rent payable 191
Accrued interest, related party 479
Other 79 99
Total accrued expenses $ 828 $ 1,403
XML 21 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
201
9
   
2018
 
                 
Weighted average grant date fair value
  $
3.69
    $
0.49
 
Weighted average assumptions used:
               
Expected dividend yield
   
0.00
%
   
0.00
%
Risk-free interest rate
   
2.00
%
   
0.83
%
Expected volatility
   
124.58
%
   
225.21
%
Expected life (in years)
   
5.00
     
4.91
 
XML 22 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Common Shares Reserved for Future Issuance [Table text Block]
(In thousands)
 
Common Shares
Reserved for Future
Issuance
 
         
Preferred Stock
   
1,067
 
2015 Plan
   
600
 
2005 Plan
   
824
 
Total
   
2,491
 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
201
9
   
201
8
 
   
Number of
Options (in
thousands)
   
Weighted
Average
Exercise
Price
   
Number of
Options (in
thousands)
   
Weighted
Average
Exercise
Price
 
                                 
Outstanding at beginning of year
   
1,235
    $
0.83
     
1,746
    $
0.68
 
Granted at price = market value
   
34
     
4.40
     
24
     
1.15
 
Granted at price > market value
   
     
     
     
 
Exercised
   
(294
)
   
0.81
     
(451
)
   
0.37
 
Forfeited
   
     
     
     
 
Expired
   
     
     
(84
)
   
0.22
 
                                 
Outstanding at end of year
   
975
    $
0.96
     
1,235
    $
0.83
 
Options exercisable at end of year
   
917
    $
0.84
     
1,172
    $
0.84
 
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
       
Options Outstanding
   
Options Exercisable
 
Range of Exercise Prices
 
Outstanding at
12/31/1
9
(in
thousands)
   
Weighted
Average
Remaining
Contractual Life (years)
   
Weighted
Average
Exercise
Price
   
Exercisable at
12/31/1
9
(in
thousands)
   
Weighted
Average
Exercise
Price
 
                                             
$ 0.34
-
$0.50
   
391
     
2.86
    $
0.42
     
383
    $
0.42
 
$ 0.51
-
$1.00
   
330
     
1.53
     
0.68
     
330
     
0.68
 
$ 1.01
-
$2.00
   
173
     
4.69
     
1.71
     
157
     
1.77
 
$ 2.01
-
$4.75
   
81
     
6.95
     
3.12
     
47
     
2.20
 
 
 
 
   
975
     
3.08
    $
0.96
     
917
    $
0.84
 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
   
Outstanding Stock
Options (Fully Vested
and Expected to Vest)*
   
Options that are
Exercisable
 
As of December 31, 201
9
 
 
 
 
 
 
 
 
Number of outstanding options (in thousands)
   
970
     
917
 
Weighted average remaining contractual life
   
3.04
     
2.71
 
Weighted average exercise price per share
  $
0.95
    $
0.84
 
Intrinsic value (in thousands)
  $
4,411
    $
4,278
 
XML 23 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options - Outstanding (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Number of outstanding options (in thousands) (in shares) [1] 970  
Number of outstanding options (in thousands) (in shares) 917 1,172
Weighted average remaining contractual life (Year) [1] 3 years 14 days  
Weighted average remaining contractual life (Year) 2 years 259 days  
Weighted average exercise price per share (in dollars per share) [1] $ 0.95  
Weighted average exercise price per share (in dollars per share) $ 0.84 $ 0.84
Intrinsic value (in thousands) [1] $ 4,411  
Intrinsic value (in thousands) $ 4,278  
[1] Includes effects of expected forfeitures
XML 24 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Note 3 - Accrued Expenses (In Thousands) (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Accrued Liabilities [Table Text Block]
   
December 31,
 
   
201
9
   
201
8
 
                 
Accrued payroll
  $
193
    $
154
 
Accrued vacation
   
311
     
310
 
Accrued bonus
   
245
     
170
 
Rent payable
   
     
191
 
Accrued interest, related party
   
     
479
 
Other
   
79
     
99
 
    $
828
    $
1,403
 
XML 25 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Description of Business (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash and Cash Equivalents, at Carrying Value, Ending Balance $ 3,334,000 $ 1,652,000 $ 224,000
Net Income (Loss) Attributable to Parent, Total $ 4,465,000 $ 2,287,000  
XML 26 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 112 359 1 true 41 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.intrusion.com/20191231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.intrusion.com/20191231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.intrusion.com/20191231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.intrusion.com/20191231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) Sheet http://www.intrusion.com/20191231/role/statement-consolidated-statements-of-changes-in-stockholders-equity-deficit Consolidated Statements of Changes in Stockholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.intrusion.com/20191231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Description of Business Sheet http://www.intrusion.com/20191231/role/statement-note-1-description-of-business- Note 1 - Description of Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies- Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Accrued Expenses (In Thousands) Sheet http://www.intrusion.com/20191231/role/statement-note-3-accrued-expenses-in-thousands Note 3 - Accrued Expenses (In Thousands) Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Commitments and Contingencies Sheet http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies Note 4 - Commitments and Contingencies Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Employee Benefit Plan Sheet http://www.intrusion.com/20191231/role/statement-note-5-employee-benefit-plan- Note 5 - Employee Benefit Plan Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Borrowings From Officer Sheet http://www.intrusion.com/20191231/role/statement-note-6-borrowings-from-officer Note 6 - Borrowings From Officer Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Income Taxes Sheet http://www.intrusion.com/20191231/role/statement-note-7-income-taxes- Note 7 - Income Taxes Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Stock Options Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options Note 8 - Stock Options Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Preferred Stock Sheet http://www.intrusion.com/20191231/role/statement-note-9-preferred-stock Note 9 - Preferred Stock Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Concentrations Sheet http://www.intrusion.com/20191231/role/statement-note-10-concentrations Note 10 - Concentrations Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Contract Assets and Contract Liabilities Sheet http://www.intrusion.com/20191231/role/statement-note-11-contract-assets-and-contract-liabilities Note 11 - Contract Assets and Contract Liabilities Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Coronavirus Outbreak in the United States Sheet http://www.intrusion.com/20191231/role/statement-note-12-coronavirus-outbreak-in-the-united-states Note 12 - Coronavirus Outbreak in the United States Notes 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.intrusion.com/20191231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies- 19 false false R20.htm 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies- 20 false false R21.htm 020 - Disclosure - Note 3 - Accrued Expenses (In Thousands) (Tables) Sheet http://www.intrusion.com/20191231/role/statement-note-3-accrued-expenses-in-thousands-tables Note 3 - Accrued Expenses (In Thousands) (Tables) Tables http://www.intrusion.com/20191231/role/statement-note-3-accrued-expenses-in-thousands 21 false false R22.htm 021 - Disclosure - Note 4 - Commitments and Contingencies (Tables) Sheet http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies-tables Note 4 - Commitments and Contingencies (Tables) Tables http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies 22 false false R23.htm 022 - Disclosure - Note 7 - Income Taxes (Tables) Sheet http://www.intrusion.com/20191231/role/statement-note-7-income-taxes-tables Note 7 - Income Taxes (Tables) Tables http://www.intrusion.com/20191231/role/statement-note-7-income-taxes- 23 false false R24.htm 023 - Disclosure - Note 8 - Stock Options (Tables) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-tables Note 8 - Stock Options (Tables) Tables http://www.intrusion.com/20191231/role/statement-note-8-stock-options 24 false false R25.htm 024 - Disclosure - Note 1 - Description of Business (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-1-description-of-business-details-textual Note 1 - Description of Business (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-1-description-of-business- 25 false false R26.htm 025 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables 26 false false R27.htm 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Valuation Assumptions (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-valuation-assumptions-details Note 2 - Summary of Significant Accounting Policies - Valuation Assumptions (Details) Details 27 false false R28.htm 027 - Disclosure - Note 3 - Accrued Expenses (in Thousands) - Accrued Expenses (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-3-accrued-expenses-in-thousands-accrued-expenses-details Note 3 - Accrued Expenses (in Thousands) - Accrued Expenses (Details) Details http://www.intrusion.com/20191231/role/statement-note-3-accrued-expenses-in-thousands-tables 28 false false R29.htm 028 - Disclosure - Note 4 - Commitments and Contingencies (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies-details-textual Note 4 - Commitments and Contingencies (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies-tables 29 false false R30.htm 029 - Disclosure - Note 4 - Commitments and Contingencies - Schedule of Items Appearing on the Statement of Operations (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies-schedule-of-items-appearing-on-the-statement-of-operations-details Note 4 - Commitments and Contingencies - Schedule of Items Appearing on the Statement of Operations (Details) Details 30 false false R31.htm 030 - Disclosure - Note 4 - Commitments and Contingencies - Future Minimum Lease Obligations (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-4-commitments-and-contingencies-future-minimum-lease-obligations-details Note 4 - Commitments and Contingencies - Future Minimum Lease Obligations (Details) Details 31 false false R32.htm 031 - Disclosure - Note 5 - Employee Benefit Plan (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-5-employee-benefit-plan-details-textual Note 5 - Employee Benefit Plan (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-5-employee-benefit-plan- 32 false false R33.htm 032 - Disclosure - Note 6 - Borrowings From Officer (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-6-borrowings-from-officer-details-textual Note 6 - Borrowings From Officer (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-6-borrowings-from-officer 33 false false R34.htm 033 - Disclosure - Note 7 - Income Taxes (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-7-income-taxes-details-textual Note 7 - Income Taxes (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-7-income-taxes-tables 34 false false R35.htm 034 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-7-income-taxes-deferred-tax-assets-and-liabilities-details Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 35 false false R36.htm 035 - Disclosure - Note 7 - Income Taxes - Income Tax Reconciliation (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-7-income-taxes-income-tax-reconciliation-details Note 7 - Income Taxes - Income Tax Reconciliation (Details) Details 36 false false R37.htm 036 - Disclosure - Note 8 - Stock Options (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-details-textual Note 8 - Stock Options (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-8-stock-options-tables 37 false false R38.htm 037 - Disclosure - Note 8 - Stock Options - Common Shares Reserved for Future Issuance (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-common-shares-reserved-for-future-issuance-details Note 8 - Stock Options - Common Shares Reserved for Future Issuance (Details) Details 38 false false R39.htm 038 - Disclosure - Note 8 - Stock Options - Number & Weighted Average Exercise Price (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-number-weighted-average-exercise-price-details Note 8 - Stock Options - Number & Weighted Average Exercise Price (Details) Details 39 false false R40.htm 039 - Disclosure - Note 8 - Stock Options - Exercise Price (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-exercise-price-details Note 8 - Stock Options - Exercise Price (Details) Details 40 false false R41.htm 040 - Disclosure - Note 8 - Stock Options - Outstanding (Details) Sheet http://www.intrusion.com/20191231/role/statement-note-8-stock-options-outstanding-details Note 8 - Stock Options - Outstanding (Details) Details 41 false false R42.htm 041 - Disclosure - Note 9 - Preferred Stock (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-9-preferred-stock-details-textual Note 9 - Preferred Stock (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-9-preferred-stock 42 false false R43.htm 042 - Disclosure - Note 10 - Concentrations (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-10-concentrations-details-textual Note 10 - Concentrations (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-10-concentrations 43 false false R44.htm 043 - Disclosure - Note 11 - Contract Assets and Contract Liabilities (Details Textual) Sheet http://www.intrusion.com/20191231/role/statement-note-11-contract-assets-and-contract-liabilities-details-textual Note 11 - Contract Assets and Contract Liabilities (Details Textual) Details http://www.intrusion.com/20191231/role/statement-note-11-contract-assets-and-contract-liabilities 44 false false All Reports Book All Reports intz-20191231.xml intz-20191231.xsd intz-20191231_cal.xml intz-20191231_def.xml intz-20191231_lab.xml intz-20191231_pre.xml http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 27 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Commitments and Contingencies (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Jan. 01, 2019
Lessee, Finance Lease, Term of Contract 3 years    
Operating Lease, Right-of-Use Asset $ 1,348,000  
Operating Lease, Liability, Total 1,599,000    
Operating Lease, Payments $ 294,000 $ 264,000  
Accounting Standards Update 2016-02 [Member]      
Operating Lease, Right-of-Use Asset     $ 1,580,000
Operating Lease, Liability, Total     $ 1,771,000
Richardson Property [Member]      
Lessee, Operating Lease, Term of Contract 5 years 150 days    
The San Marcos Property [Member]      
Lessee, Operating Lease, Term of Contract 1 year 90 days    
XML 28 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Note 11 - Contract Assets and Contract Liabilities (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Contract with Customer, Asset, Net, Current, Total $ 1,566,000 $ 1,967,000
Increase (Decrease) in Contract with Customer, Asset 401,000  
Contract with Customer, Liability, Current $ 516,000 $ 1,004,000
XML 29 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options - Exercise Price (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2019
$ / shares
shares
Outstanding at the end of the period (in shares) | shares 975
Options outstanding weighted average remaining contractual life (Year) 3 years 29 days
Options outstanding weighted average exercise price (in dollars per share) $ 0.96
Options exercisable (in shares) | shares 917
Options exercisable weighted average exercise price (in dollars per share) $ 0.84
Range 1 [Member]  
Exercise price, low end of range (in dollars per share) 0.34
Exercise price, high end of range (in dollars per share) $ 0.50
Outstanding at the end of the period (in shares) | shares 391
Options outstanding weighted average remaining contractual life (Year) 2 years 313 days
Options outstanding weighted average exercise price (in dollars per share) $ 0.42
Options exercisable (in shares) | shares 383
Options exercisable weighted average exercise price (in dollars per share) $ 0.42
Range 2 [Member]  
Exercise price, low end of range (in dollars per share) 0.51
Exercise price, high end of range (in dollars per share) $ 1
Outstanding at the end of the period (in shares) | shares 330
Options outstanding weighted average remaining contractual life (Year) 1 year 193 days
Options outstanding weighted average exercise price (in dollars per share) $ 0.68
Options exercisable (in shares) | shares 330
Options exercisable weighted average exercise price (in dollars per share) $ 0.68
Range 3 [Member]  
Exercise price, low end of range (in dollars per share) 1.01
Exercise price, high end of range (in dollars per share) $ 2
Outstanding at the end of the period (in shares) | shares 173
Options outstanding weighted average remaining contractual life (Year) 4 years 251 days
Options outstanding weighted average exercise price (in dollars per share) $ 1.71
Options exercisable (in shares) | shares 157
Options exercisable weighted average exercise price (in dollars per share) $ 1.77
Range 4 [Member]  
Exercise price, low end of range (in dollars per share) 2.01
Exercise price, high end of range (in dollars per share) $ 4.75
Outstanding at the end of the period (in shares) | shares 81
Options outstanding weighted average remaining contractual life (Year) 6 years 346 days
Options outstanding weighted average exercise price (in dollars per share) $ 3.12
Options exercisable (in shares) | shares 47
Options exercisable weighted average exercise price (in dollars per share) $ 2.20
XML 30 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
shares in Thousands
Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance, beginning of year and end of year (in shares) 949 12,808          
Balance, beginning of year and end of year (in shares) at Dec. 31, 2017 949 12,808          
Balance, beginning of year and end of year at Dec. 31, 2017 $ 1,843,000 $ 128,000   $ 56,518,000 $ (61,529,000) $ (107,000)  
Exercise of stock options (in shares)   451         451
Balance, end of year (in shares) at Dec. 31, 2018 949 13,259 (362) 56,609      
Exercise of stock options   $ 5,000   $ 163,000      
Balance, end of year at Dec. 31, 2018 $ 1,843,000 $ 133,000   $ 56,609,000 (59,242,000) (43,000) $ (1,062,000)
Balance, beginning of year and end of year (in shares) 949 12,808 (362) 56,609      
Stock-based compensation       $ 20,000      
Preferred stock dividends declared, net of waived penalties by shareholders       $ (92,000)      
Net income         2,287,000   2,287,000
Extinguishment of U.K. cumulative translation adjustment           64,000 $ 64,000
Balance, beginning of year and end of year (in shares) 949 13,259 (362) 56,609      
Exercise of stock options (in shares)   293         294
Balance, end of year (in shares) at Dec. 31, 2019   13,552 (362) 56,759      
Exercise of stock options   $ 3,000   $ 236,000      
Balance, end of year at Dec. 31, 2019   $ 136,000     (54,777,000) (43,000) $ 3,556,000
Balance, beginning of year and end of year (in shares) 949 13,552 (362) 56,609      
Stock-based compensation       $ 47,000      
Preferred stock dividends declared, net of waived penalties by shareholders       $ (133,000)      
Net income         $ 4,465,000   4,465,000
Extinguishment of U.K. cumulative translation adjustment          
Balance, beginning of year and end of year (in shares)   13,552 (362) 56,759      
XML 31 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document And Entity Information - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Feb. 28, 2020
Jun. 28, 2019
Document Information [Line Items]      
Entity Registrant Name Intrusion Inc    
Entity Central Index Key 0000736012    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity Interactive Data Current Yes    
Entity Common Stock, Shares Outstanding (in shares)   13,753,030  
Entity Public Float     $ 46,588
Entity Shell Company false    
Document Type 10-K    
Document Period End Date Dec. 31, 2019    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Amendment Flag false    
Title of 12(g) Security Common Stock, $0.01 par value    
XML 32 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Note 3 - Accrued Expenses (In Thousands)
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
3.
Accrued Expenses
(in thousands)
 
   
December 31,
 
   
201
9
   
201
8
 
                 
Accrued payroll
  $
193
    $
154
 
Accrued vacation
   
311
     
310
 
Accrued bonus
   
245
     
170
 
Rent payable
   
     
191
 
Accrued interest, related party
   
     
479
 
Other
   
79
     
99
 
    $
828
    $
1,403
 
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Income Taxes
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
7
. Income Taxes
 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets (liabilities) as of
December 
31,
2019
and
2018
are as follows (in thousands):
 
   
December 31
 
   
201
9
   
201
8
 
                 
Net operating loss carryforwards
  $
18,771
    $
20,720
 
Net operating loss carryforwards of foreign subsidiaries
   
374
     
374
 
Depreciation expense
   
(77
)
   
4
 
Stock-based compensation expense
   
36
     
28
 
Other
   
68
     
78
 
Net deferred tax assets
   
19,172
     
21,204
 
Valuation allowance for net deferred tax assets
   
(19,172
)
   
(21,204
)
Net deferred tax assets, net of allowance
  $
    $
 
 
Deferred tax assets are required to be reduced by a valuation allowance if it is more likely than
not
that some portion or all of the deferred tax assets will
not
be realized. Realization of the future benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate taxable income within the near to medium term. Management has considered these factors in determining the valuation allowance for
2019
and
2018.
 
The differences between the provision for income taxes and income taxes computed using the federal statutory rate for the years ended
December 
31,
2019
and
2018
are as follows (in thousands):
 
   
201
9
   
201
8
 
                 
Reconciliation of income tax benefit to statutory rate:
               
Income benefit at statutory rate
  $
938
    $
480
 
State income taxes (benefit), net of federal income tax benefit
   
1,066
     
57
 
Permanent differences
   
10
     
(91
)
Change in valuation allowance
   
(2,030
)
   
(450
)
Other
   
16
     
4
 
    $     $  
 
At
December 
31,
2019,
we had federal net operating loss carryforwards of approximately
$81.7
million for income tax purposes that begin to expire in
2022
and are subject to the ownership change limitations under Internal Revenue Code Section 
382.
XML 34 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Note 11 - Contract Assets and Contract Liabilities
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]
1
1
.
Contract Assets and Contract Liabilities
 
Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. For the year ended
December 31, 2019,
the Company had contract assets balance of
$1,566,000,
a decrease of
$401,000
from the prior year due to cash receipts exceeding new contract assets. For the year ended
December 31, 2018,
the Company had contract assets balance of
$1,967,000.
 
Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies deferred revenue as a contract liablility. For the year ended
December 31, 2019,
the Company had contract liabilities balance of
$516,000.
For the year ended
December 31, 2018,
the Company had contract liabilities balance of
$1,004,000.
XML 35 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options - Common Shares Reserved for Future Issuance (Details)
Dec. 31, 2019
shares
Common shares reserved for future issuance (in shares) 2,491,543
The 2015 Stock Incentive Plan [Member]  
Common shares reserved for future issuance (in shares) 600,000
The 2005 Stock Incentive Plan [Member]  
Common shares reserved for future issuance (in shares) 824,000
Preferred Stock [Member]  
Common shares reserved for future issuance (in shares) 1,067,000
XML 36 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Income Taxes (Details Textual)
$ in Millions
Dec. 31, 2019
USD ($)
Domestic Tax Authority [Member]  
Operating Loss Carryforwards, Total $ 81.7
XML 37 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Commitments and Contingencies - Schedule of Items Appearing on the Statement of Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Amortization expense – Finance ROU $ 59 $ 65
Lease expense – Operating ROU 433 316
Interest expense – Finance ROU $ 4 $ 5
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   
December 31
 
   
201
9
   
201
8
 
                 
Net operating loss carryforwards
  $
18,771
    $
20,720
 
Net operating loss carryforwards of foreign subsidiaries
   
374
     
374
 
Depreciation expense
   
(77
)
   
4
 
Stock-based compensation expense
   
36
     
28
 
Other
   
68
     
78
 
Net deferred tax assets
   
19,172
     
21,204
 
Valuation allowance for net deferred tax assets
   
(19,172
)
   
(21,204
)
Net deferred tax assets, net of allowance
  $
    $
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   
201
9
   
201
8
 
                 
Reconciliation of income tax benefit to statutory rate:
               
Income benefit at statutory rate
  $
938
    $
480
 
State income taxes (benefit), net of federal income tax benefit
   
1,066
     
57
 
Permanent differences
   
10
     
(91
)
Change in valuation allowance
   
(2,030
)
   
(450
)
Other
   
16
     
4
 
    $     $  
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Note 2 - Summary of Significant Accounting Policies - Valuation Assumptions (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Weighted average grant date fair value (in dollars per share) $ 3.69 $ 0.49
Expected dividend yield 0.00% 0.00%
Risk-free interest rate 2.00% 0.83%
Expected volatility 124.58% 225.21%
Expected life (in years) (Year) 5 years 4 years 332 days
XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - Preferred Stock (Details Textual)
12 Months Ended
Dec. 02, 2005
USD ($)
$ / shares
shares
Mar. 28, 2005
USD ($)
$ / shares
shares
Mar. 25, 2004
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Preferred Stock Dividends, Income Statement Impact | $       $ 139,000 $ 139,000
Dividends Payable, Current | $       20,000 594,000
Other Current Liabilities [Member]          
Dividends Payable, Current | $       $ 20,000 $ 594,000
Series A Preferred Stock [Member]          
Stock Issued During Period, Value, New Issues | $     $ 5,000,000    
Preferred Stock, Dividend Rate, Percentage     5.00%    
Stock Issued During Period, Shares, New Issues     1,000,000    
Share Price | $ / shares     $ 5    
Proceeds from Issuance of Preferred Stock and Preference Stock | $     $ 5,000,000    
Preferred Stock Issuance Costs | $     $ 275,000    
Convertible Preferred Stock, Shares Issued upon Conversion     1,590,331 318,065  
Preferred Stock, Conversion Price Per Share | $ / shares     $ 3.144    
Preferred Stock, Voting Rights Number     1.5903    
Preferred Stock, Liquidation Preference Per Share | $ / shares     $ 5    
Preferred Stock, Redemption Price Per Share | $ / shares     $ 5    
Preferred Stock, Shares Outstanding, Ending Balance       200,000  
Preferred Stock Dividends, Income Statement Impact | $       $ 50,000  
Series A Preferred Stock [Member] | Chief Executive Officer [Member]          
Stock Issued During Period, Shares, New Issues     140,000    
Series A Preferred Stock [Member] | Director [Member]          
Stock Issued During Period, Shares, New Issues     60,000    
Series B Preferred Stock [Member]          
Stock Issued During Period, Value, New Issues | $   $ 2,700,000      
Preferred Stock, Dividend Rate, Percentage   5.00%      
Stock Issued During Period, Shares, New Issues   1,065,200      
Share Price | $ / shares   $ 2.50      
Proceeds from Issuance of Preferred Stock and Preference Stock | $   $ 2,700,000      
Preferred Stock Issuance Costs | $   $ 173,000      
Convertible Preferred Stock, Shares Issued upon Conversion   1,065,200   460,000  
Preferred Stock, Conversion Price Per Share | $ / shares   $ 2.50      
Preferred Stock, Liquidation Preference Per Share | $ / shares   2.50      
Preferred Stock, Shares Outstanding, Ending Balance       460,000  
Preferred Stock Dividends, Income Statement Impact | $       $ 57,000  
Series B Preferred Stock [Member] | Minimum [Member]          
Preferred Stock, Redemption Price Per Share | $ / shares   $ 3.25      
Series B Preferred Stock [Member] | Chief Executive Officer [Member]          
Stock Issued During Period, Shares, New Issues   260,000      
Series B Preferred Stock [Member] | Director [Member]          
Stock Issued During Period, Shares, New Issues   60,000      
Series B Preferred Stock [Member] | Chief Financial Officer [Member]          
Stock Issued During Period, Shares, New Issues   100,000      
Series C Preferred Stock [Member]          
Stock Issued During Period, Value, New Issues | $ $ 1,200,000        
Preferred Stock, Dividend Rate, Percentage 5.00%        
Stock Issued During Period, Shares, New Issues 564,607        
Share Price | $ / shares $ 2.18        
Proceeds from Issuance of Preferred Stock and Preference Stock | $ $ 1,200,000        
Preferred Stock Issuance Costs | $ $ 100,000        
Convertible Preferred Stock, Shares Issued upon Conversion 564,607     289,377  
Preferred Stock, Conversion Price Per Share | $ / shares $ 2.18        
Preferred Stock, Liquidation Preference Per Share | $ / shares 2.18        
Preferred Stock, Shares Outstanding, Ending Balance       289,377  
Preferred Stock Dividends, Income Statement Impact | $       $ 32,000  
Series C Preferred Stock [Member] | Minimum [Member]          
Preferred Stock, Redemption Price Per Share | $ / shares $ 2.834        
Series C Preferred Stock [Member] | Chief Executive Officer [Member]          
Stock Issued During Period, Shares, New Issues 123,853        
Series C Preferred Stock [Member] | Director [Member]          
Stock Issued During Period, Shares, New Issues 27,523        
Series C Preferred Stock [Member] | Chief Financial Officer [Member]          
Stock Issued During Period, Shares, New Issues 68,808        
Series 2 Preferred Stock and Series 3 Preferred Stock [Member]          
Preferred Stock Unpaid Dividends Additional Late Fee Penalty Percentage       18.00%  
XML 44 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Description of Business
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Nature of Operations [Text Block]
1.
Description of Business
 
We develop, market, and support a family of entity identification, data mining, regulated information compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.
 
We market and distribute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.
 
References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Compliance Commander™ and TraceCop™ are registered trademarks of Intrusion Inc.
 
As of
December 31, 2019,
we had cash and cash equivalents of approximately
$3,334,000,
up from approximately
$1,652,000
as of
December 31, 2018.
We generated a net income of
$4,465,000
for the year ended
December 31, 2019
compared to a net income of
$2,287,000
for the year ended
December 31, 2018.
We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on the current forecast for the year
2020,
we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through
March 31, 2021.
As of
October 24, 2019,
our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing base and assessing what terms
may
be available to the Company, including whether any such terms available are acceptable to the Company, if at all (the “Potential Replacement Facility”). Any equity or debt financings, if available at all,
may
be on terms which are
not
favorable to us and, in the case of equity financings,
may
result in dilution to our stockholders. We expect to fund our operations through anticipated Company profits, possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly, and a possible Potential Replacement Facility. If our operations do
not
generate positive cash flow in the upcoming year, or if we are
not
able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we
may
be unable to implement our business plan, fund our liquidity needs or even continue our operations.
XML 45 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
shares in Thousands
Dec. 31, 2019
Dec. 31, 2018
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 5,000 5,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 80,000 80,000
Common stock, shares issued (in shares) 13,552 13,259
Common stock, shares outstanding (in shares) 13,542 13,249
Common stock held in treasury, at cost, shares (in shares) 10 10
Series 1 Preferred Stock [Member]    
Preferred stock, shares issued (in shares) 200 200
Preferred stock, shares outstanding (in shares) 200 200
Preferred stock, liquidation preference (in dollars per share) $ 1,013 $ 1,213
Series 2 Preferred Stock [Member]    
Preferred stock, shares issued (in shares) 460 460
Preferred stock, shares outstanding (in shares) 460 460
Preferred stock, liquidation preference (in dollars per share) $ 1,155 $ 1,385
Series 3 Preferred Stock [Member]    
Preferred stock, shares issued (in shares) 289 289
Preferred stock, shares outstanding (in shares) 289 289
Preferred stock, liquidation preference (in dollars per share) $ 634 $ 760
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income benefit at statutory rate $ 938 $ 480
State income taxes (benefit), net of federal income tax benefit 1,066 57
Permanent differences 10 (91)
Change in valuation allowance (2,030) (450)
Other $ 16 $ 4
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Note 5 - Employee Benefit Plan (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Defined Contribution Plan, Minimum age Required for Contribution of Additional Amount of Salary Per Year 50 years  
Defined Contribution Plan, Employer Matching Contribution, Percent of Match 0.25%  
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 4.00%  
Defined Contribution Plan, Cost $ 32,000 $ 30,000
Minimum [Member]    
Define Contribution Plan, Percentage of Contribution by Employees 1.00%  
Maximum [Member]    
Define Contribution Plan, Percentage of Contribution by Employees 25.00%  
XML 48 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
 
Our consolidated financial statements include our accounts and those of our wholly owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
 
Cash and all highly liquid investments purchased with an original maturity of less than
three
months are considered to be cash and cash equivalents.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Risk Concentration
 
Financial instruments, which potentially subject us to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with
two
major U.S. financial institutions. We do
not
believe that we are subject to any unusual financial risk with our banking arrangements. We have
not
experienced any significant losses on our cash and cash equivalents.
 
We sell our products to customers primarily in the United States. In the future, we
may
sale our products internationally. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. We perform ongoing credit evaluations of our customers’ financial condition and generally require
no
collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.
Accounts Receivable [Policy Text Block]
Accounts Receivable and Allowance for Doubtful Accounts
 
Trade accounts receivable are stated at the amount we expect to collect. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. Management considers the following factors when determining the collectability of specific customer accounts: customer credit-worthiness, past transaction history with the customer, current economic industry trends, and changes in customer payment terms. If the financial condition of our customers were to deteriorate, adversely affecting their ability to make payments, additional allowances would be required. Based on management’s assessment, we provide for estimated uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after we have used reasonable collection efforts are written off through a charge to the valuation allowance. There was
no
allowance at
December 
31,
2019
and
2018.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment
 
Equipment and furniture and fixtures are stated at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives vary from
1
to
5
years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from
2
to
5
years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs are expensed as incurred. Depreciation and amortization expense totaled approximately
$184,000
and
$133,000
for the years ended
December 
31,
2019
and
2018,
respectively.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Long-Lived Assets
 
We review long-lived assets, including property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may
not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are written down to fair value. During the years ended
December 
31,
2019
and
2018,
there was
no
impairment of long-lived assets.
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency
 
All assets and liabilities in the balance sheets of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation gains and losses are
not
included in determining net income but are shown in accumulated other comprehensive loss in the stockholders’ deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss and were
not
significant.
Share-based Payment Arrangement [Policy Text Block]
Accounting for Stock Options
 
We account for stock options using the guidance in Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic
718.
FASB ASC Topic
718
requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.
 
Stock-based compensation expense recognized in the statements of operations for the years ended
2019
and
2018
is based on awards ultimately expected to vest, reduced by estimated forfeitures. FASB ASC Topic
718
requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
Valuation Assumptions
 
The fair values of option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended
December 
31,
2019
and
2018,
respectively:
 
   
201
9
   
2018
 
                 
Weighted average grant date fair value
  $
3.69
    $
0.49
 
Weighted average assumptions used:
               
Expected dividend yield
   
0.00
%
   
0.00
%
Risk-free interest rate
   
2.00
%
   
0.83
%
Expected volatility
   
124.58
%
   
225.21
%
Expected life (in years)
   
5.00
     
4.91
 
 
Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award.
Earnings Per Share, Policy [Policy Text Block]
Net Loss Per Share
 
We report
two
separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted average number of common shares and dilutive common stock equivalents outstanding for the year. Our common stock equivalents include all common stock issuable upon conversion of convertible preferred stock and the exercise of outstanding options. Common stock equivalents are included in the diluted loss per share for the years ended
December 
31,
2019
and
2018
except in cases where the issuance would be anti-dilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the year ended
December 
31,
2019
and
2018
totaled
30,630
and
zero
, respectively.
Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition
 
On
January 1, 2018
we adopted ASU
No.
2014
-
09,
Revenue from Contracts with Customers
, as amended, using the modified retrospective approach. At the date of adoption there was
no
impact on the balance sheet or statement of operation. ASU
No.
2014
-
09
did
not
have a material effect on the Company’s financial position, results of operations or cash flows for the year ended
December 31, 2019.
 
We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do
not
currently offer software on a subscription basis. Warranty costs and sales returns have
not
been material.
 
We recognize sales of our data sets in accordance with FASB ASC Topic
606
whereby revenue from contracts with customers is
not
recognized until all
five
of the following have been met:
 
 
i)
identify the contract with a customer;
 
ii)
identify the performance obligations in the contract;
 
iii)
determine the transaction price;
 
iv)
allocate the transaction price to the separate performance obligations; and
 
v)
recognize revenue upon satisfaction of a performance obligation.
 
Data updates are typically done monthly and revenue will be matched accordingly. Product sales
may
include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We
may
defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally
one
year.
 
Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has
not
been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.
 
Our normal payment terms offered to customers, distributors and resellers are net
30
days domestically and net
45
days internationally. We do
not
offer payment terms that extend beyond
one
year and rarely do we extend payment terms beyond our normal terms. If certain customers do
not
meet our credit standards, we do require payment in advance to limit our credit exposure.
 
Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
 
We incur research and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major enhancements to existing services and products. Research and development costs are comprised primarily of salaries and related benefits expenses, contract labor and prototype and other related expenses.
 
Software development costs are included in research and development and are expensed as incurred. FASB ASC Topic
350
Intangibles—Goodwill and Other
requires that software development costs incurred subsequent to reaching technological feasibility be capitalized, if material. If the process of developing a new product or major enhancement does
not
include a detailed program design, technological feasibility is determined only after completion of a working model. To date, the period between achieving technological feasibility and the general availability of such software has been short, and the software development costs qualifying for capitalization have been insignificant.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but
not
limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
We calculate the fair value of our assets and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do
not
bear market rates of interest.  Capital leases approximate fair value as they bear market rates of interest. Management believes based on its current financial position that it could
not
obtain comparable amounts of
third
party financing, and as such cannot estimate the fair value of the loan payable to officer.
None
of these instruments are held for trading purposes.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
Deferred income taxes are determined using the liability method in accordance with FASB ASC
740,
Accounting for Income Taxes
. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than
not
that some portion of the deferred tax asset will
not
be realized.
 
FASB ASC
740
creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FASB ASC
740
also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. There are
no
unrecognized tax benefits to disclose in the notes to the consolidated financial statements.
 
We file income tax returns in the United States federal jurisdiction. At
December 
31,
2019,
tax returns related to fiscal years ended
December 
31,
2016
through
December 
31,
2018
remain open to possible examination by the tax authorities.
No
tax returns are currently under examination by any tax authorities. We did
not
incur any penalties or interest during the years ended
December 
31,
2019
and
2018.
   On
December 22, 2017,
the U.S. enacted the Tax Cuts and Jobs Act (“the Tax Act”) which significantly changed U.S. tax law.  The Tax Act lowered the Company’s statutory federal income tax rate from a maximum of
39%
to a rate of
21%
effective
January 1, 2018.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
On
January 1, 2019
we adopted ASU
No.
2016
-
02,
Leases (topic
842
)
. At the date of adoption there was
no
impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU
No.
2016
-
02
did
not
have a material effect on the Company’s results of operations or cash flows for the year ended
December 31, 2019.
XML 49 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Note 5 - Employee Benefit Plan
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Pension and Other Postretirement Benefits Disclosure [Text Block]
5.
Employee Benefit Plan
 
Employee
401
(k) Plan
 
We have a plan known as the Intrusion Inc.
401
(k) Savings Plan (the “Plan”) to provide retirement and incidental benefits for our employees. The Plan covers substantially all employees who meet minimum age and service requirements. As allowed under Section 
401
(k) of the Internal Revenue Code, the Plan provides tax deferred salary deductions for eligible employees.
 
Employees
may
contribute from
1%
to
25%
of their annual compensation to the Plan, limited to a maximum amount as set by the Internal Revenue Service. Participants who are over the age of
50
may
contribute an additional amount of their salary per year, as defined annually by the Internal Revenue Service. We match employee contributions at the rate of
$0.25
per each
$1.00
of contribution on the
first
4%
of compensation. Matching contributions to the Plan were approximately
$32,000
and
$30,000,
respectively, for the years ended
December 
31,
2019
and
2018.
EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - Preferred Stock
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Preferred Stock [Text Block]
9
. Preferred Stock
 
5%
Preferred Stock
 
On
March 
25,
2004,
we completed a
$5.0
million private placement of our
5%
convertible preferred stock and warrants. In the private placement, we sold
1,000,000
shares of our
5%
preferred stock at a price of
$5.00
per share for gross proceeds of
$5.0
million, less
$275,000
of issuance costs. The
5%
preferred shares were initially convertible into
1,590,331
shares of common stock at a conversion price of
$3.144
per share. Holders of the
5%
convertible preferred stock include
140,000
shares purchased by our former CEO and
60,000
shares purchased by a director of the Company.
 
The
5%
dividends related to the
5%
preferred stock are paid semi-annually on the last business day in
March 
and
September 
of each year, beginning with
September 
2004.
Preferred stockholders vote together with common stockholders on an as converted to common stock basis. Based on the conversion rate of the preferred stock, holders of our
5%
preferred stock will receive
1.5903
votes per share rounded to the nearest whole number. The liquidation preference for the
5%
preferred stock is an amount equal to
$5.00
per share plus any accrued and unpaid dividends. Holders of our
5%
preferred stock have liquidation preference rights over common stockholders.
 
All warrants previously issued to
5%
convertible preferred stockholders have expired.
 
We have the right to redeem any or all of the outstanding
5%
preferred stock at a price of
$5.00
per share plus accrued dividends at any time if certain conditions are met.
 
At
December 
31,
2019,
there were
200,000
shares of the Series 
1
Preferred Stock outstanding, representing approximately
318,065
shares of common stock upon conversion.
 
Series 
2
5%
Preferred Stock
 
On
March 
28,
2005,
we completed a
$2.7
million private placement of Series 
2
5%
convertible preferred stock and warrants. In the private placement, we sold
1,065,200
shares of preferred stock at a price of
$2.50
per share for gross proceeds of
$2.7
million, less
$173,000
of issuance costs. The shares of Series 
2
5%
preferred stock are convertible into
1,065,200
shares of common stock at an initial conversion price of
$2.50
per share. Holders of the Series 
2
5%
preferred stock include
260,000
shares by our former CEO,
100,000
shares by our CFO and
60,000
shares by a director of the Company.
 
The
5%
dividends accruing on the Series 
2
5%
preferred stock are required to be paid quarterly on the
first
business day in
March,
June,
September 
and
December 
of each year, beginning with
June 
2005.
The liquidation preference for the preferred stock is an amount equal to
$2.50
per share plus any accrued and unpaid dividends. Holders of our Series 
2
5%
preferred stock have liquidation preference rights over our
5%
preferred stockholders as well as our common stockholders. The holders of the Series 
2
5%
preferred stock are
not
entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.
 
All warrants previously issued to Series 
2
5%
convertible preferred stockholders have expired.
 
Holders of Series 
2
5%
preferred stock have the right to require us to redeem any or all of the their shares upon the occurrence of certain events within the Company’s control that are defined in Certificate of Designation at a price equal the sum of (
1
) the greater of
$3.25
and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by
$2.50
divided by the conversion price then in effect plus (
2
) any accrued but unpaid dividends on the Series 
2
5%
preferred stock plus (
3
) all liquidated damages or other amounts payable to the holders of Series 
2
5%
preferred stock.
 
At
December 
31,
2019
there were
460,000
shares of the Series 
2
Preferred Stock outstanding, representing
460,000
shares of common stock upon conversion.
 
Series 
3
5%
Preferred Stock
 
On
December 
2,
2005,
we completed a
$1.2
million private placement of Series 
3
5%
convertible preferred stock and warrants. In the private placement, we sold
564,607
shares of preferred stock at a price of
$2.18
per share for gross proceeds of
$1.2
million, less
$100,000
of issuance costs. The shares of Series 
3
5%
preferred stock are convertible into
564,607
shares of common stock at an initial conversion price of
$2.18
per share. Holders of the Series 
3
5%
preferred stock include
123,853
shares by our former CEO,
68,808
shares by our CFO and
27,523
shares purchased by a director of the Company.
 
The
5%
dividends accruing on the Series 
3
5%
preferred stock are required to be paid quarterly on the
first
business day in
March,
June,
September 
and
December 
of each year, beginning with
March 
1,
2006.
The liquidation preference for the preferred stock is an amount equal to
$2.18
per share plus any accrued and unpaid dividends. Holders of our Series 
3
5%
preferred stock have liquidation preference rights over holders of our
5%
preferred, Series 
2
5%
preferred stock and common stock. The holders of the Series 
3
5%
preferred stock are
not
entitled to vote on any matter, except as otherwise required by law or with respect to certain limited matters specified in the certificate of designations.
 
All warrants previously issued to Series 
3
5%
convertible preferred stockholders have expired.
 
Holders of Series 
3
5%
preferred stock have the right to require us to redeem any or all of their shares upon the occurrence of certain events within the Company’s control that are defined in the certificate of designation at a price equal the sum of (
1
) the greater of
$2.834
and the product of the volume weighted average price of our common stock on the trading day immediately preceding the event multiplied by
$2.18
divided by the conversion price then in effect plus (
2
) any accrued but unpaid dividends on the Series 
3
5%
preferred stock plus (
3
) all liquidated damages or other amounts payable to the holders of Series 
3
5%
preferred stock.
 
At
December 
31,
2019
there were
289,377
shares of Series 
3
Preferred Stock outstanding, representing
289,377
shares of common stock upon conversion.
 
Dividends Payable
 
During the year ended
December 
31,
2019,
we accrued
$50,000
in dividends to the holders of our
5%
Preferred Stock,
$57,000
in dividends to the holders of our Series 
2
5%
Preferred Stock and
$32,000
in dividends to the holders of our Series 
3
5%
Preferred Stock. As of
December 
31,
2019
and
2018,
we had
$20,000
and
$594,000
in accrued and unpaid dividends included in other current liabilities. Delaware law provides that we
may
only pay dividends out of our capital surplus or, if
no
surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. This has been in effect since
December 31, 2014.
However, in light of our net profits for the fiscal year ended
December 31, 2019
and
2018,
we are able to and have paid these past due dividends as of the date of this Annual Report. However, dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them, and we cannot assure you that our net assets will exceed our stated capital or that we will have sufficient net profits in order to pay these dividends as they continue to accrue in the future. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of
18%
per annum on the unpaid dividends for the Series
2
Preferred Stock and Series
3
Preferred Stock.
 

XML 52 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating Activities:    
Net income $ 4,465,000 $ 2,287,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 184,000 133,000
Noncash lease costs 232,000
Stock-based compensation 47,000 20,000
Penalties and waived penalties on dividends 6,000 47,000
Extinguishment of U.K. cumulative translation adjustment 64,000
Changes in operating assets and liabilities:    
Accounts receivable 401,000 (1,005,000)
Inventories 15,000
Prepaid expenses and other assets (61,000) (2,000)
Accounts payable and accrued expenses (496,000) 421,000
Deferred revenue (488,000) 598,000
Net cash provided by operating activities 4,290,000 2,578,000
Investing Activities:    
Purchases of property and equipment (260,000) (202,000)
Net cash used in investing activities (260,000) (202,000)
Financing Activities:    
Borrowings on loan from officer 150,000
Payments on loan from officer (1,815,000) (1,200,000)
Payments of dividends (714,000)
Principal payments on capital lease equipment (58,000) (66,000)
Proceeds from stock options exercised 239,000 168,000
Net cash used in financing activities (2,348,000) (948,000)
Net increase in cash and cash equivalents 1,682,000 1,428,000
Cash and cash equivalents at beginning of year 1,652,000 224,000
Cash and cash equivalents at end of year 3,334,000 1,652,000
SUPPLEMENTAL CASH FLOW INFORMATION:    
Interest paid on leased assets 4,000 3,000
Interest paid on loan from officer 513,000
Income taxes paid
SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:    
Preferred stock dividends accrued 139,000 139,000
Purchase of equipment through capital lease $ 128,000
XML 53 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 3,334,000 $ 1,652,000
Accounts receivable 1,566,000 1,967,000
Prepaid expenses 152,000 91,000
Total current assets 5,052,000 3,710,000
Property and Equipment:    
Equipment 1,138,000 881,000
Furniture and fixtures 43,000 43,000
Leasehold improvements 63,000 63,000
1,244,000 987,000
Accumulated depreciation and amortization (909,000) (787,000)
335,000 200,000
Finance leases, right-of-use assets, net 62,000 121,000
Operating leases, right-of-use assets, net 1,348,000
Other assets 38,000 38,000
TOTAL ASSETS 6,835,000 4,069,000
Current Liabilities:    
Accounts payable, trade 252,000 193,000
Accrued expenses 828,000 1,403,000
Dividends payable 20,000 594,000
Finance leases liabilities, current portion 43,000 58,000
Operating leases liabilities, current portion 284,000
Deferred revenue 516,000 1,004,000
Total current liabilities 1,943,000 3,252,000
Loan payable to officer 1,815,000
Finance leases liability, noncurrent portion 21,000 64,000
Operating leases liability, noncurrent portion 1,315,000
Commitments and contingencies
Stockholders’ Equity (Deficit):    
Common stock, $0.01 par value: Authorized shares — 80,000, Issued shares — 13,552 in 2019 and 13,259 in 2018, Outstanding shares — 13,542 in 2019 and 13,249 in 2018 136,000 133,000
Common stock held in treasury, at cost—10 shares (362,000) (362,000)
Additional paid-in-capital 56,759,000 56,609,000
Accumulated deficit (54,777,000) (59,242,000)
Accumulated other comprehensive loss (43,000) (43,000)
Total stockholders’ equity (deficit) 3,556,000 (1,062,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 6,835,000 4,069,000
Series 1 Preferred Stock [Member]    
Stockholders’ Equity (Deficit):    
Preferred stock 707,000 707,000
Series 2 Preferred Stock [Member]    
Stockholders’ Equity (Deficit):    
Preferred stock 724,000 724,000
Series 3 Preferred Stock [Member]    
Stockholders’ Equity (Deficit):    
Preferred stock $ 412,000 $ 412,000
XML 54 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options (Details Textual)
$ in Thousands
12 Months Ended
May 17, 2012
shares
May 19, 2011
shares
May 20, 2010
shares
May 29, 2008
shares
May 30, 2007
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
shares
Dec. 31, 2017
shares
Mar. 19, 2015
shares
May 21, 2009
shares
Number of Stock-based Compensation Plans           2        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance           975,000 1,235,000 1,746,000    
Common Stock, Capital Shares Reserved for Future Issuance           2,491,543        
Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisable Period 2           3 years        
Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisable Period 3           5 years        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period           10 years        
Share-based Compensation Arrangements By Share-based Payment Award, Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock           5 years        
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | $           $ 86        
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition           1 year 65 days        
Maximum [Member]                    
Share-based Compensation Arrangement By Share-based Payment Award Of Exercise Price Of Common Stock Percentage In Case Of Optionees Holding More Than Specified Percentage Of Voting Stock           110.00%        
Minimum [Member]                    
Share-based Compensation Arrangement By Share-based Payment Award Voting Stock Percentage To Be Held By Optionees           10.00%        
The 2005 Stock Incentive Plan [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 3,700,000 3,400,000 3,000,000   1,500,000 750,000       2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 300,000 400,000 500,000 500,000 750,000          
Aggregate Stock Options Exercised for the Plan           1,563,235        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance           824,100        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants Aggregate           3,892,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options Forfeitures Aggregate           1,504,665        
Common Stock, Capital Shares Reserved for Future Issuance           824,000        
The 2015 Stock Incentive Plan [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized           449,000     600,000  
Aggregate Stock Options Exercised for the Plan           0        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance           151,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants Aggregate           154,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options Forfeitures Aggregate           3,000        
Number of Equity Incentive Programs           3        
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture           0        
Common Stock, Capital Shares Reserved for Future Issuance           600,000        
The 2015 Stock Incentive Plan [Member] | Non-employee Board Member [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Options That Will Be Granted Upon Initial Election Or Appointment to Board           10,000        
Share-based Compensation Arrangement by Share-based Payment Award, Preceding Period With in Which Individual Should Not Be Employed           90 days        
Share-based Compensation Arrangement by Share-based Payment Award, Option That Will Be Granted to Purchase Shares On Date of Each Annual Stockholders Meeting           8,000        
XML 55 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Note 6 - Borrowings From Officer (Details Textual) - Revolving Credit Facility [Member] - Chief Executive Officer [Member] - USD ($)
Feb. 07, 2019
Oct. 24, 2019
Sep. 30, 2019
Feb. 08, 2018
Line of Credit Facility, Maximum Borrowing Capacity $ 2,700,000 $ 0   $ 3,700,000
Long-term Line of Credit, Total     $ 0  
Prime Rate [Member]        
Debt Instrument, Basis Spread on Variable Rate 1.00%      
XML 56 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Commitments and Contingencies
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
4.
Commitments and Contingencies
 
Right-of-use Asset and Leasing Liabilities
 
Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a
three
year life and are in various stages of completion. The Richardson operating lease liability has a life of
four
years and
eleven
months as of
December 31, 2019.
The San Marcos operating lease liability has a life of
fifteen
months as of
December 31, 2019.
The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of
$1,580
thousand and a related lease liability of
$1,771
thousand.
 
Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC
842
prospectively and elected the package of transition practical expedients that does
not
require reassessment of: (
1
) whether any existing or expired contracts are or contain leases, (
2
) lease classification and (
3
) initial direct costs. In addition, the Company has elected other available practical expedients to
not
separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of
12
months or less.
 
As the implicit rate is
not
readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.
 
Supplemental cash flow information includes operating cash flows related to operating leases. For the years ended
December 31, 2019
and
2018,
the Company had approximately
$294,000
and
$264,000,
respectively, in operating cash flows related to operating leases.
 
 
Schedule of Items Appearing on the S
tatement of Operations:
 
   
Year Ended
 
   
December 30, 2019
   
December 31, 2018
 
Operating expense:
               
Amortization expense – Finance ROU
   
59
     
65
 
Lease expense – Operating ROU
   
433
     
316
 
Other expense:
               
Interest expense – Finance ROU
   
4
     
5
 
 
Future minimum lease obligations consisted of the following at
December 31, 2019 (
in thousands):
 
   
Operating
   
Finance
         
Period ending December 31,
 
ROU Leases
   
ROU Leases
   
Total
 
2020
  $
362
    $
45
    $
407
 
2021
   
361
     
21
     
382
 
2022
   
369
     
     
369
 
2023
   
380
     
     
380
 
2024
   
352
     
     
352
 
    $
1,824
    $
66
    $
1,890
 
Less Interest*
   
(225
)
   
(2
)
   
 
 
    $
1,599
    $
64
     
 
 
 
*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.
 
Legal Proceedings
 
We are subject to legal proceedings and claims that arise in the ordinary course of business. We do
not
believe that the outcome of those matters will have a material adverse effect on our consolidated financial position, operating results or cash flows. However, there can be
no
assurance such legal proceedings will
not
have a material impact.
 
We are
not
aware of any material claims outstanding or pending against Intrusion Inc. at
December 
31,
2019.
XML 57 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 8 - Stock Options
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
8
. Stock Options
 
At
December 
31,
2019,
we had
two
stock-based compensation plans, which are described below. These plans were developed to retain and attract key employees and directors.
 
On
March 
17,
2005,
the Board approved the
2005
Stock Incentive Plan (the
“2005
Plan”), which was approved by the stockholders on
June 
14,
2005.
The
2005
Plan provided for the issuance of up to
750,000
shares of common stock upon exercise of options granted pursuant to the
2005
Plan. On
May 
30,
2007,
the stockholders approved an Amendment to the
2005
Plan that increased this amount by
750,000
for a total of
1,500,000
shares of common stock that
may
be issued upon the exercise of options granted pursuant to the
2005
Plan. On
May 
29,
2008
and
May 
21,
2009,
the stockholders approved an increase of
500,000
shares, respectively, of common stock that
may
be issued pursuant to the
2005
Plan for a total of
2,500,000
shares. On
May 
20,
2010,
the stockholders approved an additional increase of
500,000
shares of common stock that
may
be issued pursuant to the
2005
Plan for a total of
3,000,000
shares. On
May 
19,
2011,
the stockholders approved an additional increase of
400,000
shares of common stock that
may
be issued pursuant to the
2005
Plan for a total of
3,400,000
shares. Finally, on
May 
17,
2012,
the stockholders approved an additional increase of
300,000
shares of common stock that
may
be issued pursuant to the
2005
Plan for a total of
3,700,000
shares. At
December 
31,
2019,
1,563,235
had been exercised and options to purchase a total of
824,100
 shares of common stock were outstanding. A total of
3,892,000
options had been granted under the
2005
Plan, of which
1,504,665
have been cancelled. The
2005
Plan expired on
June 14, 2015,
and
no
shares remain for grant.
 
On
March 
19,
2015,
the Board approved the
2015
Stock Incentive Plan (the
“2015
Plan”), which was approved by the stockholders on
May 
14,
2015.
The
2015
Plan serves as a replacement for the
2005
Plan which expired by its terms on
June 
14,
2015.
The approval of the
2015
Plan had
no
effect on the
2005
Plan or any options granted pursuant to the plan. All options will continue with their existing terms and will be subject to the
2005
Plan. Further, the Company will
not
be able to re-issue any option which is cancelled or terminated under the
2005
Plan. The
2015
Plan provided for the issuance of up to
600,000
shares of common stock upon exercise of options granted pursuant to the
2015
Plan.
 
The
2015
Plan consists of
three
separate equity incentive programs: the Discretionary Option Grant Program; the Stock Issuance Program; and the Automatic Option Grant Program for non-employee Board members. Officers and employees, non-employee Board members and independent contractors are eligible to participate in the Discretionary Option Grant and Stock Issuance Programs. Participation in the Automatic Option Grant Program is limited to non-employee members of the Board. Each non-employee Board member will receive an option grant for
10,000
shares of common stock upon initial election or appointment to the Board, provided that such individual has
not
previously been employed by the Company in the preceding
three
(
3
) months. In addition, on the date of each annual stockholders meeting, each Board member will automatically be granted an option to purchase
8,000
shares of common stock, provided he or she has served as a non-employee Board member for at least
three
months. At
December 
31,
2019,
no
options had been exercised and options to purchase a total of
151,000
shares of common stock were outstanding. A total of
154,000
options had been granted under the
2015
Plan,
3,000
shares have been cancelled, and options for
449,000
 shares remained available for future grant.
No
shares have been issued pursuant to the Stock Issuance Program.
 
Common shares reserved for future issuance, including conversions of preferred stock, outstanding options and options available for future grant under all of the stock option plans totaled
2,491,543
shares at
December 
31,
2019
as follows, in thousands:
 
(In thousands)
 
Common Shares
Reserved for Future
Issuance
 
         
Preferred Stock
   
1,067
 
2015 Plan
   
600
 
2005 Plan
   
824
 
Total
   
2,491
 
 
The Compensation Committee of our Board of Directors determines for all employee options, the term of each option, option exercise price within limits set forth in the plans, number of shares for which each option is granted and the rate at which each option is exercisable (generally ratably over one,
three
or
five
years from grant date). However, the exercise price of any incentive stock option
may
not
be less than the fair market value of the shares on the date granted (or less than
110%
of the fair market value in the case of optionees holding more than
10%
of our voting stock of the Company), and the term cannot exceed
ten
years (
five
years for incentive stock options granted to holders of more than
10%
of our voting stock).
 
Stock Incentive Plan Summary
 
A summary of our stock option activity and related information for the years ended
December 
31,
2019
and
2018
is as follows:
 
   
201
9
   
201
8
 
   
Number of
Options (in
thousands)
   
Weighted
Average
Exercise
Price
   
Number of
Options (in
thousands)
   
Weighted
Average
Exercise
Price
 
                                 
Outstanding at beginning of year
   
1,235
    $
0.83
     
1,746
    $
0.68
 
Granted at price = market value
   
34
     
4.40
     
24
     
1.15
 
Granted at price > market value
   
     
     
     
 
Exercised
   
(294
)
   
0.81
     
(451
)
   
0.37
 
Forfeited
   
     
     
     
 
Expired
   
     
     
(84
)
   
0.22
 
                                 
Outstanding at end of year
   
975
    $
0.96
     
1,235
    $
0.83
 
Options exercisable at end of year
   
917
    $
0.84
     
1,172
    $
0.84
 
 
Stock Options Outstanding and Exercisable
 
Information related to stock options outstanding at
December 
31,
2019,
is summarized below:
 
       
Options Outstanding
   
Options Exercisable
 
Range of Exercise Prices
 
Outstanding at
12/31/1
9
(in
thousands)
   
Weighted
Average
Remaining
Contractual Life (years)
   
Weighted
Average
Exercise
Price
   
Exercisable at
12/31/1
9
(in
thousands)
   
Weighted
Average
Exercise
Price
 
                                             
$ 0.34
-
$0.50
   
391
     
2.86
    $
0.42
     
383
    $
0.42
 
$ 0.51
-
$1.00
   
330
     
1.53
     
0.68
     
330
     
0.68
 
$ 1.01
-
$2.00
   
173
     
4.69
     
1.71
     
157
     
1.77
 
$ 2.01
-
$4.75
   
81
     
6.95
     
3.12
     
47
     
2.20
 
 
 
 
   
975
     
3.08
    $
0.96
     
917
    $
0.84
 
 
 
Summarized information about outstanding stock options as of
December 
31,
2019,
that are fully vested and those that are expected to vest in the future as well as stock options that are fully vested and currently exercisable, are as follows:
 
   
Outstanding Stock
Options (Fully Vested
and Expected to Vest)*
   
Options that are
Exercisable
 
As of December 31, 201
9
 
 
 
 
 
 
 
 
Number of outstanding options (in thousands)
   
970
     
917
 
Weighted average remaining contractual life
   
3.04
     
2.71
 
Weighted average exercise price per share
  $
0.95
    $
0.84
 
Intrinsic value (in thousands)
  $
4,411
    $
4,278
 
 
* Includes effects of expected forfeitures
 
As of
December 
31,
2019,
the total unrecognized compensation cost related to non-vested options
not
yet recognized in the statement of operations totaled approximately
$86
thousand (including expected forfeitures) and the weighted average period over which these awards are expected to vest was
1.18
years.
XML 58 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Note 12 - Coronavirus Outbreak in the United States
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Contingencies Disclosure [Text Block]
12.
Coronavirus Outbreak in the United States
 
               
Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.  The extent of the impact of COVID-
19
on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted.  A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and
may
require additional cost and effort should our employees
not
be able to be physically on-premises.
XML 59 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Note 4 - Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2019
Notes Tables  
Lease, Cost [Table Text Block]
   
Year Ended
 
   
December 30, 2019
   
December 31, 2018
 
Operating expense:
               
Amortization expense – Finance ROU
   
59
     
65
 
Lease expense – Operating ROU
   
433
     
316
 
Other expense:
               
Interest expense – Finance ROU
   
4
     
5
 
Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block]
   
Operating
   
Finance
         
Period ending December 31,
 
ROU Leases
   
ROU Leases
   
Total
 
2020
  $
362
    $
45
    $
407
 
2021
   
361
     
21
     
382
 
2022
   
369
     
     
369
 
2023
   
380
     
     
380
 
2024
   
352
     
     
352
 
    $
1,824
    $
66
    $
1,890
 
Less Interest*
   
(225
)
   
(2
)
   
 
 
    $
1,599
    $
64
     
 
 
XML 60 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2017
Number of Major United States Financial Institutions 2    
Accounts Receivable, Allowance for Credit Loss, Ending Balance $ 0 $ 0  
Depreciation, Depletion and Amortization, Total 184,000 133,000  
Impairment of Long-Lived Assets Held-for-use $ 0 $ 0  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 30,630 0  
Period of Payment Terms Offered to Customers Distributions and Resellers Domestically 30 days    
Period of Payment Terms Offered to Customers Distributors and Resllers Internationally 45 days    
Unrecognized Tax Benefits, Ending Balance $ 0    
Income Tax Examination, Penalties and Interest Accrued, Total $ 0 $ 0  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   21.00% 39.00%
Equipment and Furniture and Fixtures [Member] | Minimum [Member]      
Property, Plant and Equipment, Useful Life 1 year    
Equipment and Furniture and Fixtures [Member] | Maximum [Member]      
Property, Plant and Equipment, Useful Life 5 years    
Leasehold Improvements [Member] | Minimum [Member]      
Property, Plant and Equipment, Useful Life 2 years    
Leasehold Improvements [Member] | Maximum [Member]      
Property, Plant and Equipment, Useful Life 5 years    
ZIP 61 0001437749-20-006294-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-006294-xbrl.zip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�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
O7XS/Q0AOW':":+2,^ M&U#N,'L@V\4?$0EG/XXPIQJ^<=2G$A[XY1U@BX+=@*AHZ3'MCV:OG4[3.X@B MU;4)@564A_4?*HG4E^EN1_',64%Y^[GPR9WS[IC>XCMCN739;*/^J&O;$L#$ M[7JX?;(_NB,NX5/0^[^4\*)Q7H;!ZLA);;.J_0APPLDD99W;,WDO?M>W+^1; M\7NSK_E/3+*\38/Q$.+&&^TZX:MY@T3@RXC#O 7S+1X[3W@DKBDN]U/M*K=> M"?KRTV?'-O.(L[+S<-=(Y(@)GN^/[K^?19Z0]QL'WU2LABD MI9Q4O8JMUVYY@9(+E>AB5K>%+39(GV[2I5ROF99OI5^NC[R;VQ_%7VCIR9HL MY#0WG(TY\7(GE39;71.0@XXI;UKI246\)O]C/%O'/%=@[NJ+REW+!5*T^+UM M\6O;,NCT_$PFM4)5>JV/HK)JB(5>^XQY^*PD20M'<]HM;_I6F%LX._2Q4NAY M6 @E;HJR8J1:WN3M5]M91:[O,GZCOR"V/=^0!P[F[+R>S17D%A<4AK/:]/\YI=:^U7(O/6M MLJ(&OS&,9#*(B3@546NJ;+>ZLX-H.5A724EN\9.,G6(.\NS<^JV.I8 '"J$/ MUEWH0X70A^LN]'N%T._766C'@GG=%A@JY ?CI\\46'S][1/L]*T*N'$ -^O' M>_73K?J7C,<;]=,0HKZ=U93(6][.6NC6.R! 1:@*"\D MS+=>%*UN M(:DS:!E^ QU.Z1?H$6)1XR;BD)H)&N!=Q4+0D9_=::)_MC&*KG MQ_$(1!:B&\I9\N)/&%$#=DWX=QKBZU)8\$_&ZO*&)LG+'+MKRP\IXDM"PFU#>\EK981X4XI:5/ MII6V6C_%[N]R>8O***^LGP(S7[75\.746'7---=N2[@>_4J^Y*/3E&6L-L?" MJW^HIL2>#0C_.-:K.(PKD]D" MRF0VQS)-7HA>8JU&I#?6@A7>_UW/;E4(;JRU*@Z\1;TV1V\=+WPN,9(6%IMK MT46OG*UIM85D-M5D M/N+A">//G;/3T_/.JG5[V5S]-TA>"=8;?^CD_WQMNL7ZY3QKV[VXN.AD_WUM M*NBNAI)IM_/[[#16&O&5+()^%-F7-\PG2:;&4@BMPA;JD[=JYJFO MO.Z9=]X]F8N@+;7>:N6JXRR$(8Q;ZO?3*HZ],1GD63;O>B>G7<[ MJFE'BIU !''B^2P6+*2!ZC[O]6OAL;'G$S'QQB%[$1)?]K@)A_%E6S+^TUOQ M4Q+]4)%=LIC*@21H- VAW5F#Y9/03\-,C3?R\[*YDOS0"'.18)Z ',1+5:^D M"IE?H@?US1^?YXF<-BD5$_6&9 1ASLR4-!GS)&'C5$!/"$AZ$>,)_3-[YN?Y%.)LUFU) M797''L2_AYB$"071BX/?B-12\/K-77Q-9S20_2AV"6U&:2+JNB$:$S'*9G4J MO&="IMD@[4"8B-4W&2COM+NF%$W]^OR_E,Y(J ;M/7#*@D'L M#3;(#(OT-0?TBQUP=. 4 3TN:!?:&Q6ANR27'/ M:>S3*0GOR2*S/@6(4#3-0]D<+8.XY_LL5:.)+,@H!*5TW^4C&A(U3PJ MP%B/F4O@A^"#G%929&.HVZ0N +N&,7 .P1!F$*=X5 5T+D :Q%(D^7B3\;B# MQ@4H]QRFA 8K92]74SE;[I()\&RUQ6,T8=8\^&^0J&7KGC.U$ =7BR@320V0&@;.@'SU&:N"U#"P E+.,!GQWC"AP;'= MIGE15\[$W;C(/4:TM"?V(^OYTI?ETCMB<@0DB_N0Q(DT6\K#G:HF)6CP#"R MY,P'",07SJ(AA"I@O2=2Q&L8%<)"D-@%\I P__O=5/GBXO,2 /$\+A2OH 09]%:M'715CZQCKAUU(X/>ZW& ^ 7[9/ MVZT74 F"99(QYT.XOY7;>9\/6[;HB#2*,IX>32!:T8_E<*FU8#"4F99"H$!V MWT!ZCJ(T\'FQJ,^.$759.(8%?^[\N-Y'U(W5QH_.:F,/^4JL$CXC81B_TG9[%73H5CH?_'6>@5LUE8X!?. \?X=FB7QUW'KOK&&A;\ MJ45+K\OUL/K1;P45-*T!74J/50F4C\'-QX(N2^$<@W./Q(J/MH_ J:\PJ!'Y MD@K^NZN];;!1ZI(-J[0ESVHM@55MVK'IH'1KQRE;5U<)]1?T3YU-'=S(SWNM M+8M9 MZ/GFP2T20ONB)QH JRU%@%V5L@O'&:I!R\B,8T2B,O5(@]-@KIH$&,Z^"]\7-1 M!?I5IS8?UR%OKT&U^3@.>=>*5)^1ZZ"WUJ>Z;)H'O+'$F-II4W)W 6*-5FU^ MQZ*"8B-6F]^1J$!GU.HS/!8E%!JYNNS<58"9![+;_.>)2ZK=Y M?6Q.F I)X+^.-K97$9>VPII7QY9?X5*!6Q/J0!E5E_;/T)F-@JW"PQF,)LSG MP=%7-Q!-V,O#=W[UU;,) WGX[G?:(!X&_M&8P+H[:.Q &P N&$A7=%/=?AS2 M?CJBG>K6Y9#&U17E5%YY#VEZ[2G'T"PW4,SR[AJA$0F5^)Z8P-J)",/KD78S ML7 IDDX07-G(?C),&R>2^BGGQ0=Z]8V;3X]M'R53A6HH"#H2*T V3H&5HM"W MMP(A+^^' '.JQ_0L^;[96U"0[K(0VY=_Y,\O&72[VKAR2UUM;%1*A4Y8& RB*6>S_+I/'89R @L@WMPIJ=GL<(^2$+A0BT6R*(*")+,* M2&^M7'(D;XD_H3'PQ;K;IAM*Y006;J=B":R6K[63<5*_I=;6A+1Y8 4;7/KA MA2-R!DQI%Z'I;$/"+8HH&@M0WNZ_*.\175L;EW%E=WHL[_+03PYM6ROWB.V. MG'4F&$?D$)AOA9,!0V+A!C&L,U+-_;!77; [J<"J).QM7=QEO)SAJ,=&(]V5:&K:9:'QE*3Y'32<: MG^'NBJ,V%0W7J+K"7OGM^[=XLKR/9(.5?+7>4[K-SD))+DZD)HMS^TS(6.0K M8T$VG(#/J _B08ZH@NQ_.4'S6Q?YFXI#E8,)U/UY(E%ZG<'NMYL:4EF HQ(H M,L0:TZ(=I!TMK+S*;OE"%751;3^[S#"5-O7N=5A?P9AQR-L]DCF(6QHS+FW/ M($Z @U"AXWLNN0V[A62B+LQ4EV#KWJMI00);:I;"+\?EE1RVQ2.CI+4-\7-% MZ^=B02L;XJZZ/-?DVCA9^?*%$-"4?[_*#BMJ;T9HJ.**1]9G4<3B=8?GB@CJ M8\#@N5BLIBGM'TU+*^4G^>LT,E6^AKFY: \K-V<038FOJ4HQ9F'C#7$"I$NL M=M*O808AR_*<>FN&HK$!)7OSR6JMW$QR2L6':: .\@FA3O8%Q,":3: ]&I36F=A6>5 MS$N%KK0.#SO]*B39K&,SBCE=RK)A\14%IB[EN&V$C;N2CWM\(^E?55?&0953 M1L&Z\C1!M5,+W^[0DQFF-5R:-TA$%G)7[G:\09C.]A%&.CM>JBD"]8[KIMX/ M=.Z1O K#@WS&"H_&GAR8J2"R=[;_6^U]0'4?T^#[?_8C:L,7MRB)KEB<"N1U M(;O;_GW;274(0RD$2O8=#:T)_4!"PK%*+VAL3?A?B9_->Y3P!8WM[;.@KK_0 M-[9U#M-PSN*('#V35BKV=CVCSK:ZY,I4P::=1BY54QF!PTPSEY(\57JN<-EQ MJ6C*")B)77&I(K5*[VG7WN:CAI^D2ZPB&"]1\:[T@//(3GWT2'8:(7MQ9O@& ML6+<4/]!#48.^Q*VR=CA>BGD(YGGQTAT9_OUC2W<);8IS]J<*C[6CZ1R (XZ M^9U;J#!D+ZHT% NIF-)-/PO;)\QL,#JUK;8/C&7]BE@*EO]0/T9$@/SF_U!+ M P04 " ";'M0)C-^!,\] #.-P4 %0 &EN='HM,C Q.3$R,S%?9&5F M+GAM;.U]:W/;.);V]ZW:_Y"W]S,G<=+7J>G=DNVXQ[5.[+*=[IU/4S0)6>RF M"#5 .E;_^A<@=;--@ D2&B:%?<_?_/E)IK?7B[;OW-JKG\-2TW'78;?_>V^7'3],707S_4;8]^^NFGM_6O MFZ8\:VLH!CUZ^W^?+FZ2&9G'45;(&4DD+3S[.Z^_O*!)7-;3V GAC;*%_"M: M-XOD5]'1^^C#T=\>>?J-F/4W;YJIBUG":$ZNR?3-ZN.7Z_.7IZ B4%W\EG_]=.SW*Y$,N 9_-%3KYY.YRHE,[CK(CF M9'Y'6$_R6L>P3F@V)X7<*5'SN+ZT*H:Q3>Y,C,>2ZHY$FR?VI%@STA[GF$SC M*B^'3_+3<90$KZE]3JI\EJ"257*TOR5T+AYX]-/1^P]';VN*!2(5N4=(_$?@F5$Y8Q$59$)?AG5G?A3;.(A?T7KL6L0%H96 MPA73DHD. M.%^'/56@)R";RACCR61!P=*P:W)C"GR8M7S]=+AY/D;_?TX6U* MLIHJ^:&>N^C=T8I=_I?XZM\?BS(KEZ=/]ED>WY'\YV]4/S/=)V0>[CO*%@\ICQ%O(4+4PI6Q,VC?E=O8O%DKF/XT5#'DB^$DC';%;QCIAR1O*A$S\\S=" MKFY.J+_+ET72G[\1?'4SW.KPZRDJ31F=@V:8]M@*XLDN\2E$HP:BCOW0+H;N M%HA&8E*\KJ?KBP*8+1#1D?57\_1,ZO5NV@^VH8A67PKF*!;UQ[R>5R'\D'OY MP1CQCLK39XOI.(?C7=7--2#\@)J?05N<_WC;(G7:E[X_1'&2B#E*(_*X$.N5 M\$;^I!6/B]14X :.YD[&-B(HB-5!K#:7BB9)0JNBY%?Q4O*M29%.FB5WD<5W M62Y6,^$MW$(A/@T<+6@502 / GD0R(- '@3R()!K!'(KYZQ+:3VE255_$')K M1.J%*$39*67SVHD&%]2! SF1T8UHV:-X/A%$I)*0LSR^;Q$V6W_?NQ!\4C$F MGRF689S_B\3L8Y&>BJEK(;"KZ=YI/5V]R8:"*\(RFIZ)[]I$]\ZVCJF5\P6C M]45+9Y2>;W>%2D*%-O=! MR^+\7##FQ_\E2Z4=0='.%95T/J?%32E.\)M9S B_K,HZ1"UB^,?BUG8O$MXD*]G[2M M'5%\EN6$G0@^>$^9FM+65HXH/!=ZE-0 L@MYU%NF:.:+R9D3SOVD!MC5S1-Q>*^;'0C@K" MU4R\M94C"G^EN5".8]9L7C6-BG:.J/Q-O,'_+>C7XH;$G!8D/>>\VMH'7E#; MT?YPG!K&E-V0I&+BH4?O[V^SLE525S7Q9DA^-896D)X4S*U]WM2>S:U@C9R: M:,..7Z/:]&H*KULT $)[CQ2:5LD%8ON #AO,M@B$]RTZ>)U:"A#9=TB108P! M0(C?(X6H%4.!V'Y B@TDM (Q_H@4(\"8 43X$U*$&F4.>ISOWY7:#QK$: +% MB%5F@9N"H4BQBC!*RQ(4&#[YI T6&3W11^WV@F/ )+0!'&Q0@OF83B*?^I(5 M3FO1]-,39K"B ]K<&E'OS8C2-K=&U B" 4=O$P!">MD9 OCH:S:2+>R!/N>1%]F@YZ^81GN M?[/.OL$!N0"L$PXP6E[0W0$'B&Z. .SE,2EQ]UQO$9#![4,RJ,]DT/T0>\M( MS"NVW%F\"HHU+4/HT5Z!P#L_^PB"$8 >8R- &=9CB-C>=H@CM[X[3"4'0?EV"MB)B^..?5;:0"VI2I&<5$ZM3;&[Y.7N4 MG[@Z>-BLYV 1C[-R1[P3?SV?2?'5OS_%C]F\FK<2K?S=$6EBYVM):_O=#6G7 M<7%/6E9>ZV\.25+.5&&+S)\Q)E2(9^6RZL\KD^HS6EUO)0)Q)H038.>B&!)TK2))P8] M#PR6?UX<3&1HE-U@(L-@(M,#:9<[:8?LAPE!G[.$#N#5HS-P]CYLT5G/3-X5 M': ZH[+X[G]]8XA4MK#.-2HTFI6LXJJTTS"!:DU"3PT,*VO VU!;L-! Z,D: MC15XMU&XP:T7W'H'[-;S:QIR[C3\-A)-YEE9DU_?R)9L;JS.MB& 0#?!&>@O)N@[M:. M/$1$O)UZ,S:W;%;S*I=A_:=DP8A@FG*/GVXC82^G:V)5_C<;X^&!+JO@;VEL MW8,VAGHU@/W;MK='_(W,"Y!,X3BQ)]G18ZE-L5#3%,T3%R@)GQH=+Y" MRVH0&D.=E95,C11R5/9E-&QA#!XA6^L$:B<9G:?5@L*%AC. F#D=I$>CX@1[ M/?T&[>[@.PR^P^ [[/(=#C'\./?\?1>1^2*G2T*B.U*(AY71(H\+T\S KF'< M^?I@E 0GW^MR\H4D.L?.H)!$%Y+HD'H*KAI139S-E^6,L"LJ"")EQNI#Y+@Y M,PS\/$.'"ZZ2D( 3#/:(K=%C2, )P?DA.#\$YP=[4[ WO3Y[DQT!U+GEZ?OH MCC)&OV;%/8_D!$1T.LV2[:0 34^=X[BS/0%)"<:G8'R"&0=.9AF9?GPD255F M#^2R64Q*8P&@M8=82D;2K#R+DRQOG^3NAKZ)UE]AJVDZ.L*#C:/PBA[RE+U6Y]4)]@&CZ\*/I?8Y9)"B3;UVQO53._!&O9 MK+KAJ(@.X?X8C.X'XST8<%Y3N-R%$;%&H:,F^A-&;$KV3.'\<'0>(JBFCLZ@ MJEUCM)=0ALK>/WS'8? T65RA?94C="M7P_>IH=$/Y8JU?2H>2'@[3 M MUHU M)]Z3>H<:JQ?*5=KOM!^T%BW=)!Q?>[A^BK!"-2%3&C^87 M+REZN_-L:PD(_NS@SWZUGC[QH@DOL^1$IF8RO=%?V]8]Z>?UEKZ-'U=7D&O] M3?K&&(C7VGF[FH\6@']7YH8RN%L/TB4XOT)>1/!LC, 6WG$R4%,F/%J[..2( M1*=Q=;X3:B2_H#(&V%NA!V(?#[:<8,O!:LN!RX3.C3<_1KP45$1-(1W3_?OWOWW8UR;O-RIQ<3L^+-'O(TBK. M%2]5V\X3J;]EY:QV?LD#?98M;JGF8!LPPH'"\V\TW0JYE],3.E\(/:BF=>71 M/*&\Y#>SF)'CF$L'Y[*N)]=E5[4T:G &]4W[$B>Y+#RKNU"]I8D_0O6WB;D6?:D%T7*TSA[U.8[. M$*M8<;2/P025@Z#?EL/@R['TUJ"6I-$YJH!Z-YJM-H0/4F.3*JI-N*]SXD!2 M.0ZAK"*60GZAK**5(IH>,X%QN2W,P( M*2_DWA,:YI]V36;)3.]B&>+,23A7@RY-%+ MAQ%/ULV+*%Q=P@BPTUY S15SC#@/J0*TQ4 ZX%F+SIVHV6JTAW"*RM-MB?=@ M"+0(587UG"A4%>[FM!C6L977JO-:H8-CPF !:K/;R$%[NQ#B#@U1D6.,PSN@ MJ$AWN\:$*P"L4*,+F33SLJ+93 8*W Y( \\-JCUG5[7%4$A^\,ZT$V4%!/TM MFNT:(IR-$84(9T<1SB"7LO/(Y:-WD7CW,J&-Q7W*K2G[NXM<[B A1"Z'R&5Q M&)[1BOU"'P@K:@M;Q4LZ)ZP]E 7>P0)AEP4YH7,QM-0ZUX]1DP5H;J78&B/$ M:+I@/2R0]N5F^Q0U.>I6KJJ]_4[99A(4,;KJ1FZ(E G/E],G5"AK/G6V'1') M_H.+)DDBJSKS:Y*0[$$*.]HPCZ[F'J(S=T_L)K#;P0#R MO]1>4KCMECY# 0L('5 M"?B"2.W! ^P5 NS[ANS%.1&G^@,I*O*9M,NSH+8A1#*$2(802<1Q:1WZ'C72 MLC !,Q&R:(\S?R18VX5C'6"MZC/: $.PK(W.G@]9D;2G:(3*[V1_QV((V=KO M&M;HOO@7LHK34"/A# GQA";8RGJJ\O"C&;MPH0?"K3NHUJJ R4_#+S5 MVHLS\1*A"88S@VC@-T3S$H><'##?!)KX*;.7"?:VCBZR,81*&2,*H5*.0J7, M_1ONXZ:.9-!1C2"*.27N->T>?$'!%Q1\06,WJ 2 M2R&=9_=%-LV26'R.&PM%5MQ'"YIGB1!.-Q_@PKGIB$Z$\GY$!6$\"..]8Y;% M^KI:K:H.6;R[@X.YGX+S M^4*\(_DV+ID0!A>4RQ(H%[2XO\@>2#JI;7TP]$.&\@"\$/(5N8T?@> ZFKL' M\)E\W3EH&2W$QX3L["L8L+[#>*CD_920#B&DH[6/0N1T05BYE+>'EH(=2%%B M(><9]IY,N_NP=G(B5#TI*IT*/3&G-7D?'^6=7D1[3!CT1&?$A;V]?H-XL(UN MKEK;O8SMVA?N!!O/_(RFXNI5BV<]D:C]R> 3MG@2PB^A.!+.'A?0A!D[V&DA1(<1 M0#CM8Y]"%Q%J"-3<0HHFRK?WJX694-$$P/;#V4/V B*V5#W0.N)^BC80]'=( M00^WW0$GX'ND$V#)= ND^(V<,$"L/R'%.L0D!157L IF MQ@9'*&"L IK._ #%AE44Z^%DA$+&*I7!O%%0E%@EL6&N*>>I(>\C7LWG,5M& M=-H9H%5*Z=DT163 $]REB@PF,D2IA2BU'MZ09$;2*A>'P%:(O8J7TK[9H.X$_#YT M!9D^R/1#9/I)L^)V;BA P19/,CB018/LGB0Q8,L_@IE<;-CTKF<_6TD MFLRSLO8!;"H09<4]*?I;U?XK)BXE^M@&1O0/>27TW=">4E2 3L:!U4@Z :!-4@J 9! M-0BJP:M1#4!GHN,E.027;6G&N0KT0Y35P5]"_'_LJ_%HQW"GX #("/K,Z])G M;/L-3LF4,$;2V_BQR6$0>[V_$Z'7:#[A?YQ.22(#]CA/5H2'$>E7]@4&YQK6CQ&7L6<1;0+- M^JE8^D'219!32HGY!-@^RN68CU-:N355U&7Q?,;%8 M*T;J0/Q'^8E_>L)7=KW*9CTMD/JYD@->3C_%OU/V13R/I#5GXT^JS0HR:A-# M&\G]1K! ^A5A&4TOIRM3R"UA:4EK^]T-:;4-M85!MO[FD"3E7+7\BHRLH4?= M<(U]DN?TJ_2CG%%V2JN[IJ"T$7 M*[._ZN\5R$VZN@<&";.=E&=$Z(!Q+J4/>3(MGS16X+8XLOMIV;G8YOEU-O\D MN72K?N$JX$9]/4!;S_#'QWB>-3+%%1%BA=R0]6TM0M00 M:JIH\*9+]1/-7R MF-$\%:^%T8?F'H#6P\:@AWL8RNNECI>W@I@6.:-'3T2P)&FMZF^/G@<&R[\4 MI"12,#8ATUQD4Q5O-.@9?$B'%\KYI1"B$+TO9!R*.#N.24&F6:F\_%C?.KC M]@JD74^E';HB)@1]3D#(C8ZJ$V9T#LS>(@*Z($F3=T4'6(11>73WO[[W$POL M?)UK3&YH5K**J]).0R:J-0D]-3"LK %O0VWQ1@.A)VLTUH+=Q@^$L)T0MG,X M83N#W;PC#=[IXPE!EW< @VIL\0#B='?[*@RGN9L#"/0[9$![F/>!2-U=<@_< MI?9]=L"9<'?1/8 _[RU'-?.XY&[K@ 9%H+<#" R!QB'06)QSUUDB9)B4"WZW$N#5 MH<5=;2V0*!_CN=D2V/K'K0QU*L![#\P8K)):[F1A0$D4_BR2 7MHOWW M[]YKPXZ,^GJ EOXNI/OZ2!4J[F?R=4NO> N%^)@T-F)-*%*O,7R$C,E['G;O M=I!JCBRP(F20."F/%/# _7Q!VEQ=T4*<%A.DHWM03ZG:W+^A0-+1VC?Y*X5: MM77TC7T3?YW=S\K+Z1=.:D,8"(.B3PC[.KRP+^EIO)Q.TJ::L/84U#4='>$F M DF(6+,3L69%1: V)6],4S1,$J,F^W1TT7"6-4Q(C@O1<2$Z3@')T*XV MTI@X4TO;2./A#(Q (XV$ QD:1QK\!C%#.@]W^"XB\T5.EX1$=TWX3;3(XV)@ MF(/AJ.["&WH1%L(:0EB#4,M.Y6(D]8&RBE64<S]8:&>5ZCG%>IY.:WKU+JC3R@OKS=AO0J/CU%?--!63)A]BLMD M)@2Y)[\WK-L,K\& 8YH$F8\E?K0^%\_&#>[N4"E__$Y7Y&5"0@F!4$(@E! ( M/H/@,SAXGX%-P\3(' DN310C=3Y8%MM'ZJ"PITN&P6 ME]),"6CMW@QR(@[NK#R+D]JCK,FT4C?T3;2V^K&NZ>@(QV#=OBME[2A6U=4@ M8Y[QFP4C<7I9_!JS3 K[LEJ!*I_-M+N'M#9QD MAOIY\!8BV)GX)7:^2E07@ M>'WJG<0+\8LR?ZW/$#Y*@POE6ZX*;;*,HI5[Q!Z.G\ ,;(V*-UD9-E"2,V)3LB\+YQ>B\QE!U M'(T+&;3&:"^A!94/RA5K^U0\D+1%F)2, M;K5J3CP*-)>@7*7]3OM!:]&2KSF$PX1PF,,)AQEN/!Y9$,PPW\5(PUHNE#X. MYX$+/T1970@[*N/'P96F88.Y"U$PH2?$)82XA!X>V]5E$2#?/[BM,$ Y/XD96TXI^RI+#2F@='<( M3K.08W40'I$.KMEV<8N608W6G@XY/M#9>CK?"34ZVU$9$>RMT .QJP<;4+ ! M(;,20 4EYS:#'R->TN2/J*FF.-1H !S-G=7 B*!@-GA=9@-%6:/)_3T3@Y?D M1BZ=RV;E?'P4IU+&Z]R]VQF124O/B.K5UP*YGVFQKDEV3 5':>05]055D/8V MR%K=K"SOW"WE#7UB3V8/Y(K1>Q:_T,E,NE@DKGY+=S&7&6GSA3BEXW5&FI9 M0#<+1-87N;YXRH0QF=A>6]:7VR:K:;4_UDM.GF"-O>&OF]#M*]GX(/_ MP0'\#QC@7T[7_.:*94F=;SV?TZ)>L]LT[//B1'2\G#8LBA#^3YJG0C[Y1!FY MG<7%S8(DV3030^]D;O]*F_K38B2KL^F69*\OIZ9=4%O^EN7Y,?E%]"CE];U7 M%4MFHG7=C5\6I^(,D=R#,_T3+$N-3 MDI65('US-.]AWK3/03 -]=O<[PPH'H$ _(M%_65!BW.I9@@!,B=U"-?5R;O-BMSP;BV!Z[BI6K;>2)5"@QU'+[DU+-L M<4LU5M !(QPH//\A*CN6@9-XD952W).*Z37AA#W4)M:S2NIAYYQ7\LX:12Q% M[W'<0UY7R+L1A&5)HX@?/Q="KE_]Q1:PL/%6B9;"Q$A,>+H-.M2"P62T0?%JQ05= M*+QBQ=$^;@!4@=3]MAR&F'=+;PWJ'QE=0#_0FHQFJPWA@]0X3!/5)MS7.7$@ MI7(.X2HK+)*PY *'ILLNW Z$0P0V?X,"3E?KELT#G"(C?O.2H*.AWC MDK)]Y^I!#7]8!'"/$>?0J<(B>&-(@-C.F:.J8#]%"T:FA#&2K@IH#:L+!A[/ M764P0Y)";;!0&TR<1%?K-=/H3G*[,[G>:IE/[.2:+3RCR+RC=4+7:ISD/ZT% M!@#-K1/UI5C$67HJ+39B:_&MN^1";-0S(F9%?"Z7VP.XF_#>0UH'UX@*U]G] MK.2MB0)&?6R491#'#.'OGSYQ4J3-]Q^>?J].Q!\PC)N<6, -8SOYK^#[R)R0 M?9858MME<0XB6]_:#=FG&2.)>("2TO8&H1A"*(: OAB"<8[*<9S+4_-F1DAY M(9\K51IULFM7?7U#6P5#;*/V M0*"4O7S H0DA*3]C=+ZVY5Q.7^CLVT755B71SF#NP:LO(7\&3'-;^9B(]B\R MF5^+K@$%O%?=?0&"VL U =C)#'KX@G%L#$/;PQ>,$V,8VAZ>2JO49Z"*ZA<- M/-8)V577-+NYLWVHS_+*ZK-\)E_KGWI58WG1&0VX7^.\(CVQM?<-965"61E0 M69EN'DOAMD&, #N-X]3<"HT19P_1E\)5&+>(+=;3 DU#)9 N6QM BB.YVS4F7 %@ @3BPU,YR2RD",UF,E#@=N]2 MA_OM4>TYNZKMH)WI+A]9OS/MA!0#05O*1@Z%SD*AL\,I=#; 3(U."H A-0^2 M0L=4+92X&/9.L11VZ'*3 N%@*14&,E+4U%&CZPM@9X/'>U-0Q)"K4U M0FT-L:W/:,5^H4(Z+.K@@HJ7@C6S]APN> <+A*VKV'Z*?Z=L\Y@VBO0M+9!R M61!95TX6FHOS]0/4,P1H;H&H6_$K,7ISL!X62/MRLWV*FAQU*T>%"IXL%T59 M '4C-T3*VZ>>K6SEM?*=;4=$LO_\FDF2T*HH^35)2/8@93EMID-7CBPV\$ \K_47E*XW-"H2?F =D,!Z%8088;E>0\$,+;J MS!$41TL7!$#DW)IMFI<]1@X#P;9?G7@OB-0>-,!>'O)UXES6,G\@A71>M@M^ MH+8A4\UGIEK(>+*2\:11'*B1N(X)F,EI37L<)B/!VBYEZ0!K96BWJ"T&/H*% M-G2QCY 527N>N:C"R.SO6 P9&/M=PQHE"O]"5G$::B1\C64-#^;$&$+M+25Q M=)DJT:Q=F/!#@69B5$MUH.2'@;=:>W$F[@8T4:UF$ U\86A>XI"3 V;D1A.Y M:_8RP6X[M_A"YD/(?#B\S >XG1S-T6 0*P6)2' ? G4DXX/$E"=E%'-.2A[% M1;K]+M]F]0T-CAK^)(=A4[:(#0%5KRN@RII/JUYG\D+E-:>8R&4H-'-].7"# MGCA@K=.&E^:X5%W= SLO$D9B3DY)\^]YH7P/"GP]1@@>L> 10^X1"VI*4%,. M4DTQ.V-'IJT,/I/0V'J&OU>]C.%271/[F=-KC;P1(1+%\J$7DJ?6>5EUZU6K M?<>P0'Z3PR=KIA;I;[&8I73SS66Q2?UK(]JLIX?8_O1WP?1KGO.9%I+EU"?% M+96W@1=)EDN_>).E>D&Y^/Y$-+EB5!*>'B^_B!/LO-B\F4DBEE!M()K<\?I8 M4:@>KA[K0=V/%UDIMKQ<@VE65K*N0I'(7YJ *@25%($D\WF0]MO3! &4CR*ZDOP[AV7P #""O&*D+I:Q6U$I)$RRAKJ=;*W'P M%VDRF _PZS,V2S]KO%^MK=R3*RVX+>K5JL;[KGJE0&(^ &:0';NO_T!H0$LV MR,L!;U8S &:0_=XL8" TH%M,(F9@-0-@!MGOS:(T(#TQ?*GQO&SC@=25Z6ZS M08ITPP9K>U[7:S'M[Q[B6J.\G*K,O("6_LB^I9/DSRJ3Q8FI6.SE\BJ/:YN& M-$XMYFIKB/D 'D#NE"E^$,_F[]Q2W^?>U&^ 1 M2NB.$=M3HHWY :)W=U_/,/1]O:#H%L$@>P'8PXWNL6P*""#%);!Z=]Q8MH'A!,#]D>@$1TLKH"NB 9UT: >W M06H!.CG _MX'!!:@8_QV9J%O6"MP.MQ=?6UG.OJGM@$GQ-UUV?N<$&TV([JE M 72=&H&V* CJIIS]*338>.MX%5&KZA=:BV[;F M.+JOH-:D]*+;N8/P]RLFL)T#1^58WT>\FL]CMI15;WAV7V33+(G%KW%CG!50 MHP7-LT06'A6G;%5[J62)TFJ^>'*_\QH(L#JK_0>[*]:Z+]I#=:'755UHGU'2 M$\;BXKY>M,?+;9.5^#3Y&K/T+,Y8+2=/M@M3\JND).F:?5^+A?\,O//G'LB4 M_DJEBU]*K*XGM?W)(Y]66:[]C)&-8N!J4G7/'=&4KJQ*OXB&I9!,&E/";T2& MC9%T\D!8?$_J'T\%OLT\V)[@851XFNZ[;J!W)MOSEK"YZB;?_3\P9,:$JLXA M@20DD(0$$M>&79^')CX#XG[GK)_.@<[)ZF&6NN5==(Y8CVM)IVJA<]4:S),# M$=2Y[?/;2#299TT6P.:ZI4R@*FK+W;229MMH+HB85_,HEVZHB-[EV7T\Q/)I M^['N[)[[H3Q8/5^7U5-1Y_N"<$[(-OIW[6QIW+\;;^\Z%NCTA3%BX"A>()P7 MUS07 ]__B\3L+'NPA$DY+ *0M&+[ +DSK'^0]:7#>T#Y9%P$,+_2?8# MQBG0'YB#Q\$.^>7Q.7@)H'3H,$L!?BC3C=92,3()-Q $Z MF$>ZC-!P/1(,NV.%R"4/P\>;RQ3H.;7@\<;R13H^/?P <=X/&<@]=0:@"7$?K$(@2 E%"($H(1 F!*(X=O%9/ MWI$&EE@RE8TL8&2?1NR11H78$<='&NHQS+8TL@3KO?BJ1IJR:DL/!\+_$1G\ MH69D(.R?D,#>DRL:*OXX+#RPO\7_TA 'A8]-_!OH-X+"QB+Q[2?:!#H+6"0_ MRW9X*'QLTMY -S$4-A8Y;S_A9-!9P"+X#?.Z0=%B$_',PEZ@*+%(0WD1H&"PR*5&808.L\3^3'BL@YC1%>U6V02 M!"TB+I->>"3^3]@#2:,I9>L,B(SS2L+HF2%B[X'N]6/JGW:TW7JG19 MG=3'KU<[]XRRLWK?GJ^V[3-T@\=Q#UD6#BV7,JF1%N)%M&X^4-L1DCZ4B5BX M>%DL^L_QG+2P%%T3?X1J)[F]T2B(1; 4V.K:DYIMM#)/2%./L3C/]AC7+&I0 MGQ +%6*AD,="Z8&8K79J=-!BQ-EZ5%'8^3"Z&+8>K,SQ.^LV1^C7&34Y<5!% M[-G=>(,"^BP!MKA@U0(ENO6I8!BTCQZ)R;V M7RGK=;),R#_)/@NW#Z;G$%_!7GF%Z>,/<8(]Q&>KY)I(&4ZLGA.A LJKQ*HXW\MU$,,I&=^T&^]9UV_#/H'!;QC\ALC] MAL'0& R-AV=H]"/6NW41H)FL#GL)<%:PI>)AE2: TXDMM<^[J R<-RRY@1@U M9> 48DLL]&+&!,X5MK1$)!9(X.QA27=T;6UQZ0@50BJG>9:*O]/H+L[K'"$^ M(Z0T\'T"!G'B[@33$3R+I. M-Q;+I!.%OKT7"-6\RN4I M!Y-1/,!-TUJ B?.K.$O/BU7PFPJ6OK4'\CG?$9">4_OD1U_$=;"(MC:>29W< M\=I: 2'Y>5L/^<@QGPG6(?^1[.,ASNODA?(D9FPIM#I=5(M17P_0\ICSRVDM M@6CS--4-1T6T_P33D^VUI7)=[%Y:JD+1W<-KCKYV^2N:^2"X,9#^EI6SDXJ7 MXGQDFZHN>@YJTM4]L/65X3#)O:,UDIN9]!@@79 ^4R+Q!S+RUY^X5Q+P^_E M] LG]Y2?^"Q."L0I$5WL?E[J("9W1/#T7$CY] MJ(UY6@S='3R V&JH8F;K T%22!AODCU54(#=O +2X.[D%\ MBI-95A"VW%7G=?NANX-[$)]I2=9G\#6IU?BKF,EY[CPR3+JBN8=)OT=@G=" MZ7Q%X'Z^(<%.=E ?#U"DW:NQ%72_$5U;WV6&=!J4IJ47LA=Q5ONW"]ZA:6C; M^B!=80CN. '!_1!!TAV&L$Z(P'Q6LB5(%_= KF72<$'2CS&3@5G\B<-BFB69 M"@Z\H\XE+1T'0G<']R!NF1#,*K;L ME";4#4,RB=LB=$K&2'7^"Y\ ]U&M37\\H*N$I7DAU#0,"E5BD*7E.9+26.#7 M" @<0Y?W @8'"$ ;776]D(YGS"1#.MY^X^(!P2SHSCD]S;M'@'EX"[K7" 8+ M#QE%=RB ,0*L=NAR&N$O4!T*A^Z-P9B+H742':.!T[\#&NK/0\=I>J$%1B2@ M6\"]P$)#%]#QH%YH36SQZ%*?>R'>3_0^NO1FNZOAA3L#72YR/\8&C1=#ET[< M"ZZ!$QU=!G _P-TN=R!0=Y><]F-J+5D@Z XHX/6MP'@O=((D@/ 634X7!(U. M>C2&",D,1">4PN.AG/ E,:C9AGA2\-1'N$53@"YQNB.VZ@/B98 \Z&1= N/*R MN#$X8LSPZ5-+TR$.>1NBQ=V^^V'ON^X['O]_/8#QV/_;"?QW[;\=AO^S]VG_ MY+]BE%50%_0K8;D#=-0EFM[>Y)6GD+^+E5M6A/B;W62'- M1JKY'U;WSUAV+JJ[;N;69 M);]OVPD^#_<>UP+M-',Z=H@#,_)'NPM'4@S V9IKM7'CBU-P-1VMMG=\<0VN MIJ/5)^!VLX3Z"Z'^PN'57W!GR\;'R]U/D-;*AX^[NY\@J&D98?1;_UM /1MC M$(;6X9M+$^,CPG@];QNYRP6',/C/^>(;Y))P&5#XY([S^E6!RJ[,C2Q3T:]OZ)_TTRRNQYX'$/VOMGOQ?2"&X42[KP:1SP?UD='J9 M/9!583(%#& O#W!D09\K1J?*6(N6%N[)W.9IG F1H4G]JVJ)<7TT'),I9:M\ MCMOXD?!/62%$@7)Y7I1$B :R:,;349H<@4]$B SBEP?1I#YQ%-/@@0)?TRR( M7ZW+8[%LU2NCH[4/\IN)UN]%12L?Y*Y?>3.3.^MD73Y""0'X30N<0T+7U? MJ[0I#M.0MM%[S^<+W7T_YD/XN&2&$Z$7R]J[I^2!Y+0N4J5GR* ^/J \D*(B MZ^/^>544,?%Y):U6LLJ6^%^ZDSSZ F#OD3S$/Y$\E[04Z:>8_4%VMK\"77>' M$'EV>'?J/+.3K8V.*_VL,HT1@BA# MM$2(E@C1$L\@#9:A1AH$ ;4^CS2$06E='&F8 5!E1A?@W$TW-9?XT;$:(Y0& M:BDZWF($U,@Y@8[/&$'M- JA8SM&\+2F;73!1H;0#$W>Z$*!#.%ZABPKJ M,6T=+BD@1'<5;HT@:EPG0&#NRMD: >MOX(;*&4C%J4'^(RAVI$(6(#@%BA"I M= 6*8$%W-L.TG6'F3'1*4&\X/:9DP$(_A/F 6?B11-@F,QDKS",Q77R'&T>D M%JBD/7&W:NZ@Z%NS1_F.S.U#+2QJ5U'%\..C9+M5QF>2ALOIES].FN*^0EV] M97'!\UHX?N:/Z-/5O<<%4*BXM7QC[_X>(+:7U];#@O3Q >7W:J5 W5(%C3LR M[,?'A,C;SY\7WU:"MCHZSNEIS^2XELR#9R59V;J%W)31])HD]+[A:$^JSO>8 M-QN/]1&VOE$&M-M%VS_:,&DN"'%)])-[ ME+3'AJ:EKU YFZ7DX-P9G;E0+[,J/1L#ZBG9#W745G@#O1O:2Q)&9^L$O\P. M!0M=* @86">C01?Z 89F8$-"%P "!@G1+]#YF>"OL)]UTUN@LJY^K16^:O< M">'+#JK60!Q=2$Z-OC?6(C\Q#& -4/C0G2$-U/G1G"PRU6YY-D M[(]"%VH(FXOA 7CN(@OUB/K[Q5T&9M37BWZ(XB01DY1&9!5S)8,.RAFMN#A/ M^#R%>W]P;A6A !HKVEH3>B;^(\9M!)5S3V1ORO<5(?A2#B%8W]%<6ZBI=2 MF]83KV_LH=R/-/68[EE8I^#R#==AA4H.H9)#,(6ZMB4 3O>1VD,A9_](;:( M.7ZD9L\N,7FD=DV(*#=2:Z2)@#=2(Z,Q.D=VN&\CT62>-:;@*"Y2F1XD#8BD M2 21$4]F)*UR(K.#,@DNBA<+$DMO0D2E?8IL4XB>UO;O:;%S1Y [VYYK3,$* M&*R YIKA65;(&W@N2,PWU3CTE4(!/?S"N):YJI?3+YS(,F+E9$Y9F?W5EE+8 ML[?'@LDUB?KWHVT;["7!7A+L)<%>$NPECE6!7D?,2 TH@!-HI/83L.SC7*7[ M(Y4,%NT!M4JJ%;F0N3I M:KG=QH\UG^=UF5R%,*EOC(#X'2/69Z)RV@)[(8"S/:/$-)_$C"VGE'V-60I^ M0=TCH(9Y1AG)[E4:R^J>,R%_L"N%= M@#H'0 !2?%A_MQ*?=D.R!=&KDI^\_4YE64X=.AT6'X5@XF0P>D-XGM.O4A:% MSH.ZIU=8.P?$@)5O,DHP@0436#"!!1-8,($Y-I[TEJ!':@8;*D./U$8VZ%@> M:?117R%\I%%)^Q>R1QK3!-$N1QK+!#%0C2QSLK>N!,3I[HJ&GCAUUCG?'HSM M'Q$C0BA+!*'U.['CMP /[\U;84AA\%$$'T6?O++553O73Y;825T2_KSH;W^R M-S":25%<2S0IST@JKUZ33+@2-"ZW_<7^-IN?8<] ,U6?J61%55)F0GG5AZOU M& $-S":$?5M5PPRBJC<:>+54(83W"T%*OG-'F1G,KE&"/3;88X,]-MAC@SW6 M>6[9WD20D5IL!YU@(S77]I:_1FJJM:V8C-2$VTLF=6X3^K&YD2RB3;IMS[J:?N%$;'GV:TXG;Q-G9X&%]/'C6A_=EGINM"MS67H@J!Q3:S% MA>J**$^7=;WP?K_Q_(B%/'^/T+K)5 M58KUAMS;5"J?-+YI.Z-L2K*R8F3?TZ9YTOBF;>?FA;WR/^5S1CUE'OB?X=,1 M3B^'<7@"DD?ZSO)>B!CE9+\X _Q,=R\R1CCA+:>'CPGO24;P+(?[8!W?!QO< MZ<&='MSIK]*=OF>E8Z0N=2\:Q,A<\9Y='R-SY&.ST(\L "!LVADR5T8O18C M32)S="D>:J[=WN#94R;2EO:-;2(&,*=-8.33CO]#Y!)V9T\OE> MC:'06<,BJ3MRL$.G!8M([M5=WAV4NOI>_D=*9^*;_P]02P,$% @ FQ[ M4&XF2BAA6@ ?1H% !4 !I;G1Z+3(P,3DQ,C,Q7VQA8BYX;6SM??USY+:Q MX.]7=?\#SKG+LU^-UBNM\Q+'R7LU^G)4T4HZ26N_E.LJ19$8#6(.,28YDL9_ M_:$!DL.9(4@0Q =GDZI4K)5 =*/1Z"\TNO_T7V^+&+W@-",T^?,7Q^_>?X%P M$M*(),]__N+3P]'TX>SJZ@N4Y4$2!3%-\)^_2.@7__6?__-__.E_'1U]CQ.< M!CF.T-,:/L'/O;XVV^__9K_M1J:D::!;-+C MK__[X_5#.,>+X(@D0)$0<,G('S/^RVL:!CDG8^<2D'0$_.NH''8$OSHZ/CGZ MW7,.+K!#_#-ET'3SAF./,IYBF> M-7\7I^G69X#'MX#'\7\ 'K]IFBU?+QEO9&2QC/$77P_&] ZGA$87B6&4FZ>U M@OM#'J2Y#>SW)S:,_R/-@]@LYOM3FL:9B3!L&.>]*0WC?(,-\\?NA.;PU4 T MWT=2$;L81EVSGXJ!,&&+4.7P"A%>FQB_Y9CIHT)J5G/3<&L1),E_98@>?WM\ M(H3L;^ W?S^GX6J!DWR:,&&1DWQ]E \.EZ,^0N6/,UO 9I=!F0](<@7N%IEJT62_@JNWA;XI =_'/R0B+& M[?=,"NRPIW.X/=G<&7ZVCTL)$T4%4+0F.(Z<'A/WFTV][:#JL95(^!N:XT=Z M21)FQI,@9D95SI$\QWE XNR1J8]5$#?)^GY?ZDA]-0BV&1JP0(\457B@"A%4 M8((*5-SK@IZ;0 =0=B"C926,H]I/Y#DA,Q(&[.<@#.F*::CD^6A)8Q(2G%4_ M-+&?B?ETF'((7-NL^K#! TTK/-!= =X]>QK9)&J<\HY-G7".HU6,;V?-JH'_ M-INN\CE-R:\X^@3AHX>WE16G9VDSK9(ENJZ .<[G2%HR,LD,N.2'+$%.@J"Y)(2_OTF]*HPE$# M[43'?& Z9BJ00<6^9^C+JP0]EMA\-2+%TG//.G6)SD8<<#3YGF0_7Z887R4Y M9HR1NXHFM\$=0S2Y"3_;IP]@'LT84$0*J/XTCKO-MA5-[MY!6YKIFR.F#!OS<.H-1]FV$Y(1;?\^XM? F'@'VB)BSG?R=O*A M4UNL]P?V"XAV42'D=7BO?0JCS-<,R@GW_0$B10"\B,J.B?TZ=J"3_U3(.HH( MZ NS243V2; Q3(XB],'Q*;6=].7Z M9L4]* @*PCYD8Y9+'*0@(2@L ]=F9&/H$MZ::&M-=^@X=;F'HST.=QVT<+$4 M4,-7L!0T+9>"F+9E2ZEEH+$QM]521GG^'3+=K+6 M(9P=]:WM>V)Z[MLGH,V0QY"VTXRALV>@+Q78PT_: MZ=ALVX] VW;0U>4R&,%,@&3\<083*QE.7YA.GM&TM( )0QQJPFBI/7/@K%Y: M]T?+SP5WX?XQ12A>TS#U*%!%#-72\[LJ4!VELC3($+WOT(?NLEN%6G,9SE;, M4$YRB?Z3#]145_L3VN9V.>1VUK6'?RZI[-.R"%X,"(4"(JJY,5X490M74'52 MN5)#R6KQA-.C5TR>YU (*'C!:?",CW#Q&O!H"<\!C:@@/5!6U4\_E+RIGAN. M)OIML%A^AWXLD$53@>SNB]A#4#Z:K-!;\0S97US-VY$0:J.F5-!7X: M^;9[M&[UIN997?!<)BG9Y"'G6X&\M"?-/(1JG[J#64]]@EF/.%T&Q,9IAGDJYQD&9?H2__QO[K5O ZW.;=D*R#O;,FNJ=/69X&X6Y8 MI^=79D5Y.;M7D8Y^*M%PF];5E_+=4KZ9G/[+E=6/0ZT$4U:] :D=#5[32J18+3VXL?P8H#S9MKV3P6_GAMV(%Y-*29PQ@Q MJ*M>VH(4?E6+:Y0A[R+B?8\7 4G8[R$#%[3\*HBM>$'6$'3M-1E?B&T!45UR M%!%[E):8H'"#2N&#':#C98^S3#AJEMGE0/+CE*D@KN=,)\EI@G>=*=<33>O^ MK;@J929]+32,:/FHGL"SO^KA+_Q3)*5X%!\N><-$8MV@#?_ (AK'09IM?ONY&D-*_.14X*@SR>[)&>T#U)!$4L M;9__,OT0UQR7($?0I9+.>$:,EFEQ8#3+)1V=_V6:#3M:!@6IUMX?UOV9?(FN M+\H&8.+I1DP#8U=/\CPL35LXCWT'3 CJS_,&!:G@^FI(37'&A>P>W3L",+6_3M8S]YJLH04CG]OW4WZ M@Z)?KI3T,%J2:,BE?ZJT$/DIL.-8'WZBQ_=L8)Y=)79#F_2RLK92V'#WA9Y+P:-GX[H,L$^\BB0:1 M;N@EVDC5E<=$G,\AXR;K6.,E36>80#%%F3XVHJBH+SH^)'D\[-5EM,%3LMRD>OVBJ1]/M4\_%TO1(?0],(5[\;8D M1<\RGPI7$PU?"K<]&-T<9TRL\A9Y\[J3XXJC*# M1>#@E":K3#%XV#QV6.!P>TY7T9(G@.HSTB8AY7Z4K8T^AV5B-=RN63*R6B!Y M>U*UA]&A&%H-J/MY@36$@M\*"B:\]E!/K5>_;3]D%==V*HP^L>K8*,=Y:<&2 MY$$,%:F8XBU2Z7C7Y>ATE=_0_&\XOPN(3!3U_5PW/TT1C&VA<<=^/V<;"W8= M_F5%EMQIR. MA+9Y;2\2!D#]Q,%:J$G52>235ET:D4*.@I?CH<@Q5(]<7B(E M#T$TDHCMWQS1V,2KJM:_)(& MKHJC-3E',JLKJ2H!KR-.C:U$0XX6M^L0]^9H$$]I>ET\0GN2RXL<_2$(>7A M28Y*!@^3HSN3NI*C+P58GX)41L]]0=I*)"^,<\_04&*:AH'#&*8VH?U,D217 MR[^SRRA---QG$BEA'&M:$8;,'NDT_&5%4GR7TB5.\_4=HVT.!>G+6)9,^?:> M0%#LKK+9.6ZJ]/P?2X60^D!M$ M<5M^.YM&$8%/@IB/RZ:K?$Y3\BLV?I.H#M'UC6(W9J._6>Q>@M,;1AL4]9/6 MM2D8N5F+&)\A5>*.[?:RQTDT<8O9EQG<2M ;1N@@FU\E+SC+1>^_2Y($2.ICF!U*#?I-6T)TZ M9')^UQ7F=_$8?4'Y782=UH\?3BT_BGJ#-U*AVMB*S$L/BXF:\NU[>F >BRL_ M96S>R<'Z)*/P1 [?__A,G XGKL:8'(R=;;[&;K3:(JKON"C<'/WZ&]O904S1WR]7[^20=_-O]@2:GRB>VGCTGP*$:!GZ83X&V MM#_!'-](9AG.9;FYVW_4O7GDD[@RFP0TK1)*FGCJU$NZA2#.].'AXO'!S]7H M]L;2=BHXO@)EI+H)%K@E9[QIB.XU9FTJZV\2V+\0 /.9(=Y(.ZI"$,=LD!95 MAA]R&OY^*9#NK2GB3S(U!:7Q8T M#QHH5-R\)JB)%9_O""04;! M_M\.7"R6,5UC_(#3%Q+B9L?WAO(+".88@(^; M\2*'];^?T:QX;'6/0_J<@,?+N;YX/RCA-*>P-1G8"8ZN3$(GB]&Q.$=*Y8$1 MMRJ2MHD;35"UBNVZ+1,$Z+._YFB-<[19P01-%Y"H[$62N3VAU"M#N#;J),E< M74\*5+_3-O0ZYK=O\M7R]RKH?L(:ZL2FVA1T_%20H19 )L$UO/>^$/6)):S6 M.E;W86#3G+99BL,JBS&CW_[F#R?'Q]^A"A5T?_O)SX.Z5@+37E3[3*Q&<3U\ M2=/B5S#NV+7YV(K$V.S(1F0/WJ!L7-6H+$M#='=B8DI-2[$(-*,IJBWC\S(U MVT^S"YM3@5470O.D> 6,KV4E:RKLL$0[-J]TP8!-UZ'GJ[ M'O9_66%J]ZBE+?%YC59U9Q '_"%GZ .N5XME6_"E_Q1&+MS:03E[5MH#)ZV' MI5;7K&%I[UX_5BA-D$ *55BAT2U[T(O::N%6KXO&3WLCV M(;1'\US%^#9I6ML6)AO+<; M[$0& +[%8?\2@'Z%ICL&[UV0;^X(^%C7$ M?/=OFG<:WGI'D23YK_R '9\4QPM^\_=']E?\/7W!:;+@A2Y$0^BLL8=-CR]Z M'CV%F6T?1 X=;X,-O^;>]8A,3Z]?_LH(&L[2V WAJ]E+V#6MAGAM-7115,.7RYB@AJBO M(F1F^9_:WJB19 0Q8[AO,E#M$]-Y0&QJ=_$F.0YZ@1:3:^KO=C40WW7B4ITQ M5'*6]BCC^)$?<_\V)L-Z8S#(PB+='^@^\I-.;-]8'*MQJ$!LVI^"(Y&ZWZ?R MX)O:1Z8E+Y_PNR-MVIJ8Z+.\9H\))W7-@M5 M@+DW-BM >^&G;MK2W@1S;!="'C2DWEPMEBE]X?=VK>S4_8&N72B=V$E6.T!& MI ;:CR'835W:GV3.+UW/@FS.]#!<"T>GZT\9CJZ23>G%," ;)$#[%,YIB,>XQ>,/91Y+0E.3K MJR3';)LA@K(]"WC"^?HCSN<: WU5Z0I3AYK&U9(TU?1X*:Z1 M"U@D-X*@0;1: WKBBR@?^>2P#%_*W/E1I"/8;1\BEZ%?/"X_Q0F>$9F+VS%Z MD"C;F]6^LUIR./2.>B&9KP2)+JKN<64'J1P_0&,())@G>/'L:$BS8'2&%T&; ME[ 2?NKUK>YC,A48KE2<$C(ZRLG2*C7RY@M,4!T5!+B(Y^A^'L3UXC,ZB*P# M\]2WWZI<9=DJ8,OC[^MV#I'J<)T,]99I;1^5+OB]<].-KL7 8[(2 S2"Y1C( MLX>"Z!E_5;+BBX2:$O!;4BZ3]V;<>E;F(05?Y9S0OA1VJVB_9[H^#6*(/$4+ MDA (..?DI:.8D^)7FLJU8W;;LJ( +R*Q6PAX43.JM*::!!R%85=42TD_!CGD M&SQO_1VS?9(FP@^?T*P)J #8LUVH@*%!8]$*/;V9?E_JB!LU",[>U/"P MW?;SB!(3_4HTMM:H=TZODAE-%^(Q/CSS"D@"0BBG"&]18=;X2,3#X>K)A'0 MU1V7K@FR.=0A8?\!9%^"F%R&'JO;W4+U:C L/[DF$'G M'!C"#WB#AX[5;FE%&K9 M2S^0PV9"6+:L<0'<828LWC&[KB0 MJ6'(?+!\CE[G=,'EU:1!:C&113;YH@@<.^@?">8D(^_3FH-D?R+YVH/-J'G( MJ8']'!H/XOKE=E;4*W_$Z2*[G3%G$4>/M*J[> ZW\D5P"FK9W;-]CF/X _LS MPRP,XGC=&#HR/[U6E,D<&FX"4N;P[1_@\4DKG3"7:.3#Y$S9B8"CC J9W(,-;\1BC$&]%V+8\,DPM9V*\ M%#HEYNBPZ>9*D),ZHI^+-%>3/)KBO,=&#Y3GUSC+,*[ZGO(0,G@!F!>/*=_: MKS\&^0J>VCWROER2A^WF)M21V(, VZ\A!,A-:KUPQ>T+1Q!Q#">HPG&"2BS1 M3QQ/I/P>WC]A]*0*@[J*@Q1$0ED$@(F450+_ACH0N @NSF+ZRB]68[ZJ?\O* MI[2,I#%O/QR7"RJN=@2)=_[V#EJ-Q*L(,RG$SALB&4IHSOZ^X &4G$[@DI9) M##9:W":U8,-$G!82'(1XTL1D),JJ%D<,UB9TL:09;V3I022:.4U_VN-ZF_>,-I2#(,_4,?YQBR9IKD6]]O=429*@PGAJ4J,KWEDKU5:AB$ M%3+%H[$"'53A4[VS&ME:C1AQ0;7Z31Q5Y*O0@@XBKR6 I!6,$_[8C-&$240L MJ%(?C98,E@=QU?MHTD&[8^BRA\-\VFU_#.!:;W@4/AMRK=,RO=.[G!8\M"\R MC*YMT*T-QZ3H;%K'!8UH@8:O9[+:DL/ZDD%H9&76F_>[%97CM7NAHDSV@9*# MOPK8@U/KB'NZW@PI/$[>1;V0;$R@S3#/&,HJR=AKBLM[^>4M(UGM /ZU18YMH6,"DLN9J:T"'3DE-/UMF[0'"66'028R^ M$)RU.&ZW^U"0H0 ">:N8.[(TY'4*BL($ 8\.DD3XRO@%]BA;XI#,B'""0WB8 M$(3Y"EZ9,S1%T>*=7,ZQ&)Q6!21UQFUN0HAEC_+S%;Y*[FG,)G[^&PY2WGUQ M0"11:5Z+ <56^$[4BPE$;445#5-'0WV_A%2L M%"]IFHN7,T&%4K!J0W+:3.K#[OIE1Z$U?1*G5L5.I31LYB.#V)M8[:7,K@^_I?! M-!:#J2;23)E+NQSK7!7\0.B1L]='SEUF-$+'Y&X4@P2)D>H'";8.1*DQ M.NEIB_>'M$3_2D/\4:XZ$DCV^I?B\*4XNB2?OOY0XF'/EX/?LX&YW7M!"0@? M5X([J!S$;> .SLZOKP;3S.L=X 0)_#W>_PTFH*8*DUW[5?=]7]*RC-$J(7GV M%7H&3$>7YV5+_IBZ<6O=WSY56+*R# MS)M\]TY>O(TQ$!1;VPV[A%?:KOT\9 M*A&@DZ@J9'&SV'[YO#6)Q_5T_NY,W(+)__R\L;1WAP2ZP9B@_NLZRA MA''1U6YS,Y529J8M6I/%.SX9DB@NF=IIDK@$!^W\:6-K&I0<+K"HWY^.9EVF M<\+Q,N U3[%8,JF6O"Q0'$U>>-=)VLT)5R*Y9U.1[9<-4[$VK0]3D8$_"%.1 M3>[M.!I;L2[73-F*>SSK^1;@<1[D/Y(X/L7? MBQ#@IR5-KA*V;T%\$6/>S?XVG2Z7E('C%2WH*66?V[@N&(J+CWL%79P/X@)" M=W'. ^WN=L'OLR98)X*%HE.,BJ4B6"LJ%HO*U:+;%-76"X]I/O>M,>VK;-V8 ML%^$=,%4<7$QPE],\1X/3UAZ>R)Y_(I6L&.DV#%<[AA3U,'VCL%,G!@3T4@] M@HHE )@PVX/]$Q3Y/! 53=@J7@A=9?%:O.'"HA',3A%3D>#/FTV$F%?CSLA; M86$[+=S_*AMP_2+,6_/9EM%A* M"6^"[FA,PC7ZJ?BOK.+JA^2DNFJZ9=8H&XN#4&=+$==Q.D.:BW%G8SJCNQ^FI MEH>*(JZP0#!@^1+19HU(+!*Q58)?]!EOA)E"KA5=BY*NT":!D?65DS5(ZMY% M)B@+#L83KOL8$O>".2UESSLV49$]QMTC'@0MBD_L.E.]_:%#5@SP^D+^R6O,Y70Y*BP.0H;@'W.0[5@5S \X28UKT4SJS*NWC))1L%!IB.= M-OC:>5:,F208MSDO(TUQ<9#TH:&\:![$O937>'9MA/DI!Y&Z82!3PVP2+TU* M?<75E:@I(Z^'I#)>*WVW95[KX>Y]I2T ZU=!,KL<(]:2=)4^LE=5N(CVIJ6) M\F#'_JD;P%XC+%*TNY_L]X/GEE:M:SKZ$LI) M<22_\K0^<2/PD =I_MFO\B*)-->HM1I+E_3R(TZ5:>96>)WQ6!$7JZIR3.43 M39'6-K5MZ796BYI-JFC:!KYWYE*B.]4AIEN6NV-SX32%_N<]N$[Q*TW&ZYC= M-N]5X$VPGZ,5ZO1_K9;Y()997AUL\)B@"['<0KY[.6FJO$8UR>OM_G96MM>Z M2TF(;VZI[9ND$];;I#1[:QJY(@X.> W MA9DEPA";]:&K! %18$A%%E30!0%AX"*:?5>UK:E]R[X1U$'_VFYSX2)<[MV2 M[QU^@[]FY1WPP MQSGL\:8U40$$/G@1&UQ<:GNN2S!RAC%XS^R!P7U91S6$-G@^TE/\%QQ'I^MJ M<4;MF[Y G5HHJLB-V\90784[M6&/KE[T?%WWUM7R(X64,5@3?/]9T=E,[O>6 M"MU2<#F%-*\YD.YI75.6D!S M5Z,RSSL'34-*0="C?*GK[NJM(^^/B3%VEN. M#E:->LSE2[GQ_RMT>? 48Y%^?F)4EW7 <*JZ)+B,6U-)D'8G,(U1S4_&LE!' M-?S+QTJ'2$*#R<-9J20X38J'1ODK/20!WR5ZD*^U#++?W:N?X M*;]*LCSE8N,TR$CVP(1!$-TF/P0I 9Z^9R@>2R[8^GZN>=.F"L95,HLJ/CIW M;O;6JJ%? 1FTP6:".#Y(( 3/1$J4T+WKDZ?-@G0HK<=ECG]P8(Y_T#R_5G Y M1'.\?VE-_U0;F3E^B"2T;HY#'^C#-\@_U&6S@ZT;*,#/\8PD@%F2I^1I!9CQ MI&*2D,5J,7W&]U <.\71)4WK@VYGTRCB]52#6#SWN9T]!'&0KAF68 \V27+K MP'1$NC6DG,AV:]CWEE CHJ.6<'3E8C&F!1HV9:IV:X0\T@0<&&H$%%T$P0E&D-D?+,5/ R2',2 MDB7TO_*@0>R+->J6&6P[!5E'_/.%VPM=0[G,$C[[^(]]NW,ZLI M>?[0M.*:N%_..+P;]^LV;]T?PMY9\K&RUKOW337J#0D0T("W&BC_5E9M>:2H M( 2DS/E.JCN$3=73^8_SRJV#NW:RP*)# Q@ HOX:+\<"=3AC_DL^!.J[\*IO M_.*^MN-%!9B N],8J%)D I2U6QB03?.>>J]0_J=-8EU;1D ]_6",;JA';:3L MR?KF:"/.\*YU58=<_]OINBA.UYP1-W@R?6=6 ZA#9U4#.TVOR0D=M)W-)E_S M;DLD;0U@?LY!T,-"9EA1KFNK=0&4\BK+7( J$)JC^M4B6&\\2@QI8@&*"A]_ MR]/TU$QZN'2@9K?6[57M51*F4/CF'(O_7B5W*5X&)#HO7I$Q3<&V&D^3Z);Q M0SK-,IS+N@(,FTSS&E.O M_RF@@0*%%5NZY1W(K]0L\8<&>\(YCE;QYF4$?_EYCT6Y1&;B7:[R58JOLFP% MSUD?X2)#UI?!W(1: 90A@&T?[!(Y81:(%V3B[7")(->" D54XHA^XEBB7+5W M@W^R:#J9BF@$-P&YX?DZYV*@U4BKSNP7QTCKQ9H)XI%B)#R?0 M".]3\SMG->WOO-ARD4PF;CDOV>]V];W26(W$/^FTGR6A,(JY= MU)I$J7RB7>U'/K7]:C\UV*-K]J1$=*I#2;?\QJN[GM$L;[5[%4=K;[GIR'S;.KI&BE@LGSG+G(TQ>!GGQPO7/VX]6H2Y61&/F_F0\ M*X:[-KU*9!TB#?7\Q!(K% BTRM(>@%#9TVF+N-6=I.@XP5S&$!*30IYFL[FH MW/$D2Q<2;;I0%->1_ X3C[)EE)/#;>PJT1RW.7%4[LHBGY+W;*WC!C@I6_,Y M7WN M&2A&[W 2Q#G!V32)?@S("R0#%;^Y36,/D% MYRO'@W%Y^4MFA48E*KV%CJT5#FTMM%1?\RC.?D]>I /(/UJSY?L4,QLKA<0^ M;Z9+.P[C,E^:<75NPOSV.?_N$*P84^0:A27S+!:S25S^)[)F.LZH?8M&A9,& M2ME[0/)$WG.JZ>\ZTJD^CVW)P6&A$_V^4<.0U3RW!=),I 70Y96()K([904Y M3_EX7=C(![237E:C6A>\[O#% J?/3 JQ@_.:S^$(!LFZ(;:E,%HCPM4RJVTV M%Z!1"1L)X*B [CS:I4)?VI-HAW.U9="F=(74R*^X1FUU'M9-EU^+5'+;U6Y9 M_NO&R_QY]W#K9=*"'73S]."&^8XCKL\U:9!^KQ0F\P5*P!(S]YH M(PVI&F%,Z*P/'3KK@R&=]<&ESOHP4&=I(SM$9WT8M<[:Y0/:22\G1O-5PIRJ M!2?W-9.45SE>M#UN:1L^P*ANFM:9D5T#CGX"\(C#=YLYKDQDVI=RKMF(Y[&K ML=#64#/LPZ?TPSH<]"BX9INN/&4=I^L%49KLT?S=,Z8I2R,TL%'0GPGEBF@\2T M+]T<,-$/-%XQMR$5O"SG'LDX;;;9F<\1OU10A8CQQ29:6_:N7UP M76]UPAU+DT!)[R(A(%2GCN#CA8AF0%)SRV]DU39ZO(>M> ME$Z#UK:7-/V4[892M+[5+3VH L-9I4$59+0*"]I9I4:YU@TF$+X&7(XX,DA@ MPQM\'\UH>K3J6JFM@H*]F(X.HK';HSB-_K'*S>YP'4.KU(D@3YOS("H<:GEWS.!O"PM6!-X2NCDAP3ZF! MQ4=%$2'^.QO2- MR$2,;)@!)P.F<^QB $C_#L86'27NQ3YQG!>:@_K;HMG!/J,-!QUE8'9-&F;A%@((,*C7[_=5-J^;A:@.#7V7AY^&(3S\SNYQ MB,E+PUVVSJ?&2K_O@_!7Z'T?%S-EW0>M<8@=50)&J>**G)5M;^&LUB+M7:0< MGX_5_'"!=QO,2(X?B5#4%O3.[:D'78\N/< MTE:G=QUO/R4:E-4[TXS65S-RF'HZ<>9VT47& S>%XJLDPF]_Q?(,&,DX_1R' M[?E<)3<(J(B#10RNKZP&"36I,HDSA%? M;( B@.J)*R24I*KD&?B&X!8Z:BT6D*@>Q&=,S%'VL_Q)@<)PG1<&+=/:9H9; MWI^NA(U*X/H/$(RN97"!'LJ6%VZ6%Q;X>'B%H,(ZM"\-'4C$QN0*V9^U):"; M1(I"\GG)H)"2C';1P7% LV"WO9!1:_:$XE>Z8RWQ&#@4"EMW%^FM!&/*E#$K<1Y6"V7 M,:^*P91=D,TO8_IZ(7Z139_ \ MW7ZKH?*HI>U1 V.:GAT]W=]<7'R]N'J?7 MZ&SZ\!=T>7W[([JZN;R]_SA]O+J]^:,7^=.+_'0(33U?ZIVNH>)&R_6OPA>F MKO0V,SMH';6K[@"TS^MA%3JWW7O)B.KIWRVBI4OOOI] MK!L55P+B++:MA(U6A-K2.C7BS-7UUP;N!%7X\>);9RF.2(ZN:99-H.D&O%0Z M#6+XNY]H=#]6I,/H[ED'@.!H?6F@\(4I';"9V9L.\/D*0872;5I 1CZW'/8( MM\2K=,TOF-IN4.4#-?EI?T)7DGP?LH[4'H3_D!2%HB.WR/.DB]LXT;,:$!"-JV]7>98'7+O) MK^84/M*_IVN9W-6E7='Z'7"8E!W@:VBH%^:W=Y^GL@54CZZ. Q!!#.W27W"R MPCBU]&ZJ0O[4LTWRFQ5PEC=L8,!,NB3TK?&$N"K]50TQ)I67X"S/M8EK6A-W#=:\I^5#'< M9K*W!W);:.F;^TK,^H6+))\9X[[MZ?URWZBB1S+"M_)?&S7=\M]-D*]2?#N[ M76*!GTS>R0=J\MC^A+:Y2D"$I[0;F.BG1_R6HU.&_L]^.*J%L%2=6FZYYC9] M#A+R*T>$<7=&8Q*)+A5)="?2Y_@_;V>7) D2R$2#VF+BDO:<9&%,,[8<-OJ! M/"=D1L(@R0N#FOGS=VR^D)D%L#5\9R0\Z0L-38YWC:[U],_:>B9H:T6\W6I] M37#JJE6AS;+09EW\F]K*T&9IJ%R;_^/JC>?H6!C)<7P-(GZ\9%ATSMM9BG<@ M(@;(_UATO2D;VT2RX)OV1+J1N=X K<>'RZ+JT&ETJ_^29JM6)TL=XB97\+S% MO VP'S5':,>7E! 5ZU+BS8-T+R>W)G-V,;D%5>M2&BDC-S1G^I0#]G3) MV+SQ5(TJ;CGYFB3,^!8I-)=!2&*2KS\&;V2Q6IS2-*6O["B>!4OVEWSW2>"0 M*31/01]0KLY('YQT3I#=-6N<+T (%&V1=U7B-$$%5JA""ZFMV](QU.)+:H+P MHS D>=Z" 3NR>QZS9J0" M3-)"IQR/R(44Z)6ID<5_BRH]13]M5.NW/4%/>$93C"YI.L,$+F+&9.JH<[=R M($EUFQP+BT:T:AM5]$4_E?1%WVQ?U1Q=)D?L0=(5,>8QJK4JH;/K"Z+@"4+?!&>05@'X%FT9 M+GY9M5T*J7VF?1'4/KV[RY]V//0N?$RO+:=Y$/<[=8^W4%7E^FIZ>G5]]7AU M\8"F-^?HX?'V[*]_N;T^O[A_X.\Y?_\=NOB_GZX>_X:^/+^XO#J[>O1CORFS M&]6E\R@T(8_;:RK"YF\MW-V,10UN(V-0"PY=I6$ER-$9JPZ4<)WB%=4H-.#^ M Y\SFO!J3#^2?%Z6CN-]PR0G4F,&8^_2I)#\O5*3HF3FS9K!%>NTRROP80JQ MP.@K*(=0(H5>&5950=D)4EBWLX=NW4S9^NQ-D>ZNK^RVFV9-PW"U6/&;HG,\ M(R&1G5GU#[6O]+H .'BE7$)$D0#IZ7Y/F=14GWZN^2[##-:<69;G^ 7'= FQ MO/;HF-(WVMS6,K?]NV0!G(?)H@UX3]RF0F6J13KG-19*CK_-YU"]=K%,\9RA M15Z8/ Z9 (:B:#(.0\HID<]%>]]//9P(7!IKG]\1;Q>L+)M'Y5*>S@"((^_F& M=30@Z_#3N[^^0V&%"\HWR*"@:CC3N_N M?4.[D0 ]1OQ/AG^VDT$#\T*^G(F M'4)^USXN4 MV<@X)ZG(]<<)GI%ZW:JNBC)#I]/D5%VPMKFXP(M')3AF:!LU5.)6K\7FO<[: MX$VDIG=F!%*XTT53_,JD+';GGDG$\7B<,U7J=XGD,3IF]^1Y#IDW!HRMO;E= M';]6)'3.G*E5#:0K\C_,N*^$N^5.,KB1G90=81:;VZ M>+MX"]G0Z0+^I:,"N^:RH0]E,$>A'&7(&=>4!J@PY#0W*RQB$ M#@PG2>>S'%_:@^LC%V>"3MZ??!B?\:BT/QKAEPZB'P+'DY>A 53I?$XYGL'U MQO'?'!#'U_=G,,?O$7V<''_#M&R!]N,KCE_P1YKD,K-:D :M.YE/\,K#?6/QXUZTMW9ZCTWR/Y(3 [ MP\"HO;,UH5.&!\#>6/[D@%A^:X<&,_T^V1V'8FB*R7,BDE##K:8FTR2J/?LN M?/"NW,_!\^F&;'3A6@_C",10B1FJH\9S0NO(C2Z@,W@[J?$]&D/3 PGWMP\V MVGK >L%PJ'=8].0(:W!'5/>^B<=4B.4XC1-2GGG(/>M^X=DV5C=MLVE.ZYJ> MY[F+VQ(_>8NME*2]R..67\I"<7:1/64>EX41\DZJCITCA^:#'X$U-CG4-UZ];TSBM;3X2"4X.SDCHW!3 N+ M4O()[UZBJ@[7*;K7,JUUDYN#1B>H HY$0?6?!/P./K&]F,%5]+)R?2K,0_L2T0C_'_?C_];A^OS?.*TC_C\VS?^&%F.*_X]'P__MS$/[ M$M%_P/X1IXO;65GAO4=@OOE#@P'X;0 ^$]2W,3&5C3YT?1I/)@4:$[3W=!)P M@9PYM34ZO%R0<%G')4(;:8VHG _]5$[K<'V5TSBM(Y7SP;3*,;084RKGPVA4 M3COST+Y$'%&WA-:LY1Y?VNB:M_0@T)5& Q.A>XSZZH=EKPGZI\#L<_ M)%QFL)]CG(O:*],%E.;XM>W^JL^GNF5:%4#89M0Z#IQ9@QIPK4JM5A:E81/5 M$9F@"A6^R#HR/FL#]F(R.H3(CON<\$ND]D)MC6-T>Y34YW+E46P!U3DJ ['6 MZ1$*GU3UXCS>239O/E6BS1B2'D1W=W;BKMA2$V@+<<<(W?Y<:\!,1M,E6B%: M]S( I2*7HL@$0],TA0+V_.>QV$-#-JLS!Z/'#O@()-6?2FY[W,>M<22%[P:% MD5KF=QM%:D%$/XAD='4#8DCEH]_Q19!4^&LO@*1,5K /@? MT725SVE*?H7PGF FWO;^Y#OTA_>3]^_?3\J>W#M_/?XP^=WO3H M@;K<2V2_ M.OG=M\6O_C!!MZL\R]D?(+[>\/4W^U]_4WWMA8VE.TU5M\^QVUCUBN,)B$$V MO\KQ(GND]QA62V)\@_--'\1'>L:&W*7TA40X.EU_8F96K3G0-&26%2^1W9&R MY0JLKG-K&3W;![:&/W3024NLH7((.QX\*XC]'OX%BT/+ G7TM*[WLZKP]I-^ MYHQ)J*^=]Z:LA.;<".YNO27[8K@*VYW9K38KM$JPT6&^+2$5HC=KDW9*>F8V M80.H,MKV:%-,)F;UPF!$F$"C8ZX=0KIKPA7,2-J#*/O9O! MNKXI-H7]CW 6;_[IYC@X!7JK 7>F4(H1*CT82I-;>) MFJ&]-WE;]'T5F@!R$-(7'%W2]'*5KU(,J@%B?MW2M]\\PV6Q&CQ7DEG8 FF! M!N_L/N.((=!?K?Q":J4!,/*;+T'V=' (Y5&+G6TGU9-=F ME:6S$:ZS=D2JVV/P)JZ!0;7RB[-I'-/7EJ/=XTOMG)U."*[NHA10T4O@,;G" M(>6T*\ H*"'S4PF1HJC,X//:KO]_# M'7QCPK/DKSU/T,XL]HLV,')F.0F9:/_(KVF*!(-SN@A(XM9M MCGXC[8.-]-5RW6&D&?KP)EKZZS#1/4MM';8?;3=SB;19EH5^(4I"\&/P1A:K MA50,-OY=0Q!NS6.;OPM@B@\Y+(B^9JK13E(XV&^2M.]WT]]U]KL^C_7]%L \ M[G*#EGRI?9/0"<&5KZR MBMZ%@845:ET1-%W[343WZ0FZ@?\K\/'Y?K /R]$!5/:I%]M2F5M&&M%[3A*: M=_3<"&2Y-%FXDSJ>+XI*LX[@[$;:JD_Q*U,71-NS>[LHR2,)9;1=!;43U*885\B:[/S BE%UF3^[Y(.-*H%2@ MN%1ZCR6-&$:(I*K, B![R..&(B>#*^3LV#MI":W!?/WC/O M_Z'J-&\--N4K\TF]N<@VZ(E$/'^!;UC"8O.,W)4XSE MT<=/2YJ(@9F\'N^ F?1OV_M"='C[WAA6R.YGUI^!500,_ M>>,MY*-J-+'/!S?! M_.MO 0;P@;V*%SK 972.=TQQR^WDQVDY/VHI%/-^T> M1WBQ%(FN).SGI75\:\1)D\!P9=(J(3,\J=O8*DVD=6^001R;425T=_&.]="I4E\S747<^G273QRXKPUC6J,>#."4S%A:6 G':&P67;(AXP'D>\ MN'L+VF+(BG15Y5-)5[F;%;QRW-%,NW:DPLB>W-0RHVVV:0'=NX&>+(&5:[75.PCD4]F4>',XFZ&F5HX3F M*"8+DL.]$YV@+(AYZ2GN!$Y*X/";$).7X"EFO\1YZ*$W7\WB'-D#UNTV:0-W(&=M9D0<>;N$)JD@M MUYZ21!E_RO!L%5^3F=Q/4OY2VTOJA.#.1^I$1<]#LK!"+?](X#%!'!/>1:'" M98($-JA[E=;<(W56HP.HZSRM&KJ8X',L_GN5E*9R$:*5'#SE[_13K]OG[\^2 M3-X]T?YM) N?72GH[FPM>@*D$Q%?">>*K$2U:>HS\G=.H"%#$MT'.41#P'0. MGM4"?^V?&HG[-8/P$_9KQF5XU,_4&DT$_4I<$" S0:K+=!+SZV W:_T?" MJ?*!FIRX/Z&+JF9%'3. B3A03PU@Y=2DZB1RRRK3(HQV7T71.HO6J'RBR3YM M4]MFI.E^0-%/US 5\E(=FCGFK"@B$!,+8GCO>9441>1E3-4^6I>?FF>USDH5 M6/XD]X@D1Z& [*D/73MM:4^">;Z(93^4ORO?A]8:94^3Z!0G>$;RK+F3]AG- ME*]L#8(R=;EK "7[*AF>*8J&[6$-=GDE/(Z[8)-[VW9K;'S#!MX1;;MAGQ*0 M4*4SEFW._S6S4BXQ<\W8S_E:&H,P.:7.[=- T$ZNM@?BV/M:RSE-ALLVI F!M+,,(P0I('1;"1A/[Z2 M.$9/F-FSOZP(?[U)F3FRAF(R*T'MJ*(VW-]S0-O/GSQ<1)J2)=3&ACOWS5:+ M%6QQQ)\_@UI(\9QI!O*"13V5QDM^[>_UO38U.-;M[MNS*S3-\Y0\K7+PA(#E M[X)4/4G GD_7 O)O M?_.'D^/??X<$!NA+9@*2D.1?^0F"*A";]J>@6P[C5=D!JZL%M'OG(;2L5?XI M?*')8RTSVV:R"C2JP_8KWE0(336H-Y*,(K6R3GT_-YU;Y+A\4T?FS<@*-O7> M')5L'".%F21>^@-."]/VJGE#JA@)Y/65%BQ\G;IH1_#W (SU)3VS 2U7.Z?F2(-#PDUOC2 MM,+90/"L:P -'Z^1=?9 1:_("#M0I6RW2[PGS_.D&!GJ5B'+X-23*"QL> M'DP!V2,Z.V+HBC=]13GJ*M6'$\:#PM!F2FID5T:B*D!F-!89T/C2M*K80!B% MJO!1FT!G%U24A8RTO@O#5D>*9ME9D*9K)D->@S12+IG9/8.Q$K)22"XJ]-3D M)P./PCK\<=R4*^Q$:^E61?+:+\MR-B=X)IH\$BBTS/LH2!OY*HS6*,W2,JOU MXBP &E6P40'<7]-?%0K3GF1SQ$47;SA0%*W%1^VA=+FJ>U0T75;!'PD4= M%*8]R>;XHI?+R2)GL^/>K'6L[@5NTYSV2T5Q<$6)?S_W8NW$I+TH-- [YUVO MOY%'QO<4<%OI&/YHZ#%G-U)L":9*@ &4B+,K\8OR&TY!DD"(# M99=2&)5Y<'8;^8!VTFNT[L E33%YEOFL^A/9=PX*@+Y]!&#.F4 %9:NGC$0D M *8=N^^PNU]Z+D3C)@P4Q9=L*S:E+JI*+7+9K/2!CK!NG=@VXP'P>IF5"KR^ M/#>\GL&YE3-8XO-FB55M(P^"78V):']*NBX.\8*S') 2J6EE.\!I4J5=2F1] MCR^U"T1T0K!]J*J^CH1CX*EX@CJAZ0#JC>+Y=A$SJ#_1E?!?_PG,/M=N .2J MI((Z1CJ%%6RN5[,A-+_(6\$#)6;FSTI$4*"X3K=OU=LXL/N->B>9W1[3,[I8 M$"Y%,B8XH) [0PTS!*7G4N$+S8/8,K/UZ,<&-+^C"NO /;6&H-M'J 1=MV>R'HYW0*:O]"JA'"TFQINA4KE'PK+Y%K>F:]EI*80 M:9C1E=IN *VCGXVL0$,1;XK$>#2&VQB"]J#1*(S=AGHT_8S=E@FLUR;R;.PV M8&30V#6RWB'&[K) "#VM:^'$<1J\;5RH591IA$=5>-,#CFK+!&:/:@,@ST>U M 2.#1]7(>DWXI:1$9*3'M(T#NX]I)YD=^Z4,17!DV'\@M^XEB,&UN<,IH=%N MX5"9HZHQA:[GV@.4J\/:!R>MUI)6UZQY8$D!&,XK/[SW!Y9V\F7&9$EC+3,$+SV-5FI;V0$&5EQ*>S))ZR)GV@:R(3\LHR#$;_Q_O3[I*Q*A_.ZRH9SL,1]4]P9BNL$ " M#01X'+T_\5XBIL=.[-?_[$->M_P)+U1N9].(\@9_K>S8-E23^YJFM,UL_)41 MDVPE5+\OCEJ)2OM0RK6.K+4,NR?9SVH$;([ M?OP?K#D>M[.JA*F$:UM&ZC[NWY_1E09I *W5X&G0"H9H@A(R. 61VA)LE1]H MX0O:@U1N^?X>Y\Q]PM%%D";L4+:7?6P?K,G]S9-:?T!70$4E6+\QB@[*TG[D M!5^3O]FBGM\SNHF,(1$-5\1$4X$0+( MJD>/D:]2*8JDI]KTM)^=^DCR&-_.KA(N^%=!_"/)Y_9X#@7GDTC7[GW M7[KI*>,=WW[((]SZK]*UO/JLPDC=@/[^C-;YI0#9JSBLK6A^"T%I#RKYL[ZN MLFP5L'7>SO;*LXI?8/9'_AL%DZS_9 ;L-'6@SCQD+>STNB2[H8-63Z&Z)5LB M!W*^J?;S!D.D0 P')JX&*TOL7MU]<1V<;>PUV)ZOH/*-=O"U96[[P=:JI].= M:!F)"OB>TQ*4"-[=0=*_"H('BS3IMEBDXP8\,MV:S\734IJ,P5:1DY(JT\>U MG=+95T%EJ+:-X;X_@E[G VOJL+VVOSJA7!<]@4>!C\';Q5NP( GWZ44K.>@( MGT15J8PP3%?24*/F+-K%4'I!WM:Y;9_5 MHJG=!JC/VW\U*E,MTKGEL1U\6HOYMX[5Y*G&.5WSDM]Z93':YK;-5!PX*BL,U\#[-6_5Z$VUB.B6VZY)@F]G(E57 MPEQ-0S1YJ3Z5*SNT#E/'R!R&LX8%>4V3YR/VW0(!:(AZ"N ^;<1&'J J1/+D MOTU7^9RFT/%6;M:U#Q[JC6U-:K\:9>5U5'!]VG(=I&UR'5KHY9N'6@VXKN'& M^,B-&=?,23Y-N4X"MW*3?X..80#U,<(SR$1.UZV&7.M8W=UQB@EX9*E7I<_23[]=UO?>$#B6TZ\RB(,+3).*>3_$,([O'(28OP5.,Q1M' M::Y1CV^ULX\48#AZS)ZA#>#1//_LMPET$&5=2]-E]2J")V[BZ"Y(F:F GV0^ ML,HGVE)3/K4K'[D-!QV?V=":S+S425!,@Z3H<2LZA7F2^ H\1'6(.(H":_Q8 M=UDBO;XU6U)M&X;UW(VRA!C_H8;'^)[Y]]J2[KIB;71VRZBG00S)X/#/*4F_"0 MC*M\!H@4R-S!6?Z#1)^2%(?T.2&_\GH,ISC!,Y++1%7':$VNDLSJR@B5@->Q M/XVM1./ZI@Z;1[]*Z!-TD410<*'@0"]GI8MS:$\B^JJ0Q\T,2"[J:++;^<'@ M6GB[$SLL@%>"9DJ] .Z[Y)V4RHUU[MI)Y[E(V3G)PIAFJQ1W.C4]/C55MJP! MA/OZ96B#A?^ :J]=:*M;UDG:/HR9E9R9X?#=,WWY.L)$,"7[89<7V:_^+MX. M\X1)7BP>GP=Y4&2.[/"?ZO">/-OP6>LHH"@Y+"%$;FTRA@,0BN;::]"1;%^V5"S.; M0XU3?!QL#KNTP5):!FCH5):8NPFD>[[V515H\*;T8.IN2KLU#FYHCK.[8 W7 M\S5UPCSS&T:T1M]#YU--8T$%A&T^O08S82EP0#GU:BST(CD=0D?'+_/F08KO M4A+*VG+M#]!]@J]&!)N#0PK8VGH(N+_/M)L8CB/1S-&/ M2+P"'[_P\]A!NG@+XU6$(Y&9MUBN\D!8+F7YS#N<&((YG=KO(,^@HQS"5R1W,6 M30G3$YKU!PL"+OJ2)"CCP+_RPN2ZFT -4=;Q8^>RQ3/T83\+TG0]H^DKM+Z2 M\&CW![K/G*43N])B<@QT5)/)]6CHFPH\ OAH"P&?#UD5^(?V)Z*G$B:/X,K) MG*7&04.+E/#);!^("AKZB/V^ MC@R9/I\.Y9X6$.YXBMFU%1:H1,-W!DVO76AB0672.JZ$LV,J%S:(A!<[1NM6 MPVF>U7IH6S05A\?43(L(FQ(%>9Z2)^9)%''$4)1XY,T:YC2.F**=H*AFBD8T MCH,TVTSAQRKMVAG:D]RC<(_V+.'3("-A/^>H?0ZSKE$S+/L9WPS(6-VB#O)W M.T4J-/62XUI&ZL4M$E3-J]4-4L]-'#C;L.S8OE"=/;@.[F?>#ML6OP9$FXAN'6O(>' B_.IX(GC94Q? MNUX;J'PRW(?:F]JI[\3?LW+P(_*9Y-1N]I4Z2.B-T1YJAUD4IE3GN.YOA[.> M'(93'JRC\6^H*#PZ'FY4V(EFME0EKX]Z:!6:'1S9,7I0-;2]61T50ZL%)/TR M61=Q]RJA=5#,L: +YSA:00.T?;.3AU"[G)G^$^B*/&5 UN5>@0F(O29/143( MO1>1T-@9.IS<;ME7!%CQ-0XR7!:TOWA;XB23W<$H?*')H"TSVY>)1>L"+."A MW_[F#R?'Q]\5476,[F\_>>%!%6I3#1+ZX[+R&*S+8D;G*Q56:_O, +\U3>_J MCKP+#YV;>WP((Y)ACXE$?,CS-,IQ/%S3-R:^%K V>N!8KUH&D-UJAEOLI. M2-A3F;R^#.;SHDT65#8&#*&ICK[UK#7;8%.Z%U27=G6)F*A5S%'C-P.CMK/U M]K#1Z!ZP,;[.P\5LAOG[^JK@]SUS=.\QD)"AS4]NST.A/^7@D]$?M,OC46&' M:K7A 4&TC>'XSLB +6T\*$/W:02>1-VHO'@+<9:U/D71FL.DCR&#Y=7AD"%E MS/LPL.HAM7/WG9$)^V^656T+_]V[L:?.C%T>B1JM1W!T:Z[357)/8P;U^6\X M2"_9-FI&!:3S6 H3[,&S?8R;./GD_N+O]R/E[Z[=Z<7G2B0?&[_7#N?C*S4AMFO3N)#:#)PGICX>*5-+]D)79N\1 M>,PLS" ;L3VV)G+"Q@#0$R.?' C;^V'-BOO$]E'"A;$F[9B3:+#4O2/599S MO%M3LI2_'I2BU0G%-J]R>'[[5"J2N:EM91_:.:X1AG/(FKU+Z0N)<'2Z_I3A MZ"HI7ATFSU,(C/+[@HX$0?V)=.N']0;H1I["X_@-[#_ZJ26FOQG4'(4=/RE1 MB.)/\TL1=0.HZL3;O5!(HX"&ZJW; M! 4Y*M!%%;Z['TV@A%/HNGJZC7-!+6[E*(RZLSEC [:DO5OY'X)X)=84Q_05 MK-=^]I[&Q&9-P1X(6.]EP5%!)$$O)6P4E,#'9#WJ;%JW8:F]$VY/R#D!>R*) MR@>K12.%:1)UUJ7M\ZDFEZN L,W'=VF9N\3?@:*HQ D%(I/>3Z/U/L2G0RCJ M./\(I\R&/:N(SM]K;;>1W\WQZ?Y"-WM(/K/UY" .&IVA#?=QZ.@G =]3VH\" MJ:D&_7RPV+0WB[5^,8C%&F=VQ&+3,;)8.ZGW6$R!?CY8[+0WB[5^,8C%&F=V MQ&*G8V2Q=E+OL9@"_5P_:=]]R"SC+.E [ M66KEO_TN[2+IF>!8+4QY"=:J!DCYGZI3:A1Q"V:B1SA:A3EAEGO[NUB-&[8 M'F07;S@-22;:V]Q#C+96F5*,RW8*66Y]@\!F?SZC"<\- M607Q([.53T8ANSJQ.PBQ)5W%*"166F*'P@UZ*"8S)KT@_?*?05IU\YDW0:7( M/!YDU*DA$I3%P(N_P-5C08HV&>0.^A 98Q]+5S($;R![+T?OF@%V#[_K73U@ M V1_:6V&F!./21.E,9@:/5'W(1O^63TB7:ZR95@,8A55@4.2_% MVV+PDOT5'KZ@=+.N98'+.ZO&'O#Q+[$%R M?XIE&#G3R!PLXG"])EQ8W%0S!U%MIT:1V,834J D+F/DN!J#>U9;Z)K%;(*; M#)J3-DUE[[H<(*(OGW""9R3_:H(2S-LWS8K7JIMAJ!@SIG2XS@WK3HE3VX6# MT2S[)[8U%U"WRNQ$2$ 'JC!0 5 :6YT>BTR,#$Y,3(S,5]P M&UL[7UK<]PVEO;WK=K_X-?[F>/(CI-X:K);K5M&M;);)7 [=_SC?YX7R9LG1!DFZ<]O M3_[VW=LW*(U(C-/'G]]^O0LF=V=75V_?L"Q,XS A*?KY;4K>_L]__^=__./_ M!<$O*$4TS%#\YF'UYGZ>IS&BYV2!WOS?Z>WUF^#-R/\A"/[['PE.__B[^+^'D*$WG(B4%?_\^>T\RY9_?_?NV[=O?WM^ MH,G?"'U\]_Z[[SZ\V[1^NVXN_AIGVP[[C3^^*_^X;?IJZ&\?BK8GGSY]>E?\ M==N4X:J&?-"3=__W^?HNFJ-%&.!4(!()6AC^.RM^>4VB,"M@K&7AC;2%^%>P M:1:(7P4G[X,/)W][9O%;COJ;-R5TE"3H%LW>B/]^O;UZ\4V<9C07$_JWB"SX ML">?3MY_.'DGFK[C9&=H@=(L2$F&Q-@1H20-GS#O$I \>Z H_(/S%V1S%.0I MYI,;%)T8Y[7X])RBV<]O^4?^"C9C"^K^JX.AL]62+S"&%\L$O7VWQ^Z2(L9' M+O"]YK]8MQS^%__5OR_2#&S/)4V)6'R$KD'KE*9K M]!@FY921NKE.&5-*^D>27-*VE>23.II'4B<)G5X&(2Y<4/7),)4+&P MN7(S(W11? ^NO $',J2W:5'3H\HVX43$@I#+)'RL4(XJ_]Z[TG:64['R+_E2 M#)-_H9!>I/$YAZZ"P+JFO=-ZOI[)DH(;1#&)+_GOJE3-VK:&J15XP6A]U=(8 MI5>[72&3\J'-;=!<)>1#FAJCM5R%\@VF;&>,RGO^(05Q^W_NG:92O#KCGZ5A MY< @=@-P,A\= D9I1 .AN0'ER ! M2?I@:'YT"1J X0@,S$\N :/0M\& ?'()$(@U#"[%.278PLWO<("9+62.W2W], M0Y&"30GS>5X'9/67YW7'3TS$3FXVV[P0W3^CQ<,K=R&T>6=$O=D9<'S37^,Q?W M+K^ARS^@LCQ9%3\:/6VSI;G_]3K;9@YX"L Z#8,9Y5E0WV$83-2?",!>%O-U M]^_S"AD3W-[G2>L1/9UM,X1O",.%@JU.5]?IZDP">#_$WE,4LIRN]G:EA&)% M2W?"^!JM,.O)ZS[$T?S"D)[^!*XA.@=*?<*V^M(<>UR?UBK1,Q:-/;ZO*30 MD]78@_R:0@,PG#FWH7J,*1_+QCGZJABPPCE-#!O.;1<-A-16$N=VD38R5687 MYVX>;53:QZX--!RG#30 ^_#8H\WUX-%V,HT]\KPQ/!V=P@.-T&D)2ZLC>*"! M.BTA:7_^#C3L7 ^76N.DV0BF\KF<($8LHG@I/A&06?"PS@\(-J1!WP6J'_+1_ORT=X_.51#^5B,GT=O*-X2@4 M=97+4M=<[0V6),$11MIJ5:.Q36I:+0CTRIOBSQPOQ:1-TO@RIRD6FTC\ MC)_%3TR>_J#7\QCT1$:S/4F9_^MPLOFO_OTY?,:+?%&)J_3OADC#J9JTJK^; M(>TV3!]1Q>:H_)M!DJ185?QUY J\(VQ8?7L8A0S-21)?+9:4/)7'4.42TNAA MGHTI?0Q3_%[4W4T-;WVW$PLF6ZG@9BT4U#W0 M9HL,&SD+A NUV>HF"8OK=GOUGJY$*0E%N+]&SP&Q)4A3)B]J]/2&.V^X\X8[ M;[CSAKL^F*^6OTF-##QVKIO4*7O6V36UYQ16SK^92:FR!<04O^5)2 MF 3&SKSRM%589\8>_JSF6VXP&SO?+>\9L/' %9Q,N _'$@OOW8=Z[D.[UB0+ MSLGO ]YD@;."@>*EUX@4I*)4$*KIC@2.9M(!J462=SD>D'4<\9X2$F]Q- ]I MS$0&3'GUROV@=6T[(.=^CN["]#,_) BK)ZB^M2$'&>(+J-B3Y5/>^2)/1.+, M.>*;G4^AV.KGNV#LZ6Q#K,S/U\5XPV%=O NTH['R>.AB*/.FY-VE=R=R.\3> M^+H4%4)Y^Q^^>Z_T=VGUM!4])RG^,UF>2W"73: P[ M9?/6=R=?>&?[-V>%9"7AM=D@(_Y=Z'U3:RP&TQGDY@4=Z7R3%8U M];X_[_L[A,/[_O:M3H[[_CJ1R4F7HN[886TG)Q*=<]L5J&J<0=WIC4XXD+K: MLAK6C[$[&+K'#6JD&?N*@_LE6NC%KH#4^LAO8#X9^];TOC_O^WN%A*;OKXV9 MRH+G[F. %LN$K! *'E"*9C@+EDF8ZF80U@UCTE<'H\4[Z0[(.@XGG4^V,^R] M\LEVMHWOCK!ATX=P@U)6AN],LSFB-X23A#),B_/HM+QD-%Q9;8?S3A2?A^1] M$=X7X7T1/@_)L/W;)T.X9/#J/1EBH/-MTM WT*GWAKZ6AKYNA'@+)K\?@@=" M*?F&TT<6" @",IOA:+?'@3:_VG%,&OV Q'BKG[?Z:1F+SN88S2Z>491G^ E- MRS4E-1X!6EN(ON7'+N@OJ%MHM6OSRN:CMSFY0@;5DUW%"_0+3]$ ME'&IDE;FR;U%12#(32C+XZAO:)?H>QJFC,^Y*)IZNMK_B^+DT1]@.$S"S;X- M1K#!YA-)GK@8]?)85>X>4!]OM'8O\O_7D&)!@3@Y%=M;ULPNP!M6 M4QL67 "V8+3Z*6 9IR,HR\WIOA\@Z6W2:*4DP1NM#!JMTDTQF%,2TKB\#>3U M[B'M';.ER=\)X ?0QSNQC/E9P;^"GY!X-$CY6 "D2U?$G>@35]_%UY+QM60& M74L&1-8]SA(TG5VE,7["<1XF$M24[2R1^AO.YH6#35R<<[R\)XI+K<4(-@WU MT]D962Q1R@H:U^[$,\(R=C?G@MYIR(1W<56<[766S(Y&';G?PA$VK&9*\H>IGW2L;>9.^-^E[D[XWZ7N3OJ^J+P<">Q&&CL&]"S3Z;!6?K3(6\5'3T]^I@=A",,"G8#L9I5==,QQ MVM]D0$ -$3XDX("LX\ACD9!XARA&[/W-9L444O\DC[G+N\4PQUI< M$4[V=B6 R%:W-D/V.:8HXA^04EK=P(<=^+"#!BZDTS#A*Q[=S1'*KL5WA8@E M]RS6-1\& TJ/8WT'"V54DY"QZ:PXX=5%5*4-1^Y1=X0-FX$!17WSLYS20K4* M'T3E&2Y */,S07UL5(/=EWEJWVE2M_;587UUV*WMH9"I)P#17*.'+39.M=E0 M]K#%QIDV&\H>%L-P]F]GQ4:I;>_#GWSXDP]_\N%//OS)AS_UMA>DEP^!JYNN M@%)KUB#Z]@-7L/%%E#MV>ZJEOK&'/C0Z9\!*EG/H^**YOFBN/:A4KB17T&EP M$ ',)*Y$++7<9A"'J7,+R4]UB]L=W# AOK M$_45<4)JC+ZA::@*U]5&1/BK21T7ZJ$@? M%=F7HT^A$A(M16SL8.C(TZ2!>.

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end XML 62 R43.htm IDEA: XBRL DOCUMENT v3.20.1
Note 10 - Concentrations (Details Textual) - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue Benchmark [Member] | U.S. Government [Member]    
Concentration Risk, Percentage 87.40% 83.90%
Revenue Benchmark [Member] | Three Government Customers [Member]    
Concentration Risk, Percentage 68.10%  
Number of Major Customers 3  
Revenue Benchmark [Member] | Four Government Customers [Member]    
Concentration Risk, Percentage   61.40%
Number of Major Customers   4
Revenue Benchmark [Member] | One Commercial Customer [Member]    
Concentration Risk, Percentage 10.40% 14.10%
Number of Major Customers 1 1
Accounts Receivable [Member] | Three Government Customers [Member]    
Concentration Risk, Percentage 78.80%  
Number of Major Customers 3  
Accounts Receivable [Member] | Four Government Customers [Member]    
Concentration Risk, Percentage   48.90%
Number of Major Customers   4
Accounts Receivable [Member] | One Commercial Customer [Member]    
Number of Major Customers 1 1